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  Articular cartilage has a limited ability to repair itself after damage due to injury 
or disease.  Regenerative therapies using chondrocytes, the primary cartilage cell 
population, result in poor quality repair tissue and often cause further damage at the 
donor site.  Furthermore, there are no current therapies which aim to regenerate the zonal 
organization and function of the tissue.  In an effort to address both cell source limitations 
and zonal tissue regeneration the goal of the presented work was to utilize a 
mesenchymal stem cell (MSC) population to generate abundant numbers of chondrocytes 
with zonal phenotypes.  To this end, zonal subpopulations of articular chondrocytes were 
isolated, characterized for differences in gene and protein expression, and exposed to 
scaffold environments designed to aid in phenotype retention.  From these results, and 
reports in the literature, it was clear a major functional difference between zones was the 
production of a lubricating protein, proteoglycan 4 (PRG4), in the superficial zone only. 
Middle and deep zone cells were found to be phenotypically similar and distinct from 
superficial zone cells.   It was further found that gene expression of PRG4 by superficial 
zone cells in alginate culture can be significantly enhanced by incorporation of matrix 
molecules hyaluronic acid (HA) and chondroitin sulfate (CS) to the scaffold environment.  
HA and CS also had favorable effects on MSC chondrogenesis by upregulating  
chondrogenic transcription factor Sox9 gene expression, and downregulating type I 
collagen (fibroblastic marker) gene expression.  The potential of soluble signals derived 
from zonal (superficial or middle/deep) cartilage explants to drive MSC chondrogenesis 
was also investigated.  Results show that signals derived from cartilage explants can  
induce chondrogenesis to varying degrees, with superficial zone explants inducing robust 
and sustained differentiation.  This differentiation was found to be dependent on the 
proximity of the MSCs and tissue explants, implying that communication between MSCs 
and chondrocytes is necessary for chondrogenic induction.  Coculture with superficial 
zone explants also upregulated MSC gene expression of PRG4.  This research highlights 
the important functional differences between zonal chondrocyte populations and 
identifies MSCs as a progenitor population capable of differentiating into zone-specific 
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1  Introduction  
 
 Articular cartilage lines the surface of articulating joints to provide frictionless 
movement and resist loading.  Cartilage tissue varies with depth and can be divided into 
three major zones: the superficial, middle, and deep zones.  Each zone has differing 
structure and composition, and is designed to resist the load and stress particular to its 
location.  Therefore, proper function of the entire tissue depends on its zonal 
construction.  Chondrocyte phenotype varies considerably by zone, and it is the activity 
of these cells that help achieve structural organization.  Despite zonal tissue structure and 
cellular phenotype, there is a distinct lack of articular cartilage regeneration treatments 
which aim to restore stratified tissue.  Previous work in the field has investigated the 
response of primary zonal chondrocytes to a variety of culture systems, with the goal of 
retaining subpopulation phenotype.  While these approaches have had success, they have 
largely ignored the role of cell source and its impact upon zonal chondrocyte phenotype.  
Cell source remains a major limitation in regenerative cartilage therapies, as culturing 
clinically relevant numbers of phenotypically stable chondrocytes is difficult without 
harvesting a damaging amount of donor tissue.  Repair tissue generated from therapies 
utilizing primary chondrocytes is suboptimal fibrocartilage which lacks the robust 
mechanical properties of native tissue. 
 To address both the issue of cell source and regenerating zonally organized tissue 
this research is focused on indentifying differences in zonal cell populations and 
evaluating the potential of mesenchymal stem cells (MSCs) to differentiate into 
chondrocytes with zone-specific markers.  Chondrocytes maintain their spherical 
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morphology in three dimensional pellet or hydrogel culture.  Therefore, such culture is 
essential for retaining chondrocyte phenotype as well as differentiating progenitor cells 
down a chondrogenic lineage.  Building on previous research in the laboratory, an 
alginate hydrogel was chosen for zonal chondrocyte and MSC culture.  Additional 
molecules, such as extracellular matrix components, can be added to alginate prior to 
gelation, and it can also be modified for injectable delivery.  Furthermore, the high water 
content and diffusive properties of alginate hydrogels provides a good system for 
studying the effects of soluble growth factors.  In the presented work we utilize alginate 
hydrogel environments and soluble signaling molecules to study zonal chondrocyte 
phenotype retention and MSC chondrogenesis during in vitro culture.  The objectives of 
the presented research are to: 
  
 1)  Classify the zonal distribution in gene expression of major extracellular matrix 
components, insulin-like growth-factor (IGF)-1 and its extracellular binding 
protein, IGF-BP3, both with and without exogenous IGF-1 delivery.   
2)   Identify the potential of hyaluronic acid (HA) and chondroitin sulfate (CS) to 
influence zonal phenotype retention of chondrocyte subpopulations as well as 
zonal-differentiation of MSCs.   
3)  Establish the potential of zonal cartilage-derived soluble factors to drive zonal 
differentiation of MSCs. 
4)  Evaluate the viability of MSCs in photocrosslinked alginate, and MSC 
chondrogenesis by transforming growth factor (TGF)-β3 in photocrosslinked 




 The presented objectives will further the understanding of the differences between 
cartilage zones and zonal populations of chondrocytes, and explore methods for retaining 
these differences in culture.  Additionally, this work will identify the feasibility using 
MSCs as a clinically relevant and abundant cell source to aid in the production of zonally 




2 Cartilage Engineering: Current Status and Future Trends*  
 
2.1 Cartilage Tissue: Structure, Function, and Disease 
2.1.1. Cellular and Extracellular Matrix Components 
 Articular cartilage, typically 2-5mm thick, is found on the surface of articulating 
joints throughout the body.  Articular cartilage, along with the synovial fluid found inside 
the joint, provides frictionless movement between bones and absorbs loads during 
motion.  The tissue is maintained by chondrocytes, which is the resident cell population.  
Chondrocytes are responsible for providing a balance between matrix synthesis and 
matrix breakdown, a process which is disrupted during disease or injury.  The tissue is 
sparsely populated with cells; comprising less than 5% of the tissue volume. [1]  
Cartilage also lacks a lymphatic system, nerve fibers, or blood supply.  As a result, all 
nutrient and waste exchange must occur through diffusion from the synovial fluid.  Low 
cell density and the limited exchange of both waste and nutrients both play key roles in 
the limited ability of cartilage tissue to repair itself once injured. 
 
2.1.2 Composition 
 Approximately 95% cartilage tissue is comprised of its extracellular matrix 
(ECM) – which the cells sustain.  The ECM is a dense collagen and proteoglycan  
 
 
* This chapter was published as: EE Coates and JP Fisher. (2010) “Cartilage Engineering: Current Status 
and Future Trends.” Biomaterials for Tissue Engineering Applications: A Review of the Past and Future 





interconnected structure.  Chondrocytes are linked to the ECM through cell-surface 
binding proteins.  These connections allow cells to respond to the mechanical forced felt 
within the ECM. [2, 3] 
Approximately 10-20% of the wet weight of the tissue is collagen.  The collagen 
network is comprised mainly of type II collagen fibers; up to 90% of the total collagen 
content is type II collagen which is crosslinked by covalent bonds throughout the tissue.  
The type II collagen fiber is a triple helix of identical polypeptide 1(II) chains, 
approximately 300nm in length.  Minor collagen types make up the rest of the tissue’s 
collagen content and include collagen type IX, XI, and X. Each type of collagen has a 
different function within the ECM.  Type IX collagen is a short fibrillar collagen that 
helps connect the type II collagen network to proteoglycans.  Type XI collagen is also a 
fiber formed with three distinct -chains.  Type XI forms co-polymers with type II 
collagen and acts to regulate fibril diameter, form bridges between fibrils, and even 
crosslinks to itself to increase the mechanical stability of the ECM.  Type X collagen is a 
short helix molecule produced only by hypertrophic cells in the calcified tissue which 
divides articular cartilage from the underlying subchondral bone. [1, 3-5] 
 In addition to collagen, the cartilage ECM is comprised of minor and major 
proteoglycans.  Minor proteoglycans within the ECM include decorin, biglycan, and 
fibromodulin.  These small proteoglycans bind to other molecules and help the stabilized 
the overall matrix structure.   Aggrecan is the major proteoglycan in the ECM.  Aggrecan 
contains many branched glycosaminoglycans (GAGs) – primarily keratin sulfate (KS) 
and chondroitin sulfate (CS).  The densely packed GAGs branch off of a central aggrecan 
backbone and give the molecule a molecular weight of 250,000 d.  Each molecule 
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contains about 100 CS chains and 60 KS chains, and repeating sulfate groups in both give 
each aggrecan molecule a large negative charge. [1, 2, 4] 
 The aggrecan molecule is bound to a long unbranched hyaluronic acid (HA) chain 
via a link protein.  Hyaluronic acid is polysaccharide chain with an average molecule 
weight of several million Daltons, with the addition of many aggrecan molecules linked 
to this backbone the aggregate molecular weight can reach up to several hundred million 
Daltons.  The networks of HA chains linked to aggrecan molecules are entrapped within 
the collagen network to give cartilage an intricately organized ECM structure. [1, 2, 5]   
 The complex ECM is maintained by the chondrocyte cell population.  
Chondrocytes have limited cell-to-cell communication, and as a result each cell acts as 
somewhat of an individual - maintaining only the tissue immediately surrounding it.  
Cells receive information through both mechanical forces and interactions with growth 
factors and cytokines.  The ECM directly surrounding a cell is called the pericellular or 
lacunar matrix.  This area contains an abundance of proteoglycans and few collagen 
fibers.  Directly outside this region is the territorial or capsular matrix – which 
encapsulates the cell or a group of cells.  The chondrocyte exists in a low oxygen 
environment, and as a result its metabolism is driven by anaerobic pathways, mainly 
glycolysis.  Although chondrocytes produce ECM components, they usually do not 
divide past adolescence.  Low cell density and division both contribute to the tissue’s 







 In addition to cellular components and a complex extracellular matrix articular 
cartilage also contains three distinct zones.  Each zone has a distinct cellular phenotype 
and ECM organization.  The superficial, or tangential zone, contains the articulating 
surface of the joint and extents to about 10% of the total tissue depth.  The middle, or 
transitional zone, comprises approximately the middle 70% of the tissue depth and is 
followed by the deep, or basal, zone which is the bottom 20% of articular cartilage.  
Below the deep zone lies the tidemark – below which the tissue becomes calcified and 
eventually turns into subchondral bone.  The calcified zone contains few blood vessels 
and effectively blocks the diffusion of nutrients and waste between the subchondral bone 
and the deep zone of the articular cartilage. [4, 9, 10]  
 The superficial zone is marked by cells and collagen fibers that are oriented 
parallel to the articulating surface.  These cells are smaller than those of the other zones, 
thin, and disc shaped.  The cell density is the highest in this zone, however the 
proteoglycan content is the lowest.  The water content of the superficial zone is the 
lowest, with approximately 65% of the total water weight of cartilage found in the lower 
two zones. [2, 11, 12]  The densely packed collagen fibers are small in diameter and 
packed in bundles parallel to the articulating surface.  The tight organization of the 
superficial layer is thought to act as a boundary to block any large, unwanted molecules 
from the synovial fluid. [13] The superficial zone cells are the only cells to secret 
proteoglycan 4 (superficial zone protein); a lubricating protein secreted into the synovial 
fluid. [14]      
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 The middle zone contains larger and more rounded chondrocytes.  The cells, 
along with the collagen fibers are randomly oriented and can often be found in clusters.  
Middle zone chondrocytes produce higher levels of proteoglycans than superficial cells, 
and the cellular density here is lower than in the superficial zone. [11, 15]  
 Deep zone cells are oval in shape, and the cells along with collagen fibers are 
oriented in vertical columns perpendicular to the articulating surface.  The deep zone 
cells produces elevated levels of collagen and proteoglycans compared to the superficial 
cells.  This zone also has a lower cell density, approximately one third of that of the 
superficial zone.  Figure 2.1 shows histological staining for primary bovine chondrocytes 





2.1.4 Proper Tissue Function and Response to Stress 
 Cartilage can withstand large numbers of repetitive strains over many years.  For 
the tissue to function properly many critical biological relationships must remain in 
balance.  Some key processes include the metabolic activity of the chondrocytes (the 
balance between matrix synthesis and breakdown), proper cell secretion and 
concentration of hormones, production of growth factors and cytokines, and proper 
distribution of mechanical loading by the ECM. 
 
Figure 2.1. Hematoxylin 
and Eosin (H&E) staining 
of cells isolation from A) 
superifical, B) middle, and 
C) deep zones of bovine 
articular cartilage. Cell 
nuclei are stained dark 
violet, cell cytoplasm are 
stained light pink, and 
extracellular matrix is 
stained slightly darker pink.  
Scale bars all 100 m.     
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The integrity of the proteoglycan and collagen networks is critical for proper 
function of cartilage tissue.  The collagen network provides tensile strength, and the 
proteoglycans are critical for resisting compressive loading.  The net negative charges on 
each proteoglycan, from the presence of the GAG groups, give the tissue a high 
osmolality.  Negative charges attract cations, which further raises the osmolality, which 
in turn increase water uptake.  The result is a high osmotic tissue pressure (350-450 
mOsm), however the strong type II collagen matrix prevents the tissue from swelling.  
High osmostic pressure results in cartilage tissue being approximately 70% water. [2, 16, 
17] 
During joint loading this high tissue pressure resists load and deformation, 
however a small amount of water is pushed outside the tissue into the joint.  Here, this 
liquid helps to further resist friction and assists in the smooth motion of the joint.  In 
addition, this liquid absorbs nutrients in the synovial cavity, and when the load is released 
the liquid flows back into the tissue and delivers these nutrients.  As a result, dynamic 
loading stimulates matrix production and is dependent on the amplitude and frequency of 
the load.  Conversely, static loading decreases the synthesis of certain matrix proteins.  
Therefore, just as proper tissue structure is necessary for loading mechanics, healthy 
loading is also necessary for proper tissue homeostasis. [2, 16, 17] 
 
2.1.5 Aged and Damaged Tissue 
 The natural aging process leaves cartilage less robust and with lower tensile 
strength as early as the third decade of life.  With age the metabolic activity of the 
chondrocytes is altered; their ability to respond to growth factors and cytokines 
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decreases.  Compromised mechanical properties and decreased activity of the 
chondrocytes leaves aged tissue more susceptible to damage. [13, 18]   
 Cartilage tissue can become damaged due to diseases such as arthritis or trauma 
which results tissue injury.  The limited cell population and reliance on diffusion for 
nutrients and waste exchange make it difficult for chondrocytes to restore a damaged 
ECM.   In unhealthy tissue the balance between matrix production and breakdown is 
disrupted and a cycle of tissue degradation ensues.  Even minor tissue injuries usually do 
not fully repair, and leave the cartilage more susceptible to the onset of disease. [2, 19]  
 
2.1.6 Disease 
 Arthritis is marked by degradation of cartilage and subchondral bone tissue which 
results in joint pain and loss of motion.  Arthritis can be divided into two major classes: 
inflammatory rheumatoid arthritis (RA) and non-inflammatory osteoarthritis (OA).  In 
both cases the complex structure and biochemistry of the tissue becomes disrupted.  OA 
is much more common, and affects a large percentage of the elderly population.  In fact, 
about 2 out of 3 people over the age of 65 show radiographic signs of OA. [20]  In both 
diseases enzymes such as matrix metalloproteinases (MMPs) cleave the bonds that hold 
the matrix together.  Inflammatory rheumatoid arthritis is an autoimmune disease, while 
osteoarthritis is a marked by degeneration of cartilage tissue.  Due to its prevalence in 
society OA disease and repair strategies will be discussed. [6] 
 There is no uniform appearance or single pathogenic mechanism that marks OA.  
It can present itself in a variety of appearances and is caused by a number of different 
factors.  Causes can include genetic defects, extended joint overloading or overuse, or 
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joint misalignment.  OA can also onset as a result of trauma which results in direct injury 
to the joint or surrounding ligaments.  OA can potentially affect any articulating joint, 
and is classified by pain, motion or gait problems, loss of ECM molecules into synovial 
fluid, loss of joint cartilage, and tissue remodeling in the subchondral bone.  Factors such 
as alcohol abuse, obesity, and diabetes increase the risk for onset of OA. [1, 3, 18] 
 Loss of integrity of the type II collagen network is an early ECM change during 
OA.  An increase in osmotic pressure results in swelling which causes proteoglycans to 
escape.  A reduction in the proteoglycan concentration lowers the tissue’s osmotic 
pressure, which compromises its ability to resist loading.  Once the process of matrix 
degradation has begun it accelerates due to the tissues inherent limited ability to self-
repair. [2, 21]   
 Disruption in production of ECM components, signaling molecules, and cytokines 
is also observed during disease. [21] In an attempt to combat matrix breakdown elevated 
levels of minor proteoglycans are usually observed in the early stages of osteoarthritis.  
Type X collagen, usually only found in the calcified zone, can be found throughout the 
various zones of articular cartilage with the progression of disease.  Elevated levels of 
enzymes such as MMPs cleave critical bonds in the collagen and proteoglycan matrices.  
Chondrocytes begin producing a meta-stable form of type II collagen (type IIa collagen), 
which is degraded before it can be functionally incorporated into the matrix. [2, 13, 18] 
 Eventually the tissue becomes fragmented, with damaged areas alongside 
remaining healthy tissue.  Failed repair events are noticeable throughout the tissue in the 
form of local accumulation of ECM precursor molecules (such as procollagen peptides), 
clumps of chondrocytes entrapped by bundles of minor collagens, and chondrocyte 
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dedifferentiation.  Damaged cartilage is heterogeneous, and can manifest itself in a 
variety of structural disruptions.  Loss of tissue height from the superficial and middle 
zones is a common manifestation of OA. [1, 3, 13, 18]  
 In the late states of the disease functional cartilage is gone, and areas of exposed 
bone-plate can be observed.  Cracks in the subchondral plate and formation of 
subchondral bone cysts also occur.  Gradually, bone marrow will make its way to the 
region and a layer of mechanically sub-optimal fibrocartilage will replace the once health 
cartilage tissue. [1, 3, 13] 
 
2.1.7 Trauma 
 Trauma can occur due to a single excessive load, or repetitive joint overloading.  
Tissue damage can occur in the form of a microfracture, where the damage to the 
articular surface is not visible, or it can occur in the form of a visible tissue disruption of 
variable length.  If the damage penetrates through the tidemark and into the subchondral 
bone it is called an osteochondral fracture. [2]  Unfortunately, defects rarely repair 
themselves and only continue to grow worse with age.  Most significant injuries to 
articular cartilage will result in the eventual onset of OA.  The healing potential and 
severity of disease are dependent on the size and location of injury, as well as patient 
health and age. [19] 
 
2.1.8 Need for Repair and Regeneration Strategies 
 Many obstacles make treating arthritis and cartilage injuries challenging.  For one, 
it is difficult to repair a tissue lacking intrinsic repair mechanisms.  Turnover in matrix 
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proteins is relatively low even in healthy tissue, in fact the half life of collagen and 
proteoglycans are approximately 100 and 3-24 years respectively. [22]  Additionally, 
there is no single reason or way tissue degradation occurs – making treatment options 
hard to identify.  Pain medication given to arthritic patients may relieve pain, but it does 
nothing to stop the tissue erosion cycle.  Some pain medications – such as non-steroidal 
anti-inflammatory drugs (NSAIDS) - are even thought to hurt matrix production.  
Furthermore, therapies that target cell populations will be ineffective if the cells have 
already become phenotypically unstable and entered hypertrophy or fibroblastic lineages. 
[3] Currently, engineered cartilage therapies are not standard practice in treating cartilage 
defects.  Standard of care still involves non-surgical interventions, or traditional surgical 
techniques.  While these treatment methods have had some successes, they have several 
key disadvantages in restoring healthy tissue. 
 
2.2 Current Standards of Care and Limitations 
2.2.1 Current Treatments in Cartilage Repair 
 To date there are many approaches for treatment of cartilage defects and OA, 
however an ideal method is yet to be developed.  The field has received much research 
attention, and many new products are in various stages of clinical trials.  Despite this, 
there is a fairly limited range of treatments that are available on large scale.  The 
estimated cost of OA and cartilage defects in the United States is between 10 [20] and 65 
[23] billion dollars annually between loss of working days and medical treatments.  
Furthermore, more than one in eight Americans over the age of 25 are thought to be 
affected with some form of the disease. [24]      
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 The main symptoms of OA are joint pain and loss of function.  However, the 
disconnect often observed between radiographic evidence of cartilage damage and 
experienced pain presents a major challenge in patient care.  In fact, more than half of 
patients with severe radiographic evidence of OA report no pain. [20]  The heterogeneity 
of the disease both in its physical manifestations and in symptoms reported by patients 
make it hard to classify, treat, and prevent.   
 The American College of Rheumatology (ACR), European League Against 
Rheumatism (EULAR), and the Osteoarthritis Research Society International (OARSI) 
all recommend the following progression of treatments: non-pharmacological, 
pharmacological, and finally surgery.  Patients should only move to the next treatment if 
the methods they are using are ineffective and pain persists. [20, 25]  
 
2.2.2 Non-Surgical Treatments  
 Non-pharmacological treatments include: weight reduction if necessary, education 
and self management, physical therapy, aerobics, muscle strengthening, and acupuncture.  
Generally, light exercise helps to reduce pain.  If none of these methods are successful 
pharmacological treatments should be used.   
 Drug administration can be divided into two groups: pain-reducing agents, and 
therapeutic agents.  Pain reducing agents are used simply to manage patient pain in order 
to improve functionality.  Therapeutic agents also help to relieve pain and additionally 
aim to stop matrix degradation and slow down disease progression. 
 The first line of pain-reducing agents are acetaminophen, NSAIDS, and 
cyclooxygenase-2 (Cox-2) inhibitors.  Acetaminophen is safe for long-term use in small 
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doses however, it is relatively weak and can have adverse effects on the liver.  While 
NSAIDS and Cox-2 inhibitors are anti-inflammatory drugs, they are used in OA 
management for their pain-relieving properties.  If inflammation due to arthritis is present 
their use will be more effective.  Neither should be used long-term or in high doses, as 
they can have adverse cardiovascular effects.  Patients at risk for gastrointestinal 
complications should avoid NSAIDS and use a Cox-2 inhibitor, but both should be used 
in as low doses as possible. [20, 25] 
 More severe pain or flare-ups can be treated with corticosteroid injections or even 
opioids.  Injections should be limited to every 3-4 months as they can have adverse 
metabolic effects and provide only short-term relief. [26]  Opioids, which are effective 
pain relievers should be used in low doses and only for severe cases. [20, 25] 
 Therapeutic drugs which aim to retard matrix erosion include glucosamines, 
chondroitin sulfate, S-adenosylmethionine (SAM), and hyaluronic acid.  Glucosamines 
are thought to have structural remodeling potential, but clinically have varying results.  
They are available in either chloride or sulfate formulations, and after absorption are 
converted to salts.  It is recommended that patients try glucosamines for a few months 
and discontinue if no benefits are observed.  They have almost no side effects.  
Chondroitin sulfate, SAM, and hyaluronic acid also have varying clinical reports success.  
SAM may increase GAG production in chondrocytes, and has been reported to decrease 
pain – but this may be due to the drug’s anti-depressant effects.  Hyaluronic acid 
injections are reported to decrease pain and improve functionality but are not effective in 
severe cases of matrix degradation or limb misalignment.  Rarely are adverse effects 
observed, but pain and infection at the injection site has been reported. [20, 25, 27] 
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 Several new compounds are in various stages of research investigation including 
inhibitors of MMPs, a new class of drugs called disease-modifying osteoarthritis drugs 
(DMOAD), and the use of growth factors. [25]  However, there is currently no ideal drug, 
or cocktail of drugs for relieving pain, improving functionality, and stopping or reversing 
matrix destruction.  The diverse nature of OA makes a single optimal treatment path 
difficult to identify. 
 
2.2.3 Surgical Treatments 
 When non-pharmacological and pharmacological treatment methods prove 
ineffective the next step is surgical intervention.  Surgical procedures can be broadly 
grouped into two classes: non-regenerative treatments and tissue 
replacement/regenerative treatments.  Non-regenerative treatments aim to physically alter 
or remove the problem joint while regenerative treatments attempt to replace or 
regenerate the damaged tissue.     
 
2.2.3.1 Non-Regenerative 
 Non-regenerative procedures include osteotomy, arthrodesis, and anthroplasty.  
Osteotomy is usually performed for joint misalignment and involves the removal of bone 
to redistribute loads to areas of healthy cartilage.  Risk factors include hemorrhage, 
inflammation, and nerve damage.  Anthroplasty refers to total joint replacement and is 
reserved for the most severe cases when all other treatments have failed.  Although this is 
a fairly common surgery in the United States there is still a relatively large complication 
rate of 5.5%, most of which is associated with post-operative infection.  Arthrodesis is 
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the induction of bone formation between two bones to immobilize a joint.  This is usually 
performed on the small joints present in the hands and feet. [25, 28] 
 
2.2.3.2 Tissue Replacement/Regenerative  
 Traditionally surgery has been used as a last resort option.  However, one of the 
biggest risk factors for developing OA is the presence of cartilage defects.  If these 
defects can been treated early and successfully with regenerative therapies, onset of 
disease may be slowed.  Regenerative and replacement techniques can be subdivided into 
three groups: bone marrow stimulation techniques, osteochondral transfer or grafts, and 
cell-based therapies. [25, 29]  
The most common bone marrow stimulation procedure is microfracture.  During 
this operation micro-penetration of the subchondral bone plate fills the cartilage defect 
with blood cells that contain a population of mesenchymal stem cells (MSCs).  MSCs can 
differentiate into chondrocytes, among other cell types.  The result of MSCs populating 
the cartilage defect is the formation of fibro-cartilage tissue containing varying amounts 
of type II collagen.  The procedure has several advantages and drawbacks.  Advantages 
include limited invasiveness, low tissue morbidity, short recovery time, and cost-
effectiveness.  The greatest level of success is observed in young, athletic patients with 
early intervention.  Drawbacks include formation of tissue lacking structure and function 
of healthy cartilage.  The fibro-cartilage layer provides limited load-bearing capacity, is 
often much thinner than native tissue, does not fully integrate with surrounding tissue, 
and often includes overgrowth of the subchondral bone.  A technique called enhanced 
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microfracture attempts to address these drawbacks by including growth factors which 
induce chondrogenesis of the MSC populations. [19, 25, 29, 30] 
 Osteochondral transfer includes both autografts and allografts.  Autografts involve 
harvesting cartilage tissue from areas of low loading and transplanting to defects in 
weight bearing sites.  There are several drawbacks of this procedures including difficulty 
in restoring proper joint architecture, pressure build up due to incongruity of restored 
surfaces, donor site morbidity, lack of integration of grafted tissue, and altered joint 
mechanics and load bearing capability.  Allografts have the advantage of no donor site 
morbidity, however all the same disadvantages exists, plus potential immune response 
and transmission of disease. [31] 
 The most modern form of the osteochondral graft is a procedure called 
mosaicplasty.  This uses several small grafts to fill a single defect.  Moscaicplasty 
treatment is most successful in patients under 50 with no joint misalignment. [19, 25]  
 The first cell based therapy introduced was autologous chondrocyte implantation 
(ACI) in 1994.  It has been used ever since with considerable success reported.  The 
procedure has two steps.  First, chondrocytes are harvested from the patient, isolated, and 
expanded in in vitro culture.  Next, the expanded cell population is injected into a 
chondral defect.  Despite positive surgical outcomes the procedure has many 
disadvantages.  Donor site morbidity, the need for a second surgery, dislocation of cells 
implanted to defect, extended recovery, loss of chondrocyte phenotype in monolayer, and 
the formation and fibrous repair tissue are all limitations of the procedure. [19, 22, 25, 29, 
30]   
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 A more advanced form of ACI, characterized chondrocyte implantation, uses the 
same procedure but during in vitro culture identifies cells with genetic markers that 
indicate high levels of matrix production.  This technique has limited approval in Europe 
and has not yet been approved in the United States. [29] 
 
2.2.4 Limitations of Current Standard Practices and Need for Engineering Approaches 
 Despite the disadvantages of each, microfracture and mosaicplasty are currently 
the most popular choice of surgical interventions for repair of cartilage defects. [29]  The 
ACI procedure is also popular, despite its challenges and potential complications. [32]  
The current standard of care treatments for cartilage defects and osteoarthritis leave much 
to be desired.  There is no current treatment capable of thoroughly repairing cartilage 
defects and regenerating tissue that demonstrates chemical and physical properties similar 
to native cartilage.  Tissue that is regenerated using current surgical methods is, at best, 
fibro-cartilage repair tissue that provides limited load-bearing capabilities and as a result 
will degrade over time. [22, 25, 29, 30]  
 The primary challenge of tissue engineering solutions is to regenerate cartilage 
tissue with composition, structure, and function comparable to that of native tissue.  
Tissue engineering can be defined as the interactions between biomaterials, growth 
factors, and cells to regenerate functional tissue.  A major challenge for engineering 
articular cartilage is obtaining a sufficiently large chondrocyte population that is 
phenotypically stable and has not begun to de-differentiate down a fibroblastic lineage. 
[32]  Many research efforts have investigated the ideal biomaterial to maintain a healthy 
and productive chondrocyte population.  Due to these efforts the field has grown 
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considerably over the last decade.  While current treatments do not usually involve tissue 
engineering approaches there are many products both abroad and in the United State in 
various stages of clinical trials.  These new technologies may soon change the standard of 
cartilage repair procedures. [22, 29, 31] 
 
2.3 Cartilage Engineering 
2.3.1 Requirements of an Engineered Construct 
 A tissue engineering scaffold can be seeded with a desired cell population and 
implanted into a defect site.  The scaffold provides both mechanical support and a three-
dimensional environment for cells to attach and proliferate.  The cell population will 
produce extracellular matrix components which will infiltrate the scaffold material and 
surrounding tissue.  Slowly the scaffold material will degrade – leaving only cells and 
native tissue.  There are many materials used for the scaffold component of an engineered 
construct.  Scaffolds can be made out of naturally or synthetically derived components.  
The majority of cartilage scaffolds contain building blocks of either proteins or 
polysaccharides.  Scaffolds can also come in a variety of physical forms, such as foams, 
viscous liquids, hydrogels, and porous matrices.     
 
2.3.1.1 Required and Desired Construct Properties 
 Fundamental requirements of all cartilage engineering scaffolds are: lack of 
immune response and inflammation, adhesion of chondrocytes, maintenance of the 
chondrocytes phenotype, and initial mechanical stability within the defect.  Beyond these 
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requirements there are many desirable, but not necessarily imperative, properties of a 
scaffold.  These include: permeability to allow diffusion of signaling molecules and 
nutrients, adhesion to the defect site, controlled release of growth factors, injectable, 
minimally invasive, and biodegradable to allow growth of new ECM tissue to eventually 
fill the defect site. [32-34]  
 Depending on the nature of the defect the desired properties of the scaffold may 
change.  An osteochondral defect which penetrates the subchrondal bone will be repaired 
differently than a chondral defect.  Depending on the location and size of the chondral 
defect it may be repaired with different approaches as well.  For example, a scaffold for 
an osteochondral defect may be biphasic – with a region for repair of the bone tissue and 
region for repair of the cartilage tissue.  If the bone marrow has been penetrated and is 
entering the defect site this will also have to be addressed.  Perhaps the bone marrow will 
be contained to the bone tissue, or factors to induce chondrogensis of the cell populations 
in the marrow will be added to the scaffold.  Additionally, the source of cells could even 
change depending on the size and location of a chondral defect.  If the defect is on the 
surface of the articulating surface, a population of superficial cell may be harvested for 
the cellular component of the scaffold.  Similarly, deep zone chondrocytes maybe be 
harvested if the defect lies in the deep zone of chondral tissue.  Because the structure and 
function of cartilage tissue varies throughout its depth and location, engineering 




2.3.1.2 Current Model for Engineering Cartilage 
 There are two major approaches to cartilage tissue engineering.  The first 
approach is to culture cells with or without growth factors in vitro for a brief period of 
time and then implant the construct into the defect site.  This method allows the cells to 
mature and become active inside the body, where they will hopefully start production of a 
healthy ECM.  The second, and more popular model, involves a much longer in vitro 
culture period before implantation.  This allows the ECM to build up before the construct 
enters the defect site, with the intention of providing mechanical support immediately 
upon implantation.  If the scaffold is mechanically and biologically mature and functional 
before introduction to the defect it will have a greater chance of remaining so while 
supporting loading regions.  In both cases the model includes gradual resorption of the 
biomaterial as the ECM is produced, as well as integration of the new ECM with the 
surrounding native tissue. [17, 25] 
 An ideal current model for tissue engineering articular cartilage involves a multi-
step procedure. First, an autologous cell population is obtained from the patient, either 
from cartilage tissue or tissue containing a population of MSCs (such as adipose tissue or 
bone marrow).  Next, these cells are multiplied in monolayer culture, and then transferred 
to three dimensional culture on the scaffold material to help maintain the chondrocyte 
phenotype and re-differentiate cells if necessary.  The scaffold is cultured for as long as 
desired, and then implanted into the defect site. [17, 32, 35]  
 Tissue engineering efforts focus on treating cartilage defects that can lead to OA, 
as designing a scaffold for treatment of advanced stages of cartilage disease is very 
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difficult.  Through early intervention and treatment ideally the onset of OA can be 
delayed or avoided all together.   
 
2.3.2 Biomaterials and Cells for Cartilage Engineering 
 Many materials have been developed for tissue engineering efforts.  Among these 
there is a large range of chemical components, mechanical strengths, structure, surface 
topography, and biochemical properties.  No ideal scaffold material has been developed, 
and each group of materials has their advantages and disadvantages.  The major goal of 
the scaffold should be to ensure the retention of chondrocyte phenotype and provide 
mechanical stability.  Hydrogels have received considerable attention in this area as they 
have properties similar to native tissue. [17, 32, 35]  Table 2.1 includes a summary of 




 Poly (L-lactic acid) (PLLA), poly(glycolic acid) (PGA), and the copolymer 
poly(lactic-co-glycolic acid) (PLGA) are some of the most popular synthetic materials 
investigated for cartilage engineering.  Synthetic polymers usually have an open lattice 
and high porosity which is good for exchange of nutrients and molecules.  Their 
degradation rates can be tailored through composition, and chondrocytes have been 
shown to adhere and maintain their signature rounded morphology on these materials.  
Animal models show some preliminary success with synthetic materials, but due to their 
limitations human trail data is largely unavailable.  Some key limitations include: 
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difficulty to mold into complex shapes, hydrophobic  – which generally means poor cell 
attachment and the need for very large chondrocytes populations, invasive implantation, 
and a strong foreign body reaction. [22, 33-35] 
 
Table 2.1. Materials that have been used in cartilage engineering efforts in either clinical or 
research settings.  
 
Materials Used in Cartilage Engineering 
Naturally  
Derived 
Reference Synthetically Derived Reference 
Fibrin [36-39] Poly(lactic acid) [40, 41] 




Co-polymers of poly(lactic 
acid) and poly(glycolic acid) 
[41, 50] 
Alginate [39, 51-57] Poly(ethylene oxide) [58, 59] 
Agarose [60-62] Poly(ethylene glycol) [63-66] 
Silk [67-69] Ceramics [70, 71] 
Chitosan [67, 72, 73] 
Pluronic (copolymer of 
poly(ethylene oxide) and 
poly(propylene oxide) 
[73, 74] 
Hyaluronic Acid [55, 74, 75] Poly(urethane) [36] 
Cellulose [76] Poly(hydroxybutyrate) [77, 78] 
Gelatin [79] Poly(ethylene-terephtalate) [80] 
  Poly(tetrafluoroethylene) [81] 
  Poly(1,9-octanediol citrate) [82, 83] 
  Poly(caprolactone) [84, 85] 
  Poly(ether ester) co- polymer [86] 
  Carbon Fiber [87, 88] 
  Calcium Phosphate [89] 




Naturally derived materials provide the advantages of usually being 
biocompatible and biodegradable.  Due to its prevalence in the ECM collagen is one of 
the most popular natural biomaterials for cartilage regeneration.  Porous collagen sponges 
have been made with and without GAGs and growth factors and show good cell 
attachment and maintenance of cellular phenotype.  However, in some cases they have 
been shown to cause a foreign body reaction which interferes with tissue integration.  
Additionally, any porous natural material would also have to be delivered through an 
invasive open surgery. [22, 34, 35] 
 Hydrogels are popular in cartilage engineering due to their similarities to native 
tissue.  Hydrogels are water-swollen polymer networks that can be chemically modified 
by crosslinks to form mechanically stable shapes.  They are made by mixing a soluble 
polymer (natural or synthetic) in water and adding a crosslinking agent.  They can be 
injectable and molded into desired shapes during gelation.  This provides the potential for 
non-invasive delivery to a defect site.  Their porosity can be adjusted by the network 
density, and their high water content and elastic properties make them similar to native 
tissue.  Chondrocytes show strong attachment and retention of their phenotype in most 
hydrogels. Some natural hydrogels include alginate, agarose, chitosan, and fibrin.  The 
main drawbacks of these materials include their lack of mechanical strength and 
difficulty controlling properties such as degradation rate.  Synthetic hydrogels allow for 
somewhat more control over properties such as degradation rate.  Some synthetic 
hydrogels used in cartilage engineering include: poly (ethylene oxide) (PEO), poly 
(propylene oxide) (PPO), poly (vinyl alcohol) (PVA), and poly(ethylene glycol)(PEG).  
Synthetic hydrogels often have more limited cell attachment properties than their 
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naturally-derived counterparts.  Limitations of both natural and synthetic hydrogels 
include cellular encapsulation and formation of a uniform gel.  Injection provides 
challenges in controlling gelation rate, and difficultly controlling the homogeneity of the 
formed gel. The use of photocrosslinking has been shown to provide more uniform 
gelation as the entire hydrogel crosslinks simultaneously upon ultraviolet light exposure. 
[8, 22, 33, 35, 92] 
 
2.3.2.2 Cell Source 
 A major obstacle in tissue engineering articular cartilage is obtaining a 
sufficiently large, and phenotypically stable autologous cell population.  Donor site 
morbidity makes a large cartilage harvest impractical and even dangerous.  The low 
number of harvested chondrocytes creates the need for expansion culture in monolayer.  
Although chondrocytes maintain their phenotype better in three-dimensional culture their 
proliferation rates are much higher in monolayer.  Monolayer culture causes 
chondrocytes to flatten, losing their rounded morphology and become more fibroblastic 
in nature.  Three-dimensional culture following monolayer helps to re-differentiate the 
cells, however this process is relatively inefficient and the native phenotype is never fully 
restored.  Quality and health of the harvested chondrocytes is also an issue of concern.  
Currently the mechanisms at play during chondrocyte differentiation and re-
differentiation are not fully understood.  Without this understanding the process will be 
difficult to control. [22, 25, 32] 
 Using MSC populations on their own or mixed with autologous chondrocytes can 
reduce the need for the invasive harvest procedure, however the optimal conditions for 
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chondrogenesis of a MSC are yet to be fully understood.  Furthermore, bone marrow 
harvest of MSC populations is also an invasive procedure.  The easiest place to harvest 
MSC is adipose tissue, where low donor site morbidity exists.  However, MSCs derived 
from adipose tissue may be more difficult to differentiate into chondrocytes than those 
derived from bone marrow. [17, 22, 25, 32] 
 
2.3.3 Engineered Constructs in Clinical Trials and Early Applications 
 Many new products have entered clinical trials or are already commercially 
available.  Most of these products seek to improve the traditional surgical treatment 
through tissue engineering strategies.  The majority of these clinical trials and products 
are not yet available in the United States and statistics on their long-term success in 
humans do not yet exist. [29]    
 
2.3.3.1 Marrow Stimulation Techniques  
 A process called scaffold-guided microfracture uses a scaffold to help the bone 
marrow stay within the defect site following micofracture.  The following products utilize 
this idea: BST-CarGel (Biosyntech Inc., Laval, Quebec, Canada), ChonDux (Biomet, Inc, 
Warsaw, Indiana), and Gelrin C (Regentis, Haifa, Israel).  BST-CarGel is a biodegradable 
and injectable chitosan-glycerol phosphate based hydrogel.  ChonDux is an injectable 
poly(ethylene glycol) hydrogel that contains an adhesive to stick to the defect site.  
Gelrin-C is a degradable and injectable copolymer of denatured fibrogen and 




2.3.3.2 Osteochondral Grafts 
 Scaffolds used in the place of tissue grafts can provide many benefits.  
Advantages include: biodegradability for new tissue to take its place, cost-effective, time-
efficient, single procedure, no donor site morbidity, and the potential to include cell 
therapies.  A drawback of using a substitute for a graft tissue, is of course, the lack of 
autologous, living tissue.  Other potential complications include wear debris, 
inflammation, and friction between implanted material and tissue.  Products developed 
for this use include: BST CarGel, Gelrin C, Salucartilage (Salumedica, Smyrna, GA),  
Chondromimetic (Ortho-mimetics, Cambridge, UK), TruFit Plug (OsteoBiologics/Smith 
& Nephew, Andover, MA), and OrthoGlide (Advanced Bio-Surfaces, Minnetonka, MN).  
SaluCartilage is another biodegradable and injectable hydrogel that solidifies in vivo.  
Chondromimetic is a dual-layer porous implant that has regions with properties similar to 
both subchondral bone and cartilage tissue.  Tru-Fit and OrthoGlide are cylindrical-
shaped polymers used for filling in circular drill holes where a defect site would lie. [29]   
 
2.3.3.3 Cell-Based Therapies 
 The matrix-induced autologous chondrocyte implantation is very similar to the 
traditional ACI procedure, with the addition of a degradable matrix to support the 
transplanted chondrocytes until they form their own matrix.  This helps keep the 
transplanted cells in the defect and provides much needed mechanical support.  There is 
potential for growth factor incorporation to the scaffolds to aid in ECM production and 
retention of chondrocyte phenotype. [29]  Developed products include: Carticel 
(Genzyme Inc, Cambridge, MA), ChondroGide (Geistlich Biomaterials, Wolhausen, 
30 
 
Switzerland), CaRes (Anthro-Kinetics, Essingen, Germany), Hyalograft-C (Fidia 
Advanced Biopolymers, Abano Terma, Italy, and Neocart (Histogenics, Waltham, MA).  
Carticel and Chondrogide are porcine-derived type I and type II collagen matrices, CaRes 
is a type I collagen matrix, Hyalograft-C is a hyaluronic acid based scaffold, and Neocart 
is made of a bovine collegen matrix. [22, 29, 93] 
 Fibrin based scaffolds are being developed on which minced harvested cartilage 
tissue is placed.  The construct is then implanted into the defect site.  A process called 
‘neocartilage implantation’ is also being developed during which harvested cells are 
grown in a scaffold in a dynamic culture system to produce and ECM.  The ECM is then 
isolated and implanted into a cartilage defect. [29]  Table 2.2 lists product information for 









Table 2.2. Name, company, and website for products which are commercially available or 
in/entering clinical trials for cartilage engineering. 
 
Commercial Products in Cartilage Tissue Engineering 
Product Name                Company          Website  
BST-CarGel 
Biosyntech Inc., Laval, Quebec, 
Canada 
www.biosyntech.com 
ChonDux Biomet Inc., Warsaw, IN, U.S.A. www.biomet.com 
Gelrin C Regentis, Haifa, Israel www.regentis.co.il 
Salucartilage SaluMedica, Smyrna, GA, U.S.A. www.salumedia.com 
Chondromimetic Orthomimetics, Cambridge, UK www.orthomimetics.com 
TrueFit Plug 
OsteoBiologics/Smith & Newphew, 





Minnetonka, MN, U.S.A. 
www.advbiosurf.com 
Carticel 












Fidia Advanced Biopolymers, 
Abano Terma, Italy 
www.fidiapharma.com 
NeoCart, VeriCart Histogenics, Waltham, MA, U.S.A. www.histogenics.com 
 
2.3.4 Current Research Efforts 
 The development of cartilage tissue engineering products has been the result of 
decades of research efforts that span many natural and synthetic scaffold materials.  
Although not all of these materials have developed into usable constructs this research 





2.3.4.1 Natural Scaffolds 
 Some of the most popular natural scaffolds used in cartilage engineering research 
include alginate, fibrin, agarose, hyaluronic acid, chitosan, and type I and II collagens.  
Studies using alginate, collagens, and fibrin are highlighted due to their prevalence in the 
literature. 
 Early studies using alginate to encapsulate chondrocytes were performed in the 
late 1980’s, these studies demonstrated retention of the chondrocyte phenotype and  
proliferation of chondrocytes seeded in three-dimensions. [51]  Following studies have 
established that chondrocytes remain phenotypically active and proliferate within 
alginate, even up to even 8 months in culture. [52-55]  Markers for phenotype retention 
include gene expression or biochemical presence of ECM components such as type II 
collagen, aggrecan, and GAGs.  High gene expression of type I collagen indicates cells 
have started to differentiate to a more fibroblastic lineage.  Alginate has been investigated 
for its potential in re-differentiating cells that have started down a fibroblastic lineage due 
to expansion in monolayer.  Results show encapsulation in alginate can aid in re-
differentiating cells to express higher levels of matrix proteins and lower levels of type I 
collagen following two-dimensional culture. [53]  Despite maintaining a healthy 
chondrocyte population alginate’s drawbacks include limited mechanical stability and 
biodegradation. [37]   
 Studies using both type I and type II collagen matrices have also shown  support 
of chondrocyte proliferation and maintenance of phenotype. [42-44]  The incorporation 
of glycosaminoglycans, such as chondroitin sulfate, within the collagen scaffold have 
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shown to further improve expression of matrix proteins. [42, 44]  Additionally, 
mechanical loading of chondrocytes seeded on collagen scaffolds has been shown to alter 
cellular gene expression. [43]  Collagen scaffolds are biodegradable, however they can be 
expensive and fairly difficult to produce. 
 Fibrin glue is made by mixing fibrinogen and thrombin to form a biodegradable, 
injectable material.  It has been studied and classified for mixing with chondrocytes and 
injecting into cartilage defect sites.  Animal trials with this method show significant 
wound healing and integration with native tissue. [37]  Fibrin biodegradation can be 
tailored and it can be mixed with other polymers to improve its relatively weak 
mechanical strength.  Various models of fibrin-alginate scaffolds have been show to 
support proliferation and the chondrocyte phenotype. [38, 39] 
 
2.3.4.2 Synthetic Scaffolds 
 Popular synthetically derived materials used in cartilage research include 
poly(glycolic acid) (PGA), poly(lactic acid) (PLA), poly (lactic-co-glycolic acid) 
(PLGA), poly (caprolactone) (PCL), and poly (ethylene glycol) (PEG).  As a result of 
their prevalence in the literature, efforts using PGA and PEG will be covered in more 
detail.  
 PGA is an alpha polyester that degrades within months into products the body can 
readily absorb, making it biocompatible.  As it degrades a loss of mechanical strength is 
observed, however in vitro culture and formation of ECM may strengthen its mechanical 
properties. [94] PGA scaffolds for cartilage engineering are usually made in the form of 
porous meshes that allow for nutrient and molecule transfer.  Production of GAGs, 
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aggrecan, and type II collagen are all observed in chondrocytes cultured in vitro for up to 
40 days on PGA scaffolds. [46, 47]  Porous PGA scaffolds seeded with bone marrow 
stromal cells and implanted subcutaneously into mice show formation of mature cartilage 
after 8 weeks. [48]  PLA is another alpha polyester with similar mechanical and 
biological properties shown to support chondrocyte adherence and proliferation.  A 
copolymer of PGA and PLA (PLGA), whose properties are similar and proportional to 
the proportion of each polymer, is also used in cartilage engineering efforts. [41, 94]  
 PEG can be formed in to an injectable hydrogel with properties similar to native 
cartilage tissue.  It is biocompatible, but not biodegradable on it own.  Therefore, it must 
to copolymerized to achieve in vivo degradation.  PEG-based polymers can be 
photopolymerized with addition of a photoinitiator.  In this model the polymer and cell 
solution would be injected to the defect site as a liquid to fill the exact shape of the 
defect, the polymer would then be photocrosslinked forming a solid matrix.  Copolymers 
of PEG and PLA as well as PEG and poly(vinyl alcohol) are biodegradable and promote 
chondrocyte adhesion and matrix molecule production. [63-65]  Additionally, 
incorporation of matrix molecules such as chondroitin sulfate has been shown to increase 
mechanical properties as well as gene expression of matrix molecules. [66]  
Poly(ethylene oxide) (PEO), a higher molecular weight form of PEG, has also been 
photopolymerized into hydrogels for cartilage applications.  PEO-based research shows 
that cells remain viable and produce significant levels of GAG and collagen in vitro 
during encapsulation in hydrogel scaffolds.[58] Copolymers with PEG have also shown 




2.3.4.3 Growth Factors 
 Growth factors known to promote chondrocyte activity are often incorporated into 
scaffolds, or delivered to culture media to stimulate the cell population.  Although many 
studies have investigated growth factor use, many of their effects – both alone and in 
combination- remain to be fully understood.  The most prominent growth factors used in 
cartilage engineering studies include; insulin-like growth factor – I (IGF-I), basic 
fibroblast growth factor (bFGF), and transforming growth factor-1 (TGF-1). [5, 56, 
95-97]  All of these have demonstrated anabolic cellular effects and increased production 
of matrix molecules.  Although the effects of these factors are generally understood, the 
ideal combination of growth factors and delivery mechanism remains to be established. 
 
2.4 Future Directions 
 Many advances have been made over the past few decades in understanding 
cartilage engineering, however major hurdles still exist within the field.  Cell source, 
maintenance of the chondrocyte phenotype in vitro, and recreation of tissue with the 
structure and properties of native cartilage are today’s major challenges.  Research which 
address these challenges include zonal cartilage engineering, the use of stem cells, and 
utilization of dynamic in vitro culture systems.  Together these fields are likely to have a 
major impact on cartilage regeneration in coming years. 
 
2.4.1 Zonal Cartilage Engineering 
 Recreation of the zonal complexities present in native cartilage tissue has become 
a focus of many cartilage engineering efforts.  Initial studies, and most currently available 
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engineering solutions, attempt to remodel cartilage as a homogenous tissue.  As the 
cellular and structural differences between cartilage zones are more fully understood, the 
need to recreate this complex tissue architecture is becoming more apparent.  Articular 
cartilage is intricately organized and heterogeneous.  It is unlikely that a homogenous 
tissue, based on a homogenous scaffold, can functionally replace this structure.  
Furthermore, it is likely that through formation of zonal organization there will be better 
integration with host tissue, and a more fluid transmission of stress between native and 
novel cartilage.  Depth dependent variations in scaffold design (pore size, porosity, 
mechanical properties, and addition of growth factors, etc) and the origin of the seeded 
cells (super zone, middle zone, or deep zone) can be used as tools in designing zonal 
scaffolds. [33, 98] 
 While there is no current model for regenerating zonally organized tissue in vitro, 
several studies have attempted to establish the difference in phenotype between zonal cell 
populations and create culture systems which more closely mimic the native 
environment.  These studies are paving the way for biomaterials which will help to 
restore defects in a zone-specific manner.  For example, research has shown the shear 
modulus to vary by up 2 orders of magnitude through the depth of a single articular 
cartilage sample. [99]  Additionally, studies show differences in matrix deposition, 
morphology, and gene expression between cultured populations isolated from distinct 
cartilage zones. [100, 101]  Further studies have developed layered culture systems based 
on materials such as PEG, PEO, agarose, and alginate. [15, 57, 60, 102]  These studies 
show both depth-dependent mechanical properties of the scaffolds and changes in 
metabolic activity of subpopulations cultured in layers. [15, 61]  The continuation of such 
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studies and the development of zonally-engineered cartilage tissue could potentially be 
very influential the next generation of cartilage repair solutions. 
 
2.4.2 Stem Cells 
 A major challenge in cartilage engineering is obtaining a sufficiently large 
chondrocyte population to seed onto the scaffold material.  Both maintaining the 
chondrocyte phenotype during culture and injury at the harvest site are significant 
challenges in this approach.  An alternative to autologous chondrocytes harvest is the use 
of MSCs.  MSC use also has significant challenges that are yet to be met.  Harvesting the 
MSC population is the first challenge.  The most classified and understood MSC 
population lies in bone marrow.  However, bone marrow harvest is both painful and a 
potentially risky procedure.  Adipose tissue also contains a MSC population and is much 
easier to harvest, however it is more challenging to induce chondrogenesis in adipose-
derived MSCs.  Other tissues with MSC populations include the synovial membrane, 
muscle, periostium, and umbilical cord. [22, 103]  Once harvested, the next major 
challenge is inducing chondrogenesis in the stem cells.  Various growth factors have been 
identified and studied for inducing the chondrocyte phenotype, however an ideal growth 
factor or combination is yet to be discovered.  Furthermore, in vitro culture often leads to 
production of fibro-cartilage features and hypertrophy in the stem cell population. [22, 
103]  Current animal and human models that have used MSCs for cartilage repair have 
shown mixed results, often plagued by fibro-cartilage formation. [17, 103, 104] 
 A biomaterial and proper incorporation or delivery of growth factors is needed 
which successfully differentiates MSCs into healthy articular chondrocytes.  Several 
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attempts to design such scaffold have been met with preliminary success.  PEG based 
hydrogels with decorin moieties are reported to promote in vitro chondrogenesis of 
MSCs, marked by deposition of ECM components such as type II collagen and aggrecan. 
[105]  Additionally, PEO based hydrogels with hyaluronic acid and TGF-3 are reported 
to induce chondrogenesis of MSC in in vivo animal models. [75]  The future of MSCs in 
cartilage engineering will rely on development of a practical harvest method and 
production of a reliable chondrocyte phenotype.  Eliminating the need for harmful 
autologous chondrocyte harvests will be a significant advancement for cell-based 
cartilage engineering strategies. 
 Embryonic stem cells for cartilage engineering have recently received 
considerable attention, and may hold promise for the future.  These cells have the 
advantage of large cell source numbers and the ability to proliferate significantly.  Their 
drawbacks include potential immune response, and differentiation challenges. [104]  
Animal models show varying reports of success depending on where the embryonic stem 
cells are injected.  Mouse models show chondral defects treated with undifferentiated 
embryonic stem cells result in the formations of teratomas.  However, embryonic stem 
cells injected to osteochondral defects in the same animal model show restoration of 
healthy tissue. [106, 107]  Control of the differentiation process to form functional 
chondrocytes is essential to establish for the use of embryonic stem cells.  Studies report 
chondrogenesis of embryonic stem cells through the use of growth factors such as bone 
morphogenic proteins, transforming growth factor-1, and insulin-like growth factor-1. 
[108-110]  Additional studies have investigated the differentiation of embryonic stem 
cells to mesenchymal-like stem cells and have reported success. [111, 112]  The ability of 
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these cells to undergo chondrogenesis has been studied using a modified PEG-based 
hydrogel.  Results indicate promise for the use of embryonic stem cells in cartilage tissue 
engineering. [112]  While these studies indicate great potential for chondrogenesis of 
embryonic stem cells, research in this field has yet to establish precise cellular 
mechanisms at work during this process. 
 Induced pluripotent stem cells may also hold promise for cartilage regeneration.  
Advantages of induced pluripotent stem cell use include production of an autologous cell 
population and elimination of harmful cartilage or bone marrow harvests. [113]  
However, there is limited research investigating the chondrogenic potential of these cells.  
Use of induced pluripotent stem cells in cartilage engineering will require research efforts 
to clearly establish differentiation parameters. 
 
2.4.3 Dynamic Culture Systems 
 Healthy loading is essential for the maintenance of cartilage in the body.  To 
understand the important relationship between loading and chondrocyte metabolism 
many studies have investigated the effects of both static and cyclic loading on 
chondrocyte activity.  Reports show mixed inhibitory and simulative effects depending 
on load magnitude, size, and which zone the chondrocytes originated from. [62, 114, 115]  
To create a culture system which mimics the dynamic in vivo environment many groups 
have designed bioreactor systems.  Culturing engineered cartilage scaffolds in dynamic 
bioreactor systems is not the current standard, but this model holds great promise for 
maintaining healthier, and more phenotypically stable cell populations in vitro. 
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 Results from bioreactor studies show increases in production of ECM molecules, 
cell proliferation, and mechanical properties. [116, 117]  For example, PGA scaffolds in a 
perfusion system showed increases in both DNA and GAG content compared to controls. 
[118]  Chondrocytes in PEG-based hydrogels exposed to dynamic laminar fluid flow 
showed increased levels of GAG and collagen production and better mechanical 
properties compared to controls. [119, 120]  Studies have also added growth factors to 
dynamic culture conditions and observed even more favorable outcomes. [95, 97]  The 
ideal combination of scaffold material, growth factors, and dynamic culture system are 
yet to be established for in vitro culture.  Understanding how these factors work together 
to affect the chondrocyte phenotype is essential for the success of cartilage engineering 
strategies.  Successful three-dimensional scaffold culture will create a plethora of stable 
chondrocytes producing ECM that can then be transplanted into cartilage defects.  
Current research strategies need to establish these culture conditions for practical 








3 Phenotypic Variations in Chondrocyte Subpopulations and Their 
Response to In Vitro Culture and External Stimuli* 
 
3.1 Introduction 
 Articular cartilage is complex in its extracellular matrix (ECM) organization as 
well as cellular phenotype.  The tissue is comprised of predominately type II collagen, 
proteoglycans, and chondrocytes.   However, the morphology and metabolic activity of 
the cells as well as the structure of the ECM components vary greatly throughout the 
tissue depth.  This intricate tissue organization allows cartilage to optimally resist loading 
and provide low-friction joint movement throughout a lifetime. 
 Cartilage tissue has a low cell density, with chondrocytes comprising only 5% of 
the total tissue volume. [1]  Furthermore, after adulthood is reached chondrocytes rarely 
divide to provide the tissue with a new cell population.  Articular cartilage lacks both a 
blood supply and direct access to the lymph system - leaving most nutrient, gas, and 
waste exchange to occur through diffusion.  All of these factors contribute to the tissue’s 
limited ability to self-heal.  Cartilage defects rarely repair themselves and as a result often 
lead to complications later in life, or even disease.  The most prevalent disease affecting 
articular cartilage is Osteoarthritis (OA).  The inability of cartilage to self-repair, and the 
growing cost of OA to society (current estimates at $60 billion dollars annually in the 
United States [23]), have made cartilage engineering the focus of many research efforts. 
 Approximately 95% of cartilage tissue volume is the extracellular matrix.  The  
 
 
* This chapter was published as: EE Coates and JP Fisher. (2010) Phenotypic Variations in 
Chondrocyte Subpopulations and Their Response to In Vitro Culture and External Stimuli. 




matrix is comprised predominately of two interconnected networks: a type II network and 
a hyaluronic acid and proteoglycan network.  Chondrocytes are linked to these networks 
through proteins on the cell surface which allow them to sense, and respond to, 
mechanical force. [2]  Collagen content makes up about 10-20% of the wet weight of the 
tissue, and 90% of the collagen content is the type II collagen network.  Type II collagen 
is a 300 nm long fiber with three identical polypeptides alpha helixes.  The collagen 
fibers are linked by strong covalent bonds and provide much of the tensile strength of the 
tissue. [3, 4] 
 Aggrecan is the major proteoglycan in the tissue and contains many branched 
glycosaminoglycans (GAGs) originating from a central backbone.  The GAGs are 
predominately keratin sulfate (KS) and chondroitin sulfate (CS), and each aggrecan 
molecule contains from 50-100 of each.  The repeating sulfate groups give the molecule a 
large net negative charge.  Each aggrecan unit is connected via a link protein to a long, 
unbranched hyaluronic acid polysacharride chain.  The negative charges on the aggrecan 
molecules provide a high osmotic tissue pressure, which acts to resist compression during 
loading.  The collagen network keeps the tissue from swelling as the proteoglycans retain 
water – which provides the tissue with further compressive strength. [2, 4, 5, 17]  
However, during loading a small amount of liquid is forced out of the tissue into the 
synovial cavity of the joint.  Here the liquid will absorb nutrients which will be delivered 
to the tissue as the load is released and the liquid flows back into the cartilage.  Thus, a 
healthy loading regime is essential for proper cartilage function. [16] 
 The average height of human articular cartilage on the femoral condyle has been 
measured at 2.4 mm, which includes superficial, middle and deep zones but not calcified 
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tissue. [121]  In comparison, the average reported height of knee articular cartilage 
reported in rabbits is 0.4 mm, [122] sheep tissue is 0.7 mm, [123]  and bovine cartilage is 
1.7 mm. [124]  Below the articulating surface the tissue has been divided into three 
zones:  superficial or tangential zone, the middle or transitional zone, and the deep or 
basel zone.  Each zone has distinct ECM organization, cell morphology, and metabolic 
activity.  Many studies use slightly different definitions of zone depth.  As a general rule, 
the superficial zone is defined as approximately the top 10-15% of the tissue and contains 
the articulating surface.  The middle zone is the approximately the middle 60% of the 
tissue and the deep zone contains the remaining 30% of tissue depth.  Following the deep 
zone is the tidemark – below which the tissue becomes calcified and eventually turns into 
subchondral bone.  This calcified region effectively blocks any diffusion from the 
subchondral bone, and anchors the articular cartilage to the bone tissue below.  This 
review will focus on cartilage engineering of the superficial, middle, and deep zones. [4, 
9, 10, 98] 
 Extracellular matrix composition and structure vary greatly between zones.  
While the collagen content per weight does not change significantly with depth its 
orientation and number of crosslinks are both depth-dependent.  The number of 
lysylpyridinoline crosslinks decreases with depth in mature cartilage, while the number of 
hydroxylysine and hydroxylysylpyridinoline crosslinks increase with depth.  It is 
hypothesized that this, along with collagen fiber orientation, accounts for the differences 
in tensile strength and stiffness throughout the tissue depth. [125, 126]  The tensile 
strength and stiffness of the tissue are highest in superficial zone and decrease into the 
middle and deep zone. [126]  Collagen fibers in the superficial zone are orientated 
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parallel to the articulating surface in tight bundles.  As well as providing tensile strength 
these fibers are thought to block any unwanted molecules from the synovial fluid in the 
joint. [13]  The collagen fibers of the middle zone are randomly orientated, and those of 
the deep zone are oriented perpendicular to the articulating surface.  During ageing and 
deformation the tissue will split parallel to the direction of the collagen fibers.  That is, 
the split lines coincide with the collagen network orientation. [127, 128]  Differences in 
proteoglycan content are also observed throughout the tissue depth.  Proteoglycan content 
increases with distance from the articulating surface, and with it so does the compressive 
modulus of the tissue. [129]  Consequently, the water content is lowest in the superficial 
zone, with approximately 65% of the water content of the tissue residing in the middle 
and deep zones.  Furthermore, as a result of diffusion from the synovial fluid the oxygen 
concentration within the tissue is highest in the superficial zone and decreases through 
the middle and deep zones. [2, 98]  Figure 3.1 shows the distribution of water content, 










Zonal differences in matrix organization and content are largely due to variations 
in cellular activity. [11, 12]  Among zones cells display differences in morphology, 
density, and metabolic activity.  Superficial zone cells are the smallest and the most 
densely populated; they are elongated, thin, and oriented parallel to the articulating 
surface.  These the major cells within articular cartilage responsible for producing 
proteoglycan 4 (PRG4), a large glycoprotein that aides in lubrication in the synovial 
fluid. [14]  Proteoglycan 4 is also commonly referred to as superficial zone protein or 
lubricin.  Middle zone cells are larger, less densely populated, and do not have a 
water            oxygen         compressive     tensile
content pressure          strength     strength
Figure 3.1 Schematic 
demonstrating the distribution of 
water, oxygen, compressive 
strength, and tensile strength 




particular orientation.  Deep zone cells are also larger than superficial cells and are 
oriented in columns perpendicular to the articulating surface which serve to anchor the 
articular cartilage to the calcified layer below.  While superficial and middle zone 
chondrocytes usually exist on their own, deep zone cells are often found in clusters of 5-8 
cells. [13, 121]  Several secreted proteins also exists as markers for cells of various zones, 
however their functions are not fully understood. [130-132]  Relative maintenance of 
subpopulation phenotypes in vitro has been demonstrated in many studies throughout the 
past two decades, however comprehensive knowledge of the cellular mechanisms behind 
these differences has not been achieved.  Furthermore, differentiation of chondrocyte 
progenitor cells into distinct chondrocyte subpopulations is yet to be demonstrated or of 
practical use. 
 While many cartilage engineering products are beginning to make their way into 
the clinical settings, there is a lack of commercial products which attempt to reconstruct 
the zonal organization of articular cartilage.  Since zonal organization is integral to the 
proper function of the tissue, it is unlikely that a homogenous approach to tissue repair 
can adequately regenerate cartilage tissue.  For the success of zonal cartilage engineering 
efforts maintaining and/or differentiating the subpopulation phenotype must be achieved 
both in vitro and in vivo.  As maintaining the chondrocyte phenotype is a major challenge 
in all cartilage engineering efforts, adding variations within this phenotype provides an 
even greater obstacle. [22, 32]  The first step in achieving this goal is thorough 
understanding and classification of the cellular mechanisms which make these cells 




 This review provides a comprehensive analysis of the variations in zonal 
chondrocyte phenotype.  In an effort to better understand the cellular differences among 
zones we have reviewed the literature for studies which attempt to establish and classify 
the zonal variations in cell activity.  Complete understanding of chondrocyte function 
will aid cartilage engineers in creation of zonally organized tissue.  Our aim is to aid in 
this understanding and help to clearly identify cellular and structural properties which 
must be achieved for proper tissue restoration.  We will investigate explant studies, 
monolayer and three-dimensional culture models, dynamic culture models, growth factor 
delivery, mechanical stimulation models, and multi-layer culture systems as they pertain 
to chondrocyte subpopulation variations. 
 
3.1 Explant Culture 
 Studies which investigate cell populations immediately following harvest with 
limited culture time provide understanding as to the native function of the cells.  Such 
studies show variations in metabolic, mechanical, and morphological properties of zonal 
cell populations.  A study in 1994 which examined explants from different zones of 12-
18 month-old bovine articular cartilage was one of the earliest works to identify a novel 
proteoglycan synthesized and secreted only in the superficial zone. [133]  The 
proteoglycan was termed superficial zone protein (SZP) and monoclonal antibodies were 
raised against the protein to confirm its presence in the superficial zone and in the 
synovial lining in adult and fetal human articular cartilage.  The same study also showed 
the protein was not present in the deep zone of articular cartilage, nasel septal cartilage, 
or synovial stromal cells.  Analysis using flow cytometry showed the following 
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percentages for immunopositve cells isolated from full-thickness articular cartilage, 
superficial zone, deep zone and synovial cells respectively: 37.4, 52.5, 3.4, and 7.5. [134]  
Gene expression analysis has identified elevated levels of expression of the superficial 
zone protein in the superficial layer of articular cartilage. [135]  It has been established 
that SZP is encoded by the proteoglycan 4 (PRG4) gene, which also is responsible for 
other proteins with very similar structure and function to SZP.  Taken together, these 
group of proteins are sometimes referred to as PRG4. [136] 
 Additional zonal protein markers include clusterin, developmental endothelial 
locus-1 (Del1) protein, cartilage intermediate layer protein (CILP), and potentially 
cartilage oligomeric matrix protein (COMP).  Clusterin is a glycoprotein whose exact 
function in cartilage tissue is yet to be identified.  Its mRNA and protein are reported at 
elevated levels in diseased tissue, and in healthy tissue it is thought to play a role in a 
plethora of important biological functions.  Gene expression for clusterin has localized it 
to the superficial zone only, [137, 138] identifying it as a marker for that zone.  Del1 is 
thought to play a role in vascularization regulation and restricts endothelial cells during 
early development.  When the Del1 receptor v3 was antibody-bound it was shown to 
inhibit angiogenesis. [131]  This protein has been reported in the cell-associated matrix of 
isolated superficial chondrocytes and is enriched in tissue explants from the superficial 
zone versus the deep zone. [132]  CILP, a protein thought to be unique to articular 
cartilage, is found only the middle zone of the tissue.  Its exact function is yet to be 
identified, however it is thought to have a role in the progression of diseases such as 
osteoarthritis. [130]  COMP is a large extracellular glycoprotein thought to stabilize 
matrix bonds and found in the matrix surrounding a chondrocyte.  Studies have identified 
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its upregulation as a marker for osteoarthritis and rheumatoid arthritis, [139, 140] 
however it is also thought to be a marker for deep zone cartilage. [141, 142]  
 The Notch family receptors and their ligands also have zonal distributions.  Cell-
cell Notch receptor signaling is important for a variety of cell functions including 
proliferation, differentiation, and apoptosis.  Four Notch receptors have been identified in 
humans (Notch-1,2,3, and 4), which are bound by the ligands Delta, Jagged-1, and 
Jagged-2.  Murine studies show Notch-1 elevated in the superficial zone during 
development, but found Notch-1 distribution limited to deeper zones in mature tissue.  
Similarly, Notch-2,4, Delta, and Jagged-2 were found throughout the tissue during 
development, but the receptors were observed only in the deep zone of mature samples.  
The same model reported Notch-3 and Jagged-1 absent from all zones of developing 
cartilage but present in deep, mature tissue. [143]  Human models show Notch-1 
concentrated in superficial and deep zones, Notch-2 in all zones, Jagged-1 in deep zones, 
and Delta in only the superficial zone.  While the exact reason and function of these 
distributions are not known, it is hypothesized they play a role in development of the 
zonal organization of the tissue, and that the Notch-1 receptor may be a marker for 
mesenchymal progenitor cells. [144, 145] 
 Yet another biochemical difference among zones includes the processes by which 
pH is regulated in the tissue.  Chondrocytes exists in a low-oxygen environment and as a 
result their metabolism relies mostly on glycolysis, the products of which are acidic.  
This, along with a high concentration of cations gives the tissue a fairly low pH.  
However, at pH values below 6.8 proteoglycan synthesis is hindered.  It is important for 
the pH of the tissue to be carefully maintained.  Maintenance of pH in cartilage was 
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previously hypothesized to be dependent solely on the Na+/H+ exchanger, however it 
was recently demonstrated that superficial zone chondrocytes use a HCO3
-  dependent 
regulation system which is not found in the middle or deep zones. 
 Variations in mechanical properties of explanted tissues and cells have also been 
observed among zones.  Single cell analysis of porcine chondrocytes using atomic force 
microscopy (AFM) indentation and micropipette aspiration show higher instantaneous 
modulus, relaxed modulus, and apparent viscosity for superficial cells versus middle/deep 
zone cells. [146]  Results from fetal and newborn cartilage show average increases in 
compressive modulus by a factor of 4-5 from the top 0.1 mm (28+/-13 kPa) to 1 mm into 
the tissue (141+/-10 kPa).  These increases correlated with an increase in GAG content.  
A weak correlation between collagen content and compressive modulus and an inverse 
correlation between modulus and cellular content are also observed. [147]  However, 
investigations of the canine pericellular matrix demonstrated no difference in the 
Young’s modulus between the pericellular matrix of superficial and middle/deep zone 
cells. [148] 
 Morphological and structural variations among zonal subpopulations have also 
been found to exist.  In addition to the shape and size differences that have been well 
classified, variations in cellular density, cell-cell communication abilities, and cellular 
grouping have been identified.  Using rabbit articular chondrocytes four different cell 
groups were isolated through centrifugation and a percoll density gradient.  Of these four 
groups two displayed differing properties following a brief culture period.  The cells of 
lowest density were large with low proliferation, maintained phenotype, and secreted 
large amounts of proteoglycan; it was hypothesized these cells originated in the deep 
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zone.  The cells of highest density were small with large nuclei, proliferated slowly, 
expressed less ECM molecules, and produced larger amounts of interleukin 1-induced 
nitric oxide; it was hypothesized these cells were from the superficial zone. [149]  It is 
commonly thought that chondrocytes have little cell-cell communication and function 
mainly in isolation. [6]  However, a study examining cells from rabbit articular cartilage 
showed populations from the superficial zone may function in pairs, with rapid 
communication possible between the two cells. [150]  Cells of the superficial zone also 
exist in patterned groups such as lines, clusters, and pairs. [151] 
 
3.3  Monolayer Culture 
 In two dimensional culture gradual trends towards homogenization of 
subpopulations and loss of the chondrocyte phenotype are observed.  The initial 
differences that are maintained show large variations in chondrocyte metabolism and 
further highlight the differences between zonal cells.  Due to similarities in native tissue 
structure and cellular activity most studies pool middle and deep zone chondrocytes and 
study the superficial zone separately.  Traditional monolayer culture studies demonstrate 
the inadequacy of two-dimensional culture techniques for zonal phenotype retention. 
 Differences in production of matrix components have been observed between 
populations in two-dimensions.  Cells isolated from the middle and deep zones produce 
significantly thicker tissue with higher compressive modulus and substantially more 
glycosaminoglycans, large aggregating proteoglycans, and collagen than their superficial 
zone counterparts. [101, 152-154]  Superficial zone cells also showed weaker and slower 
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cell attachment, and formation of clusters that were mainly cellular with little matrix. 
[101, 153] 
 Testing following a brief culture period showed that cells also retain their 
differences in mechanical properties.  That is, cells isolated from the superficial zone 
demonstrated significantly higher relaxed and instantaneous moduli. [155]  These 
differences were measured after only 18 hours in culture, so it is possible that cell 
populations had not yet been fully influenced by monolayer culture.  A longer study over 
7 days showed a loss in the differences in mechanical properties between superficial and 
middle/deep zone cells.  Culture micropatterned surfaces aimed to restore spherical 
morphology only partially restored differences in mechanical properties. [156]         
 Many investigations report a loss of zonal phenotype with increasing culture time.  
A study which cultured 8 month old goat subpopulations in monolayer and transferred 
them to alginate beads after passages 1 to 4 concluded loss of cellar phenotype was rapid 
upon two-dimensional plating and was not restored with culture in alginate.  Initially, 
superficial cells showed gene expression levels of proteoglycan 4 more than twice that of 
cells from middle/deep zones.  The middle/deep zone population expressed 20 times 
more collagen than superficial cells.  After three passages these differences were no 
longer detected and after four passages gene expression of type I collagen had increased 
1200 fold and 8000 fold for the superficial and middle/deep zone cells respectively.  
Furthermore, suspension in alginate did not restore gene expression levels to initial 
values.  Overall, monolayer culture resulted in conversion of subpopulations to a 
homogenous population and rapid loss of cellular phenotype. [157]  Loss of 
subpopulation phenotype results in a cell population producing type I collagen and little 
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proteoglycan or type II collagen. [152]  Additionally, the smaller size of the superficial 
zone cells disappears in two dimensional culture. [101] 
 Zonal equine chondrocytes lose their subpopulation phenotype in two-
dimensional culture, however upon encapsulation in alginate hydrogels some zonal 
differences reappeared after four weeks.  These zonal differences included expression of 
clusterin in the superficial zone, COMP in the deep zone, and increased GAG production 
in the deep zone. [158]  Non-adhesive culture over agarose also helped in retaining 
cellular phenotype, and showed middle and deep zone cells to be significantly more 
active in producing ECM components. [152, 159] 
 Table 3.1 provides a summary of monolayer studies on zonal chondrocytes and 
highlights key findings.  Monolayer culture results indicate two important factors; 
middle/deep zone chondrocytes are more active in production of matrix proteins that 
superficial cells, and eventually the subpopulations will converge to a homogenous 
population which does not retain the chondrocytes phenotype.  Transferring cells to a 
three-dimensional environment or culturing on the surface of biomaterials such as 











Table 3.1.  Summary of monolayer studies on zonal chondrocytes including zone definitions, 
species and age of cell population, culture time, and key results found. 
 
Monolayer Culture of Zonal Chondrocyte Populations  





Key Results Observed 
[152] Superficial zone: 





32 days Initially:  deep cells 
synthesize more keratin 
sulphate (KS), with time HA 
and type II collagen (t2c) 
synthesis decrease 
After 14 days: morphological 
differences between 
populations disappear, both 
fibroblastic 
After 32 days: both 
populations producing 
predominantly small 
proteoglycans unable to form 
aggregates with HA 
[157] Superficial zone: 








Initially: superficial cells 
express 2.3 times more SZP, 
growth zone expresses 20 
times more t2c 
1
st
 passage: dramatic changes 
in ECM expression observed 
3
rd
 passage: no differences 
between populations detected, 
t1c expression increased 1200 
fold and 8000 fold for 





zone.  Isolated 
middle/deep  (MD) 








Deep zone cells: produce the 
thickest tissue 
MD cells: produce most 
proteoglycans, and tissue with 
highest compressive modulus 
[153] Superficial zone: 
top 20-30% of 
tissue 
Porcine 21 days Initially:  Deep zone cells 






With culture: superficial cells 
produce KS, remain more 
rounded with reduced 
substrate adhesiveness than 
deep cells 
[101] Upper cells: top 
third of tissue 
(100-200µm) 
Lower cells: 
bottom third of 
tissue (200-
350µm) 
Porcine 32 days Initially:  upper cells smaller 
and produce less KS than 
lower cells 
With Culture: cell size 
differences not maintained, 
differences in KS production 
lost after several days, deep 
zone cells produce larger 
numbers of proteoglycans and 
higher percentage of 
aggregating proteoglycans 
[155] Superficial zone: 




Bovine 3 and 18 
hours 
Superficial cells exhibit 
significantly higher relaxed 
and instantaneous modulus at 
both time points 
 
3.4 Three Dimensional Culture 
3.4.1 Scaffoldless Culture 
 With regard to recreating zonal differences, studies which attempt to layer high 
density chondrocytes subpopulations or culture subpopulations in micromass have shown 
differing results.  Bovine superficial and middle zone cells cultured in alginate beads for 
one week and then seeded in high density constructs reported results similar to those 
observed in monolayer.  That is, constructs of only superficial cells produced less matrix 
and had lower compressive moduli than those made with cells from the middle zone.  
Hybrid constructs made of a layer of superficial cells a top a layer of middle cells showed 
properties in between the two controls and production of SZP was limited to the 
superficial region. [160]  Seemingly in contrast, another group which cultured both 
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superficial and middle bovine chondrocytes in micromass reported lower type I to type II 
collagen ratio (indicating phenotypic stability) and higher gene expression of aggrecan 
and SZP in superficial zone micromass cultures than middle zone cultures.  Interestingly, 
greater differences were observed in immature samples (1-4 months in age) versus adult 
samples (18-36 months in age). [100]  Furthermore, high density scaffoldless cultures of 
superficial cells atop middle cells failed to produce constructs which mimicked the 
mechanical properties of native tissue.  That is, the trends in depth-dependent mechanical 
properties observed in native cartilage were not observed in the layered high density 
cultures. [147]  Layered high density cultures of superficial and middle cells also failed to 
retain zonal organization or produce significant amounts of matrix when implanted into 
mini-pigs.  [161]  Results from scaffoldless constructs are varying at best, and usually do 
not maintain or mimic the zonal organization of articular cartilage.  Despite challenges in 
creating zonal organization, it is important to note that scaffoldless cultures are not 
necessarily undesirable.  Scaffoldless constructs treated with growth factors can display 
mechanical properties close to those of native cartilage tissue. [162]  These constructs 
were formed in a process called ‘self-assembly,’ and formed tissue with biochemical and 
mechanical tissue properties similar to native tissue during non-adhesive culture over 
agarose. [163]          
 
3.4.2  Scaffold-Based Culture 
 Constructs which support chondrocytes in a three-dimensional environment have 
shown further success in retention of phenotype and zonal properties.  Table 3.2 provides 
a summary of scaffold-supported zonal chondrocyte studies.  Culture of bovine 
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subpopulations in agarose demonstrated deep zone cells proliferating at the greatest rate, 
producing the most extracellular matrix, and highest amounts of aggregating 
proteoglycans.  Superficial zone cells produced smaller non-aggregating proteoglycans 
that were degraded before they could be used in matrix assembly. [11, 12] Incorporation 
of matrix components to three-dimensional scaffolds can further aid in cell stability and 
activity.  Chondroitin sulfate, type I collagen, and hyaluronic acid all had varying effects 
on bovine subpopulations encapsulated within poly(ethylene glycol) (PEG) gels.  PEG 
containing chondroitin sulfate or type I collagen saw the greatest matrix accumulation by 
deep zone cells, while PEG containing chondroitin sulfate or hyaluronic acid saw the 
greatest production of matrix by superficial zone cells.  Over all, the chondroitin sulphate 
group had the highest gene expression and production of ECM proteins, and in all cases 
the deep zone cells produced more GAG and matrix accumulation than the superficial 
zone group. [164] 
 Scaffold-based culture models have demonstrated retention of zonal markers such 
as clusterin and proteoglycan 4.  Equine subpopulations were tested for clusterin 
immnuostaining in two culture groups.  One group had immediately been encapsulated in 
a hydrogel and the other group had been cultured in monolayer to first passage and then 
transferred to alginate beads.  Results showed monolayer culture resulted in loss of the 
chondrocytes phenotype and no clusterin staining.  Superficial cells which were 
immediately encapsulated in an alginate hydrogel continued to express clusterin, while 
those of the lower zones did not. [165]  Similarly, bovine chondrocytes in decelluarized 
cartilage constructs showed increased production of PRG4 in superficial cells over 
middle and deep cells, a difference which was maintained throughout culture. [136] 
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 Variations in cytoskeletal organization of subpopulations in agarose culture have 
also been reported.  A marked increase in organization of cytoskeletal elements (actin 
microfilaments, microtubules, and vimentin intermediate filaments) was observed over 
culture time for both superficial and deep zone cells.  Additionally, deep zone cells were 
measured to have more organized cytoskeletal components than the superficial 
population. [166]  An interesting study published in 1994 reported the self-organization 
of two distinct chondrocytes subpopulations as a result of a homogenous population 
cultured for 8 months in alginate beads.  The authors report a stable chondrocytes 
phenotype and a layer 1-3 cells thick on the surface of the beads which were flattened, 
elongated, and sparse in matrix production.  The second cell population, present 
throughout the rest of the bead, was larger, rounded, and surrounded by a matrix rich in 
proteoglycans and collagen. [52] 
 Scaffold-supported three dimensional culture aids in retention of phenotype and in 
differences among zonal chondrocytes populations.  It is likely that dynamic culture 
systems which help to further mimic the three-dimensional environment may provide 
additional benefits.  There is little data on subpopulation phenotype retention in dynamic 
cultures, however one recent study helps to shed light on the potential of such systems.  
Three dimensional fibrin-polyurethane scaffolds were seeded with full thickness and 
zonal chondrocytes populations and tested in a bioreactor that approximates kinematics 
and surface motion of joints.  One hour of surface motion with cyclic compression was 
delivered twice a day for 3 days.  Gene expression of hyaluronan sythases 1 and 2 (HAS1 
and HAS2) and PRG4 as well as protein production of hyaluronic acid and PRG4 were 
tested and compared to both initial levels and static three-dimensional culture values.  
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HAS2 is thought to be responsible for production of hyaluronic acid in chondrocytes.  
Initially, PRG4 expression was elevated in superficial cells and HAS2 was elevated in 
middle and deep zone cells.  Static three dimensional culture resulted in increased PRG4 
expression at the surface of deep and full thickness chondrocytes scaffolds as well as 
increased HAS2 expression in superficial constructs.  Dynamic culture increased PRG4 
expression in superficial zone constructs and further increased expression in the top 
sections of deep and full thickness scaffolds.  Interestingly, the PRG4 expression was 
highest in the top section all constructs compared with the bottom sections.  Dynamic 
culture also increased HAS2 expression in all top sections of scaffolds, with the highest 
expression in the top section of superficial constructs.  The increases in the gene 
expression in the top sections of the scaffold may be attributed to oxygen levels, access to 
nutrients, and proximity to loading force.  Release studies indicated increases in 
hyaluronic acid in all groups, and no measureable amount of PRG4 were found in media 
from deep zone cells. [116]  Dynamic culture clearly resulted in increased matrix 
production across populations, and demonstrated variations in response based on both 










Table 3.2. Summary of scaffold-supported zonal chondrocyte culture including zone definition, 
species and age of cell population, culture time, biomaterial used, and key findings 
 
Scaffold-Based Culture of Zonal Chondrocyte Populations.   






Key Results Observed 
[164] Superficial zone: 
top 10% of tissue 
Deep zone: bottom 




PEG + HA, 





PEG + CS: highest gene 
expression for matrix 
molecules and matrix 
accumulation in both cell 
groups 
PEG + CS, PEG + t1c: 
highest matrix 
accumulation in deep cells 
PEG + CS, PEG + HA: 
highest matrix 
accumulation in superficial 
cells 
Overall: Deep cells 
accumulate more matrix 
than superficial 
[166] Superficial zone: 








Deep zone cells show 
greater organization of 
cytoskeletal components 








Middle zone: half 









Deep zone cell populations 
produce most 
proteoglycans, higher ratio 
of aggregating : non-
aggregating proteoglycans, 
superficial cells produce 
proteoglycans which are 
quickly degraded  
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[165] Superficial zone: 
top 200 m 
Deep zone: bottom 













Initially: faint clusterin 
staining in superficial 
populations, none in other 
populations 
Monolayer expansion: All 
differences disappear, no 
clusterin anywhere 
Re-differentiation in 
alginate: Clusterin stain 
reappears, mostly in 
superficial cells  
[136] Superficial zone: 
 top 250 m  
 Middle zone:  500-
1000 m  
 Deep zone:  1250 









Superficial cells excrete 
significantly more PRG4 
than other populations, this 
is stimulated by ascorbic 
acid 
[102] Superficial zone: 
top 200 m    
Deep zone: bottom 









Bilayers:  Deep zone cells 
produce more matrix than 
superficial, deep zone cells 
in bilayer produce more 
matrix than controls, 
bilayers demonstrate 
greater shear and 
compressive strengths than 
controls 
[15] Superficial zone: 
 top 10% of tissue 
 Middle zone:  
middle 10% of 
tissue  
 Deep zone:  









Bilayers:  Show similar 
histological findings to 
native tissue: cell 
morphology and increases 
in proteoglycans and t2c 
with depth 
[61] Superficial zone: 
top 10% of tissue  
Middle/Deep zone: 
discarded bottom 
15% of tissue and 
used bottom 50% of 
remainder  
Bovine, calf 42 days, 
single layer 
and bilayer 
agarose of 2 
and 3 %  
Bilayer constructs: matrix 
production and zonal 
markers increase in both 
cell populations when 
layered next to the other.  
Bilayers show depth 
dependent mechanical 






3.5  Mechanical Stimulation 
 Additional studies have attempted to classify the distinct responses of 
subpopulations to mechanical stimulation.  Generally, dynamic compressive strains 
appear to stimulate GAG production in middle/deep zone cells while dynamic tensile 
strains stimulate superficial zone cells.  Bovine chondrocytes seeded in agarose and 
tested under static compressive strain (15%) and dynamic compressive strain (0.3, 1, 3 
Hz at 15% strain) produced varying results based on subpopulation.  Initially, deep zone 
cells underwent greater deformation, but after the 72 hours of testing this was reversed 
due to matrix accumulation.  Deep zone cells produced significantly more GAG at all 
time points, and GAG production in these cells was unaffected by static loading or 
dynamic loading at 3 Hz.  However, loading at 0.3 Hz reduced GAG accumulation and 
loading at 1 Hz stimulated GAG production.  Production of GAG by superficial cells was 
inhibited by all loading regimes and in general cell proliferation was stimulated by 
dynamic strain and reduced by static strain. [62]  Another investigation using the same 
testing parameters reported similar results; GAG production by deep zone cells was 
greater than superficial cells, and dynamic strain at 1 Hz significantly stimulated GAG 
production in deep zone cells. [167]  A study using bovine subpopulations seeded in a 
fibrin hydrogel demonstrated that oscillatory tensile loading (1 Hz, 5% strain) stimulated 
proteoglycan synthesis in superficial cells only.  Furthermore, proteins secreted by the 
deep zone became altered to more closely resemble the molecular characteristics of 
proteins present in the superficial zone. [114]  These results are intuitive as the superficial 
zone typically resists higher tensile loads than the deeper cartilage zones.  Therefore, 
middle and deep zone cells may be stimulated by experienced compressive strain, and 
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superficial zone cells may be stimulated by experienced tensile strain.  In general, 
dynamic loading appears simulative and static loading inhibitory.  Further studies which 
investigate the effects of long-term loading and bioreactor culture will provide more 
accurate picture of the importance of mechanical loading for long-term phenotype 





Table 3.3. Summary of mechanical stimulation studies on zonal chondrocytes including zone 
definition, species and age of cell population, biomaterial used, culture time, load delivered, and  
key findings. 
 
Mechanical Stimulation of Zonal Chondrocyte Populations 







Key Results Observed 
[114] Superficial zone:  
Top 200 m of 
tissue 
Middle zone: 500-
1000 m of tissue 
Deep zone: 1250 
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Tensile loading stimulated 
proteoglycan synthesis in 
superficial cells only, 
proteins excreted by deep 
cells after loading were 
altered in molecular structure 

















1, 3 Hz at 
15% strain 
amplitude 
Initially: deep zone cells 
deform more than superficial 
cells. After loading: deep 
zone cells deform less than 
superficial zone cells due to 
matrix accumulation, deep 
zone cells have higher 
proliferation and matrix 
accumulation at all time 
points than superficial, 1 Hz 
stimulates GAG production 
in deep cells, inhibits 
superficial GAG production 
but stimulates superficial 
proliferation  
[116] Superficial zone: 
top 10-20% of 
tissue 
Deep zone: 













a day for 1 
hr for 3 
days: 0.1 Hz 
Stimulation: Increases PRG4 
gene expression in 
superficial constructs and top 
sections of deep constructs, 
increases gene expression for 
HAS1 and HAS2 in all 
groups, more pronounced at 
top surface of constructs, HA 
synthesis increased in all 







3.6 Layered Culture Systems  
 An approach that aims to mimic the in vivo environment is a layered cell culture 
construct.  These systems attempt to recreate more realistic environments by culturing 
chondrocytes in layers corresponding to their native arrangement.  While only a handful 
of such systems have attempted to classify the behavior of layered chondrocyte 
subpopulations, results indicate that cell activity is significantly influenced by the 
presence of another cell population. 
 An agarose system has demonstrated varying mechanical properties and cellular 
activity between construct layers.  Constructs seeded with a mixed chondrocyte 
population containing a layer of 2 weight percent agarose atop of a layer of 3 weight 
percent agarose contained two regions with distinct mechanical properties.  Initially, the 
3% agarose region displayed stiffer compressive properties; however after 28 days in 
culture this difference become less noticeable and the scaffold properties became more 
homogenous. [60]  When this system was used to layer chondrocyte subpopulations 
modulations in cell activity depending both on weight percent agarose and the 
surrounding cell population were observed.  After 42 days in culture it was found that 
superficial zone cells produced the highest levels of collagen and GAGs with higher 
agarose concentrations and when layered next to a population of middle/deep zone cells.  
Similarly, middle/deep zone cells produced more GAGs and had higher proliferation 
rates when layered next to a superficial zone population.  Furthermore, bilayered 
constructs seeded with a superficial zone cell population and a middle/deep zone cell 
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population displayed depth-dependant compressive properties similar to those of native 
tissue. [61]   
 Culture systems based on photopolymerizable poly(ethylene oxide) diacrylate 
(PEODA) and poly(ethylene glycol) (PEGDA) have also been used to culture layers of 
chondrocyte subpopulations.  In PEODA hydrogels it was reported that culturing deep 
zone cells next to a layer of superficial zone cells lowered their cell proliferation rate but 
increased production of matrix components. [102]  Additionally, a PEG-based system 
which layered superficial, middle, and deep zone cells demonstrated histological staining 
similar to that of native tissue after 3 weeks in culture.  Cells in the upper layer remained 
small and flattened, while those in the middle and deep layers were more rounded and 
larger.  Furthermore, the upper layer contained little matrix, and collagen and 
proteoglycan staining increased with construct depth. [15]  A layered system based on the 
popular hydrogel alginate has also been reported.  This system has demonstrated 
mechanical properties similar to those of non-layered constructs, and production of 
matrix components over several weeks of culture with a mixed chondrocyte population. 
[57, 168] 
 There are fairly limited results for layered culture systems.  The few existing 
models demonstrate increased matrix production, especially in middle/deep zone cells, 
when cells are cultured in a zonally organized fashion.  Layered hydrogels show much 
potential for in vitro production of tissue with depth-dependent mechanical properties 
which are on the same scale of native tissue.  Current results seem promising for creating 
zonally organized tissue in vitro and it is likely that a zonally organized culture method 
will aid in subpopulation retention. 
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3.7 Growth Factors and Cytokines  
3.7.1  Growth Factors 
 Major growth factors used to stimulate in vitro matrix production in chondrocytes 
include insulin-like growth factor 1 (IGF-1), transforming growth factor-β1 (TFG-β1), 
basic fibroblast growth factor (bFGF), and bone morphogenetic proteins (BMPs).  While 
these growth factors are generally understood to stimulate synthesis of ECM proteins, the 
mechanisms behind their varying effects on subpopulations are not yet fully understood.  
Identification of optimal growth factor delivery for each zonal population will further aid 
in phenotype retention in vitro and zonal engineering efforts.  Table 3.4 provides a 
summary of key finding and experimental parameters for growth factors delivered to 
zonal cell populations.  
 Several studies have shed light on the effects of growth factors delivered to 
chondrocyte subpopulations.  Delivery IGF-1 (10, 100 ng/mL), bFGF (10, 100 ng/mL), 
and TGF-β1 (5, 30 ng/mL) over three weeks resulted in distinct effects on superficial 
versus middle/deep zone cells.  All concentrations of IGF-1 increased gene expression for 
aggrecan and type II collagen in the middle/deep zone populations, while all 
concentrations of TGF-β1 decreased expression in the same cells.  The lower 
concentration of bFGF was found to increase aggrecan expression in the growth zone, 
while the higher concentration increased type II collagen expression.  Superficial zone 
cells displayed lower expression for matrix proteins in all conditions, and were found to 
increase proteoglycan 4 expression for both concentrations of TGF-β1 and 100ng/mL 
IGF-1. [96]  Results indicate that IGF-1 may be optimal for middle and deep zone cells to 
promote matrix production and reduce type I collagen, and TGF-β1 may be important for 
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superficial cells to aid in production of proteoglycan 4 and matrix components.  Delivery 
of IGF-1 increases expression of aggrecan and type II collagen, but also decreases 
expression of tissue inhibitor of metalloproteinases-1(TIMP-1).  This suggests that IGF-1 
stimulates chondrocytes to produce elevated levels of matrix, but does not protect against 
the activity of MMPs which degrade existing ECM. [169]  Additional results have 
demonstrated that TFG-β1 and IGF-1 stimulate production of the proteoglycan 4 in 
superficial cells, while interleukin-1β (IL-1β) and IL-1 both act to inhibit production. 
[170, 171] 
 Growth factors have also been shown to effect the cytoskeletal organization and 
mechanical properties of chondrocyte subpopulations.  Unconfined creep compression 
testing of single chondrocytes showed that delivery of 5 ng/mL TGF-β1 or 100 ng/mL 
IGF-1 over 18 hours increased stiffness in both superficial and middle/deep cells.  
Furthermore, superficial cells showed higher stiffness values for both control and 
experimental groups.  Similarly, staining for cytoskeletal F-actin was stronger in all 
groups with growth factor delivery. [172] 
 Bone morphogenetic proteins (BMPs) stimulate matrix production in 
chondrocytes, [173-175] however their effects on zonal cell populations are less 
documented.  A recent study reported higher endogenous BMP activation in the deep 
zone cells versus superficial zone cells.  Furthermore, adenovirus-mediated delivery of 
both BMP 2 and 7 resulted in increased matrix accumulation in superficial cell culture 
pellets with no change in cell diameter.  Conversely, deep zone cells in culture pellets 
experienced an increase in diameter and no increase in matrix production.  The BMP 
antagonist noggin decreased both matrix accumulation and cell diameter in both 
69 
 
superficial and deep zone cells. [176]  These results indicate that BMPs may more 
appropriate for delivery to superficial zone cell population. 
 Trends in growth factor delivery in two-dimensional culture indicate TGF-β1 and 
BMPs may by influential in stimulating superficial zone chondrocytes while IGF-1 may 
be important for middle/deep zone chondrocytes.  While these results provide much 
insight the majority of these models have examined chondrocytes in monolayer.  It has 
been well-documented that chondrocytes and zonal phenotype are unstable in such 
environments.  Several studies report that even with growth factor delivery 
morphological differences among zonal populations in two dimensional culture are not 
maintained. [96, 172]  Further studies which utilize three dimensional culture will 





Table 3.4. Summary of growth factor delivery to zonal chondrocytes including zone definition, 
species and age of cell population, culture time, delivered growth factor, and key findings. 
 
Growth Factor Delivery to Zonal Chondrocyte Populations 








Key Results Observed 
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Single cell testing showed 
all growth factor exposed 
groups were stiffer, 
superficial cells were 
stiffer than growth in all 
groups, more intense 
staining for actin filaments 
in growth factor groups, all 
cells exposed to growth 
factors were more rounded 
and less spread, no 
morphological differences 
between cell populations  
[96] Superficial zone: 

















 Superficial groups lower 
gene expression of 
aggrecan, t1c, and t2c in all 
groups and lower 
production of GAG.  Both 
IGF-1 concentrations 
increase aggrecan and t2c 
gene expression in growth 
zone, both TGF-1 
concentrations decrease 
same expression.  Lower 
concentration of bFGF 
increases aggrecan 
expression in growth zone 
and higher concentration 
increases t2c expression.  
Both TGF-1 
concentrations and higher 
IGF-1 concentration 
increase SZP in superficial 
cells. 
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[171] Superficial zone: 


















Elevated gene expression 
of SZP in all superficial 
zone groups compared to 
deep.  IL-1 decreases SZP 
synthesis in superficial 
cells, TGF- and IGF-1 
increase SZP synthesis in 
superficial cells 
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Deep zone: 

















BMP:  superficial cells 
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increasing cell diameter, 




Noggin: decreased matrix 
accumulation and cell 
diameters in both groups 
 
3.7.2  Catabolic Cytokines 
 In damaged or diseased cartilage elevated levels of cytokines such as interleukins 
(ILs) and tumor necrosis factors (TNFs) are often present.  These cytokines have been 
shown to increase MMPs, cell death, and production of nitric oxide (NO).  NO is 
involved in inhibition of proteoglycan synthesis and further contributes to the diseased 
state of the tissue.  The production of cytokine-induced NO and subsequent metabolic 
inhibitions take place in a zone-dependent manner.  Superficial zone cells produce 
significantly higher amounts of nitric oxide in response to IL-1 delivery than deep zone 
cells.  Higher levels of NO production correspond to more severe inhibition of 
proteoglycan synthesis.  Conversely, NO production can be inhibited by dynamic 
compressive loading regimes. 
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 Cultures of superficial zone cells produced 2-3 times as much NO in response to 
IL-1 delivery. [177, 178]  Delivery of TNF and bacterial lipopolysaccharide (LPS) also 
stimulated superficial zone cells to produce more NO than deep zone cells. [179]  
Superficial zone cultures respond to lower concentrations of delivered IL-1 in terms of 
inhibition of aggrecan synthesis.  One study indentified the minimum concentrations of 
delivered IL-1 for a 50% reduction in aggrecan synthesis to be 0.7 ng/mL and 4.5 ng/mL 
for superficial and deep zone cultures respectively. [178]  Superficial zone cells were also 
less responsive to the therapeutic effects of the IL-1 receptor antagonist protein (IRAP), 
showed twice as many high affinity IL-1 binding sites, and produce elevated levels of 
MMPs in response to delivered cytokines. [180, 181]  However, dynamic compression 
loading can inhibit NO release in IL-1 stimulated superficial zone cells and in 
unstimulated mixed zone cells. [182, 183] 
 Together these studies once again highlight the distinct metabolic activities of 
zonal chondrocyte populations.  They demonstrate the elevated susceptibility of 
superficial zone cells to cytokines present in tissue, and identify dynamic loading as a 
possible mechanism for NO inhibition. 
 
3.8 Progenitor Cells 
 A population of cells with characteristics of mesenchymal progenitor cells (MPC) 
has recently been identified in osteoarthritic human articular cartilage.  Fluorescence-
activated cell sorting (FACS) was used to identify a cell population of 2-12% MPC 
following harvest and 24-48% MPC after several passages in monolayer.  These MPCs 
demonstrated chondrogenic, osteogenic, and adipogenic differentiation potential.[184]  
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Further studies using FACS have demonstrated that a population of progenitor cells can 
be isolated to the superficial zone only.  These progenitor cells show a high affinity for 
fibronectin, colony forming, and expression of the Notch-1 gene. [145]  Furthermore, 
stimulation of the progenitor population in the superficial zone with BMP-7 enhanced 
SZP expression, while stimulation with TGF-1 upregulated type II collagen expression. 
[185] 
 
3.9 Conclusion  
 Recreating the complex organization of articular cartilage following disease or 
injury is optimal for reestablishing tissue functionality.  Subpopulations of chondrocytes 
which remain phenotypically stable may be able to produce a zonally organized matrix in 
vivo.  Zonal tissue engineering has not yet achieved this goal, or become clinically 
practical.  For this to happen, the differences among cell populations should be clearly 
identified, understood, and engineered to produce functional tissue.  To aid in this process 
this review has classified the known differences among chondrocyte subpopulations and 
their responses to in vitro culture, mechanical stimulation, and growth factor delivery.  
Explant studies identify PRG4, Del1, clusterin, CILP, and COMP as zonal protein 
makers, as well as a zonal distribution in Notch-receptors and their binding ligands.  
Single cell analysis show superficial cells to have higher moduli and apparent viscosities 
than their counterparts from lower zones, while the compressive modulus of the tissue 
increases with tissue depth and GAG content.  Further studies indicate that superficial 
zone cells may communicate in pairs and exists in groups of different sizes. 
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 Monolayer culture of subpopulations highlights distinct metabolic activates 
between cell populations, but also shows a trend towards homogenization and loss of 
phenotype.  Such culture studies show middle/deep zone cells producing significantly 
more ECM components and tissue with a higher compressive modulus than that of the 
superficial cells.  However, a large number of reports show loss of differences and 
convergence to a non-chondrogenic phenotype following several passages in two-
dimensional culture.  Studies in three-dimensional culture provide a more native 
environment and help to retain both chondrocytes and subpopulation phenotypes.  
Encapsulation in alginate, agarose, devitalized cartilage constructs, PEG, and fibrin-
polyurethane all show retention of zonal differences and increased ECM molecule 
production in middle/deep zone cells. 
 Studies which attempt to further mimic the native environment involve 
mechanical loading and layering of zonal populations.  Results from mechanical loading 
indicate that dynamic compressive loading helps to stimulate middle/deep zone cells, 
while dynamic tensile loading stimulates superficial zone cells.  Layered systems clearly 
demonstrate increased metabolic activity in zonally organized cells, as well as creation of 
tissue which histology indicates is zonally organized. 
 While some three-dimensional culture systems have achieved mechanical 
properties approaching native values, creating engineered cartilage with the desired 
mechanical properties remains a challenge.  As the functionally of the tissue is greatly 
dependent on these properties, this issue is critical for load-bearing capacity and success 
of the engineered cartilage.   
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 Growth factors such as IGF-1 may be important for stimulating matrix production 
in middle/deep zone cells and TGF-1 and BMPS may serve to stimulate superficial zone 
cells.  Superficial zone cells appear more susceptible to the catabolic influences of 
cytokines, and the superficial zone is likely to contain a population of mesenchymal 
progenitor cells. 
 
3.10 Future Directions 
While all these results are important and demonstrate the distinct activity between 
chondrocytes populations, tissue engineers have still not been able to manipulate these 
cells to produce functional tissues or clinically relevant solutions.  For this to happen 
clear methods for retaining and/or creating phenotypically stable zonal cell populations 
must be established.  Filling in existing knowledge gaps will facilitate this process.  For 
example, identification of an optimal culture method is needed.  While three-dimensional 
culture has proven beneficial it is likely that dynamic culture systems such as bioreactors 
may help further to retain zonal phenotype.  There are very limited studies investigating 
this area, which could potentially be of great use.  Mechanical loading studies also need 
further investigation.  While it has been demonstrated that compressive loading benefits 
middle/deep zone cells and tensile loading stimulates superficial cells, perhaps there is a 
combination of these two loading regimes which can stimulate both groups.  As the tissue 
experiences both compressive and tensile loading in vivo, such systems may help retain 
or organize zonal tissue in vitro.   The role of mechanical loading (in vivo and in vitro) in 
both maintaining zonal phenotype and production of zonally organized tissue is yet to be 
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fully established.  Understanding the role mechanical loading plays in cell activity and 
tissue formation will aid in identification of an optimal tissue engineering strategy.      
Layered cell systems show much potential, but provide many questions.  Current 
studies demonstrate increased productivity of layered cells, but do not clearly 
demonstrate that each population’s phenotype is maintained.  If this can be established, 
then a practical and simple method for in vitro culture and phenotype retention could be 
possible.  Optimal growth factor delivery for subpopulation in three-dimensional culture 
also needs to be defined.  While several growth factors have shown positive results in 
subpopulation maintenance, few of these studies have been conducted in three-
dimensions, and optimal growth factors and delivery mechanisms per zone are yet to be 
established.  The progenitor cells located within articular cartilage hold potential.  
Preliminary studies have indicated that it may be possibly to zonally-differentiate these 
cells, but no clear trends have been established.  If these, or other progenitor cell 
populations, could be used to create populations of zonal chondrocytes in vitro, then they 
could be used for implantation to produce zonally organized tissue in vivo. 
As mentioned, establishing culture methods to retain subpopulation differences is 
important for both studying these cells and potentially for creating zonally organized 
tissue.  As superficial zone cells appear the least robust in both phenotype retention and 
matrix production, the retention of this cell type may be a challenge.  Furthermore, for 
use of zonal cell populations in cartilage engineering strategies a clinically relevant 
method of maintaining or differentiating cell subpopulations should be established.  
Future studies utilizing progenitor cell populations could address this issue.   
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Yet to be investigated are studies which directly compare uniform scaffolds to 
those with zonal design.  In vivo loading may have the potential to zonally organize a 
homogenous scaffold.  Studies which compare organized scaffold and homogenous 
scaffold in the native loading environment may help to define the importance scaffolds 




4 Gene Expression of Alginate Embedded Chondrocyte 
Subpopulations and their Response to Exogenous IGF-1 Delivery*  
 
4.1 Introduction 
 Articular cartilage is an alymphatic and avascular tissue whose extracellular 
matrix is maintained by the resident chondrocyte cell population.   Nutrition and waste 
exchange occur through diffusion, lending to the tissue’s limited ability to repair. [1, 2, 6]  
While initial research strategies attempted to model cartilage as homogenous, more recent 
work recognizes cartilage as a complex tissue comprised of three major zones with 
distinct extracellular matrix organization and cellular phenotype. [98, 102, 161, 186]  
Regeneration of healthy articular cartilage can only be complete with formation of all 
cartilage zones.   In order for proper restoration of zonal structure to occur phenotypical 
differences between chondrocyte populations must be fully understood.  If the response 
of chondrocyte subpopulations to growth factors and external stimuli can be classified, 
then potentially they can be engineered to recreate native cartilage tissue structure. 
 The three zones of articular cartilage are the superficial, middle, and deep zones.  
Below the deep zone is the tidemark – where the tissue starts to become calcified and 
eventually turns into subchondral bone.  The superficial zone is approximately the top 10 
percent of articular cartilage. [2, 9, 10]  Here the cells are smaller than the chondrocytes 
of other zones, thin, and disc shaped.  The cells, along with the extracellular matrix  
 
 
* This chapter was published as: Coates, E. and J.P. Fisher. (2012) Gene expression of alginate 
embedded chondrocyte subpopulations and their response to exogenous IGF-1 delivery. J Tissue 




collagen fibers are oriented in bundles parallel to the articulating surface.  The orientation  
of the collagen fibers give the superficial zone the highest tensile stiffness and strength, a 
property that decreases with tissue depth. [125, 126]  The superficial cells secrete 
relatively low levels of extracellular matrix proteoglycans, [11, 12] but are the only 
chondrocyte population that produce proteoglycan 4; a lubricant secreted into the 
synovial fluid of articulating joints. [14]  The superficial zone is also the only region of 
the tissue thought to contain a population of mesenchymal progenitor cells (MPC). [145, 
185] 
The middle, or transitional zone, of articular cartilage comprises approximately 
60-70 percent of the tissue and contains larger and rounder chondrocytes. [2, 9, 10]  The 
chondrocytes and the collagen fibers are randomly oriented, and sometimes found in 
small groups or clusters.  Middle zone chondrocytes produce significantly more 
proteoglycans than those of the superficial zone, as well as increased levels of type II 
collagen.  Higher concentrations of proteoglycans give the middle zone a higher 
compressive modulus than that of the superficial zone. [12, 15, 129] 
 The deep zone is approximately the bottom 10-15 percent of tissue located before 
the tidemark of the calcified region. [2, 9, 10]  Deep zone chondrocytes also produce 
elevated levels of both proteoglycan and type II collagen compared to those of the 
superficial zone and are oval in shape.  Consequently, the compressive modulus is 
highest here.  The cells along with the type II collagen fibers are oriented in vertical 





4.1.1 Growth Factors and IGF-1 
 Articular chondrocytes produce and secrete growth factors which modulate cell 
activity.  Many cartilage engineering efforts have focused on delivery of growth factors 
to chondrocyte populations to stimulate extracellular matrix component production.  The 
most widely investigated anabolic growth factors for cartilage include; insulin-like 
growth factor-1 (IGF-1), transforming growth factor –β (TGF-β), and bone 
morphogenetic proteins (BMPs). 
 IFG-1 was chosen for this study based on its importance in tissue homeostasis, 
and its well-documented effects on chondrocytes found both by our laboratory in the 
literature. [5, 56, 187, 188]  IGFs are small, soluble proteins found in tissues such 
placenta, heart, lung, bone, and cartilage.  IGF-1 belongs to a family of peptide hormones 
that has a single polypeptide structure similar to insulin.  IGF-1 has been shown in 
enhance chondrocyte proliferation and differentiation as well as stimulate production of 
extracellular matrix components such as proteoglycans and type II collagen. [7, 188]  
Extracellulary, IFG-1 remains stable through interaction with one of its binding proteins.  
There are six known IGF-1 binding proteins (IGF-BPs), of which IGF-BP3 has the 
highest binding affinity.  For cellular interaction IGF-1 must dissociate from its binding 
protein and bind to the IGF-1 receptor found on the cell surface.  Surface receptor 
binding initiates several intracellular pathways including the PI3K and MAPK pathways.  
The PI3K pathway has been implicated in the production of both proteoglycans and type 
II collagen. [5] 
 While the mechanical and biochemical response of heterogeneous chondrocyte 
populations to IGF-1 delivery has been reported, [56, 97] there is limited information on 
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the responses of chondrocyte sub-populations to IGF-1 delivery.  Previous sub-
population studies report the response to growth factors of zonal chondrocytes in 
monolayer.  These works show distinct responses based on the chondrocytes’ original 
location within the tissue.  Most notably, chondrocytes isolated from the middle and deep 
zones show increases in type II collagen and proteoglycan expression following IGF-1 
delivery.  However, IGF-1 delivery does not appear to have the same stimulatory effect 
on chondrocytes isolated from the superficial zone. [96, 169]  Furthermore, despite IGF-1 
delivery type I collagen expression continues to increase for all zones with time. [96]  
Additionally, IGF-1 has been shown to increase proteoglycan 4 accumulation in 
chondrocytes isolated from the superficial zone. [14]  These results indicate significant 
differences in response of chondrocyte sub-populations to delivered growth factors.  As 
chondrocytes are known to maintain their phenotype better in three-dimensional cultures 
than monolayer, [189]  establishing sub-population behavior in three dimensions is the 
next logical step in this work.  To this end, we have chosen an alginate bead hydrogel 
model to culture primary bovine chondrocyte sub-populations in three dimensions. 
 Encapsulation in alginate allows chondrocytes to maintain their spherical 
morphology, and has been shown to support chondrocyte proliferation and 
differentiation. [190-192]  Alginate beads have been used for chondrocytes culture both 
in our laboratory’s work [54, 56] and many other studies, [192-194] and results clearly 
demonstrate a favorable environment for chondrocytes.  Previous studies in our 
laboratory have determined an optimum alginate concentration of 2.0% w/v and an 
optimum cell seeding density of 100,000 cells per bead. [54] 
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 To the best of our knowledge, this work is the first to classify the zonal 
distribution in gene expression of endogenous IGF-1 and IGF-BP3 both with and without 
exogenous IGF-1 delivery.  Furthermore, it is the first known study to investigate the 
effects if IGF-1 on ECM molecule gene expression of zonal chondrocytes encapsulated in 
three-dimensions.  Through classification of the zonal effects of delivered growth factors 
the ideal culture method for retaining zonal phenotypes can be established.  Culture of 
stable chondrocyte subpopulations will be a step forward engineering zonally organized 
articular cartilage. 
 
4.2 Materials and Methods 
4.2.1 Superficial, Middle, and Deep Zone Chondrocyte Isolation 
 Zonal chondrocyte sub-populations were isolated using a procedure similar to our 
lab’s protocol for isolating full-thickness chondrocytes. [54, 56]  Specifically, 4 mm 
diameter cartilage plugs were harvested from the femoral condyles of 20 week old calves 
using a Sklar Tru-Punch disposable biopsy punch (Sklar Instruments, West Chester, PA).  
The cartilage plugs ranged from 3 - 6 mm in depth and contained all cartilage tissue up to 
the subchondral bone.  The top 10% (0.3 - 0.6 mm) was removed using a razor blade and 
taken as the superficial zone.  The middle 70% of the plug (2.1 – 4.2 mm) was removed 
using a razor blade and labeled as the middle zone. Finally, the bottom 20% (0.6 – 1.2 
mm) was labeled as the deep zone.  Once the tissue zones were separated they were 
minced into smaller pieces and rinsed three times in Dulbecco’s Modified Eagle 
Medium/Nutrient Mixtures F-12 Ham (DMEM/F12) media (Gibco/Invitrogen, Carlsbad, 
CA) with the following additives: 50 g/mL ascorbic-2-phosphate (Sigma-Aldrich, St. 
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Louis, MO), 1 mg/mL bovine serum albumin (Sigma-Aldrich),  1.2 mg/mL sodium 
bicarbonate (Sigma-Aldrich), 0.1% penicillin/streptomycin (Gibco/Invitrogen), and 0.1% 
sodium pyruvate (Gibco/Invitrogen).  The cells of each zone were isolated by digesting 
the cartilage in 0.2 % collagenase P (Roche, Basel Switzerland) for 24 hours at 37°C and 
5% CO2,filtering through a 40 µm mesh, and washing again in supplemented 
DMEM/F12 to remove any undigested tissue.  The final cell solution was suspended in 
supplemented DMEM/F12 with 10% fetal bovine serum, and cell counts were performed 
using a hemacytometer (Hausser Scientific, Horsham, PA). 
 
4.2.2 Viable Cell Density Per Cartilage Zone 
 Following harvest, cell counts were taken of each chondrocyte sub-population 
(superficial, middle, and deep), and the cellular density for each zone was determined 
using the dimensions of the explanted cartilage plugs.  Trypan blue stain 0.4% 
(Gibco/Invitrogen) was used to determine viable cells.  Viable cells appeared round and 
clear while non-viable cells absorbed the dye and appeared blue.  Cell count per volume 
of explanted tissue was determined for each cartilage zone; average cell densities and 
associated standard deviations are reported (n=3). 
 
4.2.3 Histological Preparation 
 Explants of full thickness cartilages were taken in 4mm diameter cartilage plugs 
as described above.  Following isolation the samples were fixed in 4% paraformaldehyde 
(Sigma-Aldrich, St. Louis, MO) and then decalcified in a solution of 0.24 M 
ethylenediamine tetraacetic acid (EDTA) tetrasodium salt (Fisher Scientific, Pittsburgh, 
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PA) and 0.24 M EDTA disodium salt (Fisher Scientific) for 10 days at 4°C.  The EDTA 
solution served to remove ions such as calcium that might have been in the explanted 
samples. Following decalcification the explants were placed in histological cassettes and 
dehydrated through a series of ethanol washes (40%, 50%, 60%, 70%, 95%, and 100% x 
3) for 15 minutes each followed by two 15 minute washes in Citrisolv (Fisher Scientific).  
The samples were embedded in paraffin (Paraplat X-tra, Fisher Scientific) and cut into 15 
µm sections and mounted on a glass slide (Superfrost, Fisher Scientific). 
 
4.2.4 Histochemical Staining 
 Samples were dried at 64°C for two hours, deparaffinized using Citrisolv in two 
washes for 3 minutes each, and rehydrated in 100% and 95% ethanol for one minute 
each.  The samples were then rinsed in distilled water and stained using either Masson’s 
Trichrome, Alcian blue, or Safranin O, Fast Green, and Weigert’s iron hematoxylin 
staining solutions. (Poly Scientific, Bay Shore, NY).  All samples were viewed under an 
Axiovert 40CFL light optical microscope (Zeiss, Thornwood, NY) and images were 




 Samples were dried at 64°C for one hour, deparaffinized using Citrisolv in two 
washes for 5 minutes each, and rehydrated in 100%, 95%, and 70% ethanol.  The samples 
were then rinsed in tap water and deionized water.  Samples were then incubated with 
PEROXIDAZED1 (Biocare, Concord, CA), an endogenous peroxidase blocker, and 
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BackgroundSNIPER1 (Biocare), a blocking reagent.  Samples were then stained with 
antibodies to detect either IGF-1 or type II collagen.  Primary antibodies used were anti-
hIGF-1 (goat IgG antibody, AF-2910NA; R&D Systems) and anti-type II collagen (rabbit 
polyclonal antibody, ab300; Abcam, Cambridge, MA).  Both antibodies were diluted 
200x.  The HISTOSTAIN-SP kit (Zymed, San Francisco, CA) was used to visualize 
type II collagen presence by using horseradish peroxidase (HRP)-streptavidin-biotin 
system.  The complex formation was then detected by a 3,3’-diaminobenzidine 
tetrahydrochloride (DAB) chromogen.  For IGF-1 visualization, a HRP-conjugated 
secondary antibody (goat IgG antibody, ab6885; Abcam) was used a 500x dilution and 
detected by a histochemical substrate (Liquid DAB Substrate Kit, Zymed).  All samples 
were counterstained with hematoxylin, dehydrated in 95% and 100% ethanol twice for 1 
minute, cleared in Citrisolv, and covered with a glass coverslip using Permount (Fisher 
Scientific). 
 
4.2.6 Chondrocyte Encapsulation in Alginate and Culture 
 Chondrocyte encapsulation and culture techniques were done using protocols 
previously established by our lab. [54, 56]  Briefly, 2.0% w/v alginate solution was 
prepared by mixing and heating alginic acid sodium salt from brown algae (Sigma-
Aldrich), 0.15 M sodium chloride (Sigma-Aldrich), and 0.025 M HEPES, sodium salt 
(J.T. Baker, Phillipsburg, NJ) into deionized water (pH 7.4), and then sterile filtered, 
using a 0.22m sterile filter.  The alginate solution was mixed with the desired 
chondrocyte population and injected through a 18-gauge syringe into continuously stirred 
0.1 M calcium chloride (CaCl2) (Sigma-Aldrich).  The resulting cellular density was 
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approximately 100,000 cells per bead, and each spherical bead had a diameter of 
approximately 5mm.  The beads were incubated in CaCl2 and supplemented DMEM/F12 
for 15 minutes each.  Five beads were then transferred into each well of a six-well plate 
and cultured in supplemented DMEM/F12 media and 10% fetal bovine serum (FBS) 
(Gibco/Invitrogen) at 37°C for 2 days to stabilize the chondrocytes within the alginate 
hydrogel. [51]  The media was changed on day 3 with supplemented DMEM/F12 and 
relevant experimental groups received human insulin-like growth factor (IGF-1; R&D 
Systems, Minneapolis, MN) at a concentration of 100 ng/mL.  Media was changed every 
other day and IGF-1 was delivered daily.  At days 1, 4, and 8 chondrocytes were isolated 
from the alginate beads by addition of 4 mL of 0.1 M EDTA for 25 min at 37°C.  The 
solution was then centrifuged to form a cell pellet, which was resuspended in phosphate-
buffered saline and then used for RNA isolation. 
 
4.2.7 RNA Isolation 
 Following isolation of chondrocytes from alginate beads, RNA was isolated using 
the RNeasy Mini Kit (QIAGEN, Valencia, CA).  Total RNA was eluted into 30 µL of 
RNase free water and detected using a NanoDrop ND-1000 Spectophotometer 
(NanoDrop Technologies, Wilmington, DE).   RNA concentrations at 1, 4, and 8 days 
were approximately 20, 50, and 200 ng/L respectively. 
 
4.2.8 Quantitative Reverse Transcriptase-Polymerase Chain Reaction (qRT-PCR) 
 All isolated RNA was reverse transcribed using a cDNA Archive Kit (Applied 
Biosystems, Foster City, CA), which can convert up to 10g of RNA to cDNA.  The 
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cDNA was normalized to the lowest concentration (day 1), and then combined with 
Universal Master Mix (Applied Biosystems) and oligonucleotide primers and Taqman 
probes (Applied Biosystems) for the genes of interest as well as a control gene.  The 
genes of interest were type I collagen, type II collagen, aggrecan, IGF-1, and IGF-BP3 
and the endogenous control gene was glyceraldehyde 3 phosphate dehydrogenase, 
GAPDH).  Table 4.1 shows the sequences for all forward primers, reverse primers, and 
probes used.  The reaction volume was 20 l, the reaction was performed in technical 
triplicates, and the final concentration of cDNA per reaction well was approximately 
5ng/l.  The reaction was conducted on a 7900HT Fast Real-Time PCR System Prism 
7000 sequence detector (Applied Biosystems).  The thermal profile followed was 2min at 
50°C, 10min at 95°C, 40 cycles of 15s at 95°C, and 1 min at 60°C.  Gene expressions 
were analyzed using the comparative Ct method, with glyceraldehydes 3-phosphate 
dehydrogenase (GAPDH) used as the endogenous control gene.  The superficial zone 
samples were used as calibrators in all analysis since there metabolic activity is known to 
be the lowest of the chondrocyte subpopulations, and would serve as a consistent 
calibrator. [12, 152, 160]  Fold changes in gene expression were calculated and are 
reported as the mean RQ values with associated standard deviations (n=3), in accordance 
with methods previously described by our laboratory: [55, 195] 
RQ = 2
-Ct
 , where Ct = Ct,sample -  Ct,ref 
where Ct,sample is the Ct value for the sample normalized to the endogenous control gene, 





4.2.9 Statistical Analysis 
 Each experiment was performed at minimum in triplicate.  All data was analyzed 
using one-way analysis of variance (ANOVA) and Tukey’s multiple-comparison test to 
determine statistical differences.  A confidence interval of 95% (α = 0.05) was used for 
all analysis and means and standard deviations are shown on each figure.  
Table 4.1. Forward primer, reverse primer, and probe sequences used for GAPDH, Type II 
Collagen, Type I Collagen, Aggrecan, IGF-1, and IGF-BP3 used for qRT-PCR. 
 
Primer and Probe Sequences used for qRT-PCR 
Protein  Sequence 
GAPDH Forward Primer TGCCGCCTGGAGAAACC 
 
Reverse Primer CGCCTGCTTCACCACCTT 
Probe CCAAGTATGATGAGATCAA 
Type II Collagen Forward Primer CGGGCTGAGGGCAACA 
 
Reverse Primer CGTGCAGCCATCCTTCAGA 
Probe CAGGTTCACATATACCG 
Type I Collagen  Forward Primer AGAACCCAGCTCGCACATG 
 
Reverse Primer CAGTAGTAACCACTGCTCCATTCTG 
Probe AGACTTGAGACTCAGCC 
Aggrecan Forward Primer GGGAGGAGACGACTGCAATC 
 
Reverse Primer CCCATTCCGTCTTGTTTTCTG 
Probe CAGGCTTCACCGTTGAG 
IGF-1 Forward Primer CCCAGACAGGAATCGTGGAT 
 
Reverse Primer ACATCTCCAGCCTCCTCAGATC 
Probe CTGCTTCCGGAGCTG 
IGF-BP3 Forward Primer CGCCTGCGCCCTTACC 
 






4.3.1 Chondrocyte Subpopulation Isolation 
 Both cellular density and histological images confirm isolation of zonal 
chondrocyte populations.  The average cellular density is the highest in the superficial 
zone, followed by the deep zone, and then the middle zone (Figure 4.1).  Histological 
images show varying cell density, cell size, and extracellular matrix content throughout a 
sample of full thickness cartilage (Figures 4.2 and 4.3).  Figure 4.2 depicts a full-
thickness sample stained with Safranin-O, which stains negatively charged proteoglycans 
orange, and Iron Hematoxylin, which stains the cell nuclei black.  Figure 4.3 depicts a 
full-thickness sample stained with Masson’s Trichrome where all tissue elements are 
stained red, collagen fibers are stained blue, and the cell nuclei are stained black.  The 
cells near the articulating surface are the smallest and have the highest density.  The cells 
grow larger as the distance from the articulating surface increases until the deep zone is 
reached where the cells appear largest (Figures 4.2 and 4.3).  The cells in the superficial 
zone appear small and oriented along the articulating surface, the middle zone cells 
appear round and without particular orientation, and the deep zone cells appear slightly 
elongated and columnar perpendicular to the surface.  (Figure 4.2 B, C, and D as well as 
Figure 4.3 B, C, and D).  Staining intensity varies throughout the sample.  For both 
proteoglycan and collagen content the stain is most intense at the base of the sample, 






4.3.2 Aggrecan mRNA Expression  
 Figure 4.4 shows aggrecan mRNA expression fold change for superficial, middle, 
and deep zone cells over the 8 day culture period.  Gene expression remains elevated over 
the 8 days, but decreases marginally by day 8.  Middle and deep zone cell expression is 
significantly higher than superficial zone cells throughout the study, with the exception of 
the deep zone group which received IGF-1 delivery at days 4 and 8.  Addition of IGF-1 
does not stimulate cell to express significantly more aggrecan mRNA, and in the deep 
zone on days 4 and 8 addition of the growth factor reduces gene expression to levels 
comparable to the superficial zone.  The exception is the superficial zone on day 8, whose 
aggrecan expression is increased significantly by the addition of IGF-1. 
 
4.3.3 Type I Collagen mRNA Expression 
 Figure 4.5 depicts type I collagen fold change for chondrocytes isolated from the 
superficial, middle, and deep zones over 8 days.  All zones show an increase in 
expression from days 1 to 8, and expression between zones varies.  A general trend of 
increasing type I collagen expression with time is observed throughout the study.  
Initially, cells isolated from the superficial zone show significantly higher expression of 
type I collagen than the middle or deep zone cells.  Statistically higher expression of type 
I collagen by the deep zone cells versus the middle zone cells is also observed at day 1.  
At day 4 middle zone cells express significantly lower type I collagen, and by day 8 this 
trend has changed and the superficial cells express significantly lower levels of type I 
collagen.  IGF-1 delivery generally increases type I collagen expression in superficial 
zone cells, and by day 8 it has also increased expression in the middle zone cells.  Deep 
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zone cells however, express significantly lower levels of type I collagen on both days 4 
and 8 when exposed to IGF-1 delivery. 
 
4.3.4 Type II Collagen  mRNA Expression 
 Figure 4.6 shows the gene expression profiles for type II collagen for the zonal 
chondrocytes over 8 days.  A trend of decreasing expression is observed throughout the 
study, and the superficial zone cell activity is distinct from the middle and deep zone cell 
activity.  Throughout the study middle and deep zone cells have significantly higher 
expression compared to superficial cells, with the exception of the middle zone group 
with IGF-1 delivery on day 1.  On days 1 and 4 the middle zone control group has the 
highest expression, and on day 4 this group is significantly higher than all other groups.  
By day 8 however it is the deep zone group with IGF-1 delivery which statistically has 
the highest expression.  Again, IGF-1 delivery does not appear to significantly stimulate 
type II collagen expression with the exception of the deep zone on day 8 and the 
superficial zone on day 1. 
 
4.3.5 IGF-1 mRNA Expression 
 Figure 4.7 depicts expression of endogenous IGF-1 by zone over the course of the 
study.  A trend of decreasing expression by zone and with time is observed.  The changes 
in expression which occur in the deep zone appear the least severe over the length of the 
study.  IGF-1 delivery generally decreases cell expression of endogenous IGF-1, with the 
exception of the superficial zone on day 1, the middle zone on day 4, and the deep zone 
on day 8. 
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4.3.6 IGF-BP3 mRNA Expression 
 Figure 4.8 shows the gene expression profiles for IGF-BP3 throughout the study.  
A trend of decreasing expression with time is observed, as well as lower expression by 
the superficial zone population.  On days 1 and 4 similar profiles are observed; 
superficial cells display lowest expression and the middle zone control group has the 
highest expression.  By day 8 this pattern has changed and expression increases from 
superficial to middle to deep zone cells.  Delivery of IGF-1 affects different zones in 
distinct ways and is time-point dependent.  At days 1 and 4, there is statistically no 
differences between superficial groups, the middle zone experimental group is 
significantly higher than the control group and the deep zone experimental group is 
significantly lower than the control group.  However, by day 8 each experimental group 
is significantly higher than the control with the exception of the deep zone.  Furthermore, 
changes in expression levels of the middle zone cells appear the most dramatic over the 
course of the study, and deep zone cells have significantly higher expression levels than 
superficial or middle zone cells by the last time point. 
 
4.3.7 Histology 
 Figures 4.9 and 4.10 show histological staining of both control and experimental 
groups at days 1 and 8.  It is difficult to visually identify differences between control and 
experimental groups, or between zones.  However, images show that all groups have 
formed cell clusters by day 8, and these clusters are observed in higher concentrations at 
the periphery of the alginate beads.  Figures 4.11 and 4.12 show additional staining using 
Alcian blue.  In these images the cell nuclei is stained pink to red, the cell cytoplasm is 
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stained pink and acidic proteoglycans such as chondroitin residues, sulphated residues, 
and hyaluronic residues are stained blue (not be confused with the alginate bead which 
also stains blue).  The cell clusters are again seen at day 8, with a build-up of acidic 
proteoglycans seen in the center of the clusters.  In the day 1 images, the deep zone cells 
appear slightly larger than the superficial zone cells. 
 
4.3.8 Immunohistochemistry 
 Protein production of IGF-1 and type II collagen by encapsulated chondrocytes is 
confirmed by immunohistochemistry for each protein.  Figure 4.13 shows staining for 
IGF-1, both with and without exogenous IGF-1 delivery and Figure 4.14 shows staining 
for type II collagen, both with and without exogenous IGF-1 delivery.  For both groups 
the protein presence is observed directly around the single cells on day 1, and in between 
and around the cell clusters on day 8.  In all cases protein presence increases from day 1 
to day 8, and indicate that both proteins are present throughout the study.  Again, most 









































Figure 4.1. Average cellular density in cells/mm3 from explanted cartilage 
tissue samples from bovine femoral condyles.  The superficial (S), middle 














Figure 4.2. Histology of cartilage explants from femoral condyles of 20 week 
old calves stained with safranin-o, fast green, and iron hematoxylin.  Cell 
nuclei are stained black, and red staining indicates proteoglycan content.  A) 
Full thickness sample showing superficial zone, middle zone, and deep zone.  
Scale bar 500 m.  B) Magnification of superficial zone.  Scale bar 100 m.  
C) Magnification of middle zone.  Scale bar 200 m.  D) Magnification of 







Figure 4.3. Histology of cartilage explants from femoral condyles of 20 week old 
calves stained with masson’s trichchrome.  Cell nuclei are stained black, all tissue 
elements are stained red, and collagen fibers are stained blue.  A) Full thickness 
sample showing superficial zone, middle zone, and deep zone.  Scale bar 500 m.  
B) Magnification of superficial zone.  Scale bar 100 m.  C) Magnification of 








Figure 4.4. Aggrecan mRNA expression for chondrocytes isolated from superficial 
(S), middle (M), and deep (D) zones and cultured in alginate beads over 8 days.  Two 
groups are represented for each zone, a control with no growth factor delivery and a 
group which received 100 ng/mL IGF-1 daily.  Day 1, superficial zone control is the 
calibrator.  A symbol indicates that a group is statistically different from all other 
groups.  Multiple groups marked with the same symbol indicates the groups are 
statically similar to each other, and statistically different from all others.  Means and 







Figure 4.5. Type I Collagen mRNA expression for chondrocytes isolated from superficial 
(S), middle (M), and deep (D) zones and cultured in alginate beads over 8 days.  Two 
groups are represented for each zone, a control with no growth factor delivery and a group 
which received 100 ng/mL IGF-1 daily.  Day 1, superficial zone control is the calibrator.  
A symbol indicates that a group is statistically different from all other groups.  Multiple 
groups marked with the same symbol indicates the groups are statically similar to each 
other, and statistically different from all others.  Means and standard deviations are 






  Figure 4.6. Type II Collagen mRNA expression for chondrocytes isolated from superficial 
(S), middle (M), and deep (D) zones and cultured in alginate beads over 8 days.  Two 
groups are represented for each zone, a control with no growth factor delivery and a group 
which received 100 ng/mL IGF-1 daily.  Day 1, superficial zone control is the calibrator.  
A symbol indicates that a group is statistically different from all other groups.  Multiple 
groups marked with the same symbol indicates the groups are statically similar to each 
other, and statistically different from all others.  Means and standard deviations are 






  Figure 4.7. IGF-1 mRNA expression for chondrocytes isolated from superficial (S), 
middle (M), and deep (D) zones and cultured in alginate beads over 8 days.  Two groups 
are represented for each zone, a control with no growth factor delivery and a group 
which received 100 ng/mL IGF-1 daily.  Day 1, superficial zone control is the calibrator.  
A symbol indicates that a group is statistically different from all other groups.  Multiple 
groups marked with the same symbol indicates the groups are statically similar to each 
other, and statistically different from all others.  Means and standard deviations are 






  Figure 4.8. IGF-1 Binding Protein 3 mRNA expression for chondrocytes isolated from 
superficial (S), middle (M), and deep (D) zones and cultured in alginate beads over 8 days.  
Two groups are represented for each zone, a control with no growth factor delivery and a 
group which received 100 ng/mL IGF-1 daily.  Day 1, superficial zone control is the 
calibrator.  A symbol indicates that a group is statistically different from all other groups.  
Multiple groups marked with the same symbol indicates the groups are statically similar to 
each other, and statistically different from all others.  Means and standard deviations are 
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Figure 4.10. Histology staining with Safranin-O for IGF-1 delivered experimental groups, 
all scale bars 100 m. 
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Superficial                                   Middle                                       Deep      
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Day 8
Figure 4.12. Histology staining with Alcian blue for IGF-1 delivered experimental 
groups.  Proteoglycans stained blue and cell nuclei and cytoplasm stained pink.  Cell 
proliferation to form clusters with blue staining in between the cluster is observed 
between days 1 and 8.  Note the alginate hydrogel stains a dark blue and 
proteoglycans around the cells a slightly lighter blue.  All scale bars 100 m.  
 
Figure 4.11. Histology staining with Alcian blue for control groups.  Proteoglycans 
stained blue and cell nuclei and cytoplasm stained pink.  Cell proliferation to form 
clusters with blue staining in between the cluster is observed between days 1 and 8.  
Note the alginate hydrogel stains a dark blue and proteoglycans around the cells a 
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Figure 4.13. IGF-1 immunohistochemistry staining at days 1 and 8 for control and IGF-1 
delivered experimental groups.  Cell nuclei are stained dark violet, and IGF-1 staining is 
brown.   Single cells are stained at day 1 and cell clusters with staining around them are 
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Figure 4.14. Type II collagen immunohistochemistry staining at days 1 and 8 for control 
and IGF-1 delivered experimental groups.   Cell nuclei are stained dark violet, and Type 
II Collagen staining is brown.  Deep zone staining at day 8 with IGF-1 delivery appears 






 To successfully engineer all three cartilage zones, the cellular phenotype and 
function of each chondrocyte subpopulation must be fully understood.  Additionally, the 
response of subpopulations to delivered growth factors must be known if they are to be 
used to enhance extracellular matrix production.  Only a handful of studies have 
investigated the gene expression of articular chondrocytes subpopulations with delivered 
growth factors. [96, 169-172, 176]  These studies have identified trends in growth factor 
delivery, but have mainly been performed on chondrocytes in monolayer.  It has been 
demonstrated that in two-dimensional culture chondrocyte subpopulations lose their 
phenotype and converge to a homogenous population expressing and producing little 
matrix proteins and high levels of type I collagen. [152, 157]  Therefore, information 
about how growth factors affect zonal chondrocytes in three-dimensional culture is 
critical.  Monolayer studies indicate that IGF-1 can improve mechanical properties of 
cells from both superficial and middle/deep zone populations, [172] increase gene 
expression for aggrecan and type II collagen in middle/deep zone populations, and 
increase SZP gene expression in superficial cell population. [96]  The one known such 
study performed in three dimensional culture demonstrated that superficial cells 
encapsulated in agarose increased SZP synthesis in response to IGF-1 delivery. [171]  
The aim of this study was to determine subpopulation response to IGF-1 in terms of 
matrix component gene expression, and classify the distribution of IGF-1 and IGF-BP 
expression throughout cell populations.  To meet these aims, gene expression of 
aggrecan, type I collagen, type II collagen, IGF-1, and IGF-BP3 by chondrocyte 
subpopulations both with and without delivery of IGF-1 was examined. 
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 Isolation of subpopulations of bovine articular chondrocytes by methods similar 
to ours have been reported in the literature. [14, 15]  Cell counts and histological 
evidence both support successful isolation of superficial, middle, and deep zone 
chondrocytes.  Cell counts of chondrocytes located from each zone show the highest 
density of cells in the superficial zone, followed by the middle and deep zone, this trend 
is also reported in the literature [15] for explanted cell populations, as well as within 
native cartilage tissue. [2]  Histological evidence also confirms isolation of all three 
cartilage zones, as seen in Figures 4.2 and 4.3. 
 The chondrocyte phenotype is indicated by cellular production of matrix 
components such type II collagen and aggrecan.  Production of type I collagen indicates 
chondrocytes have become more fibroblastic in nature.  While the increased levels of 
mRNA expression of type I collagen at day 8 for all culture groups indicate that cells are 
less phenotypically stable than on day 1, the expression of type II collagen and aggrecan 
at measurable levels throughout the study indicates chondrocytes are still active in 
production of matrix proteins. 
 Furthermore, differences in subpopulation gene expression are maintained 
throughout the study, indicating that stable zonal populations are retained.  Elevated gene 
expression of matrix components by middle and deep zone cells compared to superficial 
cells is evident throughout the study as shown in Figures 4.4 and 4.6 (aggrecan and type 
II collagen fold change).  Several studies have confirmed the elevated production of 
matrix proteins by middle and deep zone cells compared with superficial cells, [11, 12, 
164] and these differences are supported by the tissue’s native extracellular matrix 
composition.  The differences observed between the cell groups are likely a result of both 
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chondrocyte phenotype and zonal chondrocyte phenotype remaining stable in the three-
dimensional environment.  Retention of differences observed in native tissue is 
encouraging for stable culture techniques and manipulation of these cells in tissue 
engineering applications. 
 Endogenous IGF-1 gene expression decreased by tissue depth and by time.  
Superficial cells continuously expressed the highest levels of endogenous IGF-1 followed 
by the middle zone and finally the deep zone.  Conversely, IGF-BP3 expression was 
elevated in middle and deep zone cells compared to superficial zone cells throughout the 
study, and overall expression also decreased with time.  To our knowledge, this is the 
first study to report such distributions.  It is interesting to note that the cell populations 
which express the highest levels of mRNA for ECM components also express lowest 
amounts of growth factor mRNA and highest amounts of growth factor binding protein 
mRNA.  Furthermore, even though superficial zone cells express elevated levels of IGF-1 
mRNA, their matrix molecule mRNA expression is the lowest.  These trends could be a 
result of a disconnect between mRNA expression of IGF-1 and IGF-1 protein available 
for cell binding.  However, there also may be other growth factors or cellular signals at 
play which influencing matrix production.  Quantified investigation of IGF-1 protein 
production, as well as endogenous expression of other major growth factors may provide 
further insight. 
 A concentration of 100ng/mL of IGF-1 was delivered to one group of cell isolated 
from each zone.  The dose of 100ng/mL was chosen based on previous studies in our lab, 
[56] and doses commonly reported in articular chondrocytes studies. [96, 97, 169]  Our 
goal was to investigate how the addition of IGF-1 may affect cells of distinct 
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subpopulations differently.  Significant differences in subpopulation responses were 
observed.  Overall, IGF-1 did not have the expected stimulative effect on expression of 
matrix component, with the exception of the deep zone group on 8 for expression of type 
II collagen.  Within in the same group IGF-1 delivery lowered type I collagen expression 
on days 4 and 8, indicating a stabilizing effect on the chondrocytes phenotype.  
Therefore, it may be likely that IGF-1 is most appropriate for stimulating cell from 
deeper zones of articular cartilage during in vitro culture.  It is unknown why IGF-1 
would be a more effective at stimulating matrix production when acting on cells of one 
zone over another, but other literature appears to indicate this phenomenon as well. [96] 
 In general, IGF-1 delivery decreased or had no significant impact on endogenous 
expression of IGF-1.  This is consistent with previous reports on mixed populations of 
chondrocytes, which report decreased endogenous IGF-1 expression with delivery. [56]  
We hypothesize that as cells sense delivered IGF-1 which is available for cell binding, 
they reduce their endogenous production of the protein.  On day 1 the superficial zone 
cells do not follow this trend, nor do the deep zone cells on day 8, however neither of 
these groups were significantly different than their controls.  Interestingly, the effects of 
IGF-1 delivery on IGF-BP3 expression vary by zone.  Delivery consistently increases 
expression in the middle zone, while expression in the deep zone is decreased until day 8 
where when it increases, and there are no significant effects observed in the superficial 
zone until day 8 where expression in increased.  At day 8 there is an overall trend of 
increasing IGF-BP3 expression during IGF-1 delivery, a trend also supported by previous 
studies in our laboratory. [56]  We hypothesize that with increased IGF-1 available, 
cellular production of IGF-BP3 increases in an effort to utilize the molecule. 
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 Histological staining, Figures 4.9, 4.10, 4.11, and 4.12 do not visually 
demonstrate differences in proteoglycan production between cell groups, but confirm cell 
proliferation and production of proteoglycans.  While aggrecan mRNA expression shows 
significant differences between superficial and middle/deep zone groups, visually these 
differences are not seen in proteoglycan staining.  However, the histology serves to 
confirm proteoglycan production on the protein level. 
 Immunohistochemistry results confirm protein production of IGF-1 and type II 
collagen, as seen in Figures 4.13 and 4.14.  On day 1, single chondrocytes  with staining 
immediately surrounding  the cells are observed.   By day 8 cells have formed clusters 
with staining around and inside the cell clusters.  For type II collagen on day 8 (Figure 
4.14), staining appears most intense in the IGF-1 delivered deep zone group, the same 
group which expressed significantly higher type II collagen mRNA than all other groups 
at this time point.  Here the stain for the protein connects cell clusters and is especially 
pronounced along the bead periphery. 
 The presented techniques inherently have their limitations, which can also affect 
the observed results.  The Ct method for quantifying PCR results presented here is 
depended on consistent expression of the endogenous control gene, GAPDH.  It is also 
important to note that mRNA expression quantifies the gene expression activity of the 
cell, but does not always correlate to protein expression of that gene.  Limitations in our 
hydrogel model potentially include unequal distribution of nutrients (oxygen, FBS, 
delivered IGF-1) to those cells on the periphery of the bead.  Furthermore, use of FBS in 
our experimental media may limit the effects of delivered IGF-1.  Serum-free studies 




 Differences in gene expression of chondrocyte subpopulations are observed 
throughout the study.  Middle and deep zone cells display similar behaviors in terms of 
matrix production and express significantly higher amount of aggrecan and type II 
collagen mRNA compared to superficial zone cells.  IGF-1 expression decreases from 
superficial to middle to deep zone cells, a trend which is consistent throughout the study.  
IGF-BP3 expression is elevated in middle and deep zone cells throughout the study.  
Both IGF-1 and IGF-BP3 expression decrease with time.  Exogenous delivery of IGF-1 
did not have the simulative effects anticipated, but did positively affect phenotype 
retention in deep zone cells.  Furthermore, delivery of IGF-1 generally decreased 
expression of endogenous IGF-1 and had varying effects by zone on IGF-BP3 
expression.  However, by day 8, IGF-1 delivery increased binding protein expression 




5  Matrix Molecule Influence on Chondrocyte Phenotype and 
Proteoglycan 4 Expression by Alginate-Embedded Zonal Chondrocytes 
and Mesenchymal Stem Cells 
 
5.1 Introduction 
 Studies suggest that proteoglycan 4 (PRG4), a large glycoprotein encoded by the 
PRG4 gene, is the critical boundary-lubrication mechanism in articular cartilage. [196]  
Superficial cells secrete elevated levels of PRG4 to provide lubrication at the articulating 
surface. [14]  Middle and deep zone cells are more active in production of collagens and 
proteoglycans, and increased concentrations of matrix components are found with tissue 
depth to provide the strength needed to resist loading. [197, 198] 
 Despite advances, retaining both the chondrocyte phenotype and zonal 
phenotypes during in vitro culture remain challenges.  Monolayer culture results in 
homogenization of subpopulations and loss of chondrocyte phenotype. [101, 152, 158]  
Constructs which support chondrocytes in a three-dimensional environment have shown 
success in retention of chondrocyte phenotype. [11, 12, 164, 199]  However, robust 
retention of zonal chondrocyte phenotype for utilization in clinical treatments remains a 
major unmet challenge. [22, 25, 32]  Cartilage tissue engineering research efforts focused 
on lubrication have resulted in several important findings which highlight the distinct role 
of superficial zone cells and the ability of progenitor populations to secret PRG4.  
Superficial zone cells in culture secrete elevated levels of PRG4 compared to 
chondrocytes of the middle and deep zones, and monolayer culture promotes PRG4 
production in these cells compared to three dimensional culture. [136, 200]  Surface 
motion [201] and ball oscillations [202] on engineering cartilage constructs seeded with a 
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mixed zone population can upregulate PRG4 mRNA expression as well as protein and 
secretion into media.  Additionally, it has been demonstrated that bone marrow 
mensenchymal stem cells, articular chondrocytes (mixed zone population), meniscal 
fibrochondrocytes, [203] and mesenchymal progenitors from the synovium and 
infrapatellar fat pad [204] are all capable of secreting PRG4 in three dimensional culture.  
Bone marrow MSCs were shown to secret up to 10 times as much PRG4 in alginate 
culture than mixed zone chondrocytes or mensical fibrochondrocytes.  However, MSC 
hydrogel constructs had poor ability to localize and utilize PRG4 to improve lubrication. 
[203]  These results highlight the importance of engineering a construct with lubricating 
properties, however the optimal cell population and scaffold environment for achieving 
this goal is yet to be established.  
  Both hyaluronic acid (HA) and chondroitin sulfate (CS) are major components of 
the cartilage ECM and have been implicated in altering chondrocyte proliferation and 
metabolic activity.  CS has been implicated in regulating chondrocyte phenotype, 
intracellular signaling, and cell surface connection to ECM components.  In the literature, 
CS incorporation to collagen and poly(ethylene glycol) based scaffolds stimulated 
chondrocyte matrix production, [164, 196] and CS delivered in culture media increased 
mRNA expression of aggrecan and type II collagen. [205]   
Chondrocytes bind to HA directly via the CD44 receptor on the cell surface.  HA 
has been shown to affect cell proliferation, migration, and differentiation in various 
animal models.  In chondrocyte culture, HA incorporation to poly(ethylene glycol) (PEG) 
based hydrogels stimulated matrix accumulation in superficial zone cells, [164] and when 
delivered in media increased cell proliferation and glycosaminoglycan production. [206]  
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A porous HA-collagen scaffold has been investigated for chondrocyte culture, [207] as 
well as composites of gelatin-HA-CS [208] and collagen-HA-CS. [209]  Each of these 
systems indicate favorable effects on matrix production and chondrocyte phenotype.  We 
hypothesis that CS and HA incorporation to our alginate scaffolds will have varying 
effects by chondrocyte subpopulation on matrix production, cell proliferation, and 
phenotype retention via PRG4 production.   
We further hypothesize that HA and CS addition to alginate scaffolds will 
influence differentiation markers and zonal phenotype markers during stem cell 
chondrogenesis.  While methods for inducing basic chondrogenesis of MSCs are fairly 
well established there is no established method of producing populations of chondrocytes 
with varying morphologies which mimic the superficial and middle/deep zone 
chondrocyte cell populations.  MSC-derived chondrocytes are largely evaluated for their 
potential to secret structural ECM components such as collagens and proteoglycans.  The 
work presented here aims to investigate HA and CS to influence zonal-differentiation of 
MSCs as well as zonal phenotype retention of primary chondrocytes.  We focus on 
manipulating scaffold properties to influence the production of PRG4, a critical 
component of a functional superficial zone cartilage.   
 
5.2 Methods 
5.2.1 Superficial and Middle/ Deep Zone Chondrocyte Isolation 
 Zonal chondrocyte sub-populations were isolated according to a previously 
published laboratory protocol. [198]   Briefly, cartilage plugs (4 mm diameter, 3-6 mm 
height) were harvested from the femoral condyles of 20 week old calves using a Sklar 
115 
 
Tru-Punch disposable biopsy punch (Sklar Instruments, West Chester, PA).  The top 10% 
(0.3 - 0.6 mm) was taken as the superficial zone, and remaining tissue up was defined as 
the middle and deep tissue zones.  Samples were minced, rinsed in Dulbecco’s Modified 
Eagle Medium/Nutrient Mixtures F-12 Ham (DMEM/F12) media (Gibco/Invitrogen, 
Carlsbad, CA), digested in 0.2% collagenase P (Roche, Basel, Switzerland), filtered 
through a 40 µm mesh, and washing again in DMEM/F12 to remove any undigested 
tissue.  A population of mixed zone chondrocytes was also obtained, omitting the zonal 
separation step. 
 
5.2.2 Bone Marrow Stromal Cell Isolation 
 Primary bovine bone marrow tissue was harvested from the tibia 3 week old 
calves.  The tissue was suspended in growth media (Minimal Essential Medium , 
(Gibco/Invitrogen) supplemented with 0.1% penicillin/streptomycin antibiotics and 0.2 
mM of ascorbic acid), filtered through a 70 m mesh, and centrifuged to isolate the cell 
population.  This population was then enriched for mesenchymal stem cells via plastic 
adhesion by plating in monolayer and culture in growth media with 10% fetal bovine 
serum.  After two passages cells were trypsinized (Gibco/Invitrogen) and counted using 
Trypan blue staining and a hemacytometer.  
 
5.2.3 Hyaluronic Acid and Chondroitin Sulfate Addition to Alginate Scaffolds 
 2.0 % control alginate was prepared using protocols previously established by our 
laboratory. [54, 56, 210]  Briefly, alginate solution was prepared by mixing and heating 
alginic acid sodium salt from brown algae (Sigma-Aldrich, molecular weight 80,000-
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120,000 Da, M:G ratio ~1.56, viscosity ≥ 2,000cP ), 0.15 M sodium chloride (Sigma-
Aldrich), and 0.025 M HEPES, sodium salt (J.T. Baker, Phillipsburg, NJ) into deionized 
water (pH 7.4), and then autoclaved for sterilization.  Addition of HA (Sigma-Aldrich, 
MW 1.64x106 Da) and CS (Sigma-Aldrich, MW approximately 45,000 Da) to alginate 
scaffolds were done using protocols previously established by our laboratory. [55]  
Specifically, 2.0% w/v alginate was used as the base polymer, and various concentration 
of CS and HA were added to the liquid alginate solution.  Concentrations were chosen 
based on previous results using HA from our laboratory. [55] as well as reports from the 
literature. [164, 205] HA and CS were added for the following concentrations: 0.1 
mg/mL and 1 mg/mL CS and 0.1 mg/mL, 2 mg/mL, and 5 mg/mL HA.  The solution was 
prepared by mixing and heating alginic acid, CS or HA, 0.15 M sodium chloride, and 
0.025 M HEPES into deionized water.  Final solutions were autoclaved for sterilization.     
 
5.2.4 Cell Encapsulation and Culture 
 Alginate solutions were mixed with the desired cell population (superficial zone 
chondrocytes, middle/deep zone chondrocytes, MSCs) and injected through a 18-gauge 
syringe into continuously stirred 0.1 M calcium chloride (CaCl2) (Sigma-Aldrich).  The 
resulting cellular density was approximately 100,000 per bead, and each spherical bead 
had a diameter of approximately 5 mm (approximately 2 x 106 cells\mL).  Zonal 
chondrocyte populations were cultured in supplemented DMEM/F12 + FBS for 14 days.  
At days 1, 7, and 14 chondrocytes were isolated from the alginate beads by addition of 4 
mL of 0.1 M EDTA for 25 min at 37°C.  The solution was then centrifuged to form a cell 
pellet, which was resuspended in phosphate-buffered saline (PBS) and then used for 
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RNA and DNA isolation.  Culture time was chosen to assess changes in chondrocyte 
subpopulation phenotype, which can happen quickly upon isolation. [157]   MSC 
populations were cultured in serum-free chondrogenic media for 21 days, following 
standard culture time for MSC chondrogenesis. [211]  Chondrogenic media contained; 
high glucose αMEM (Gibco/Invitrogen) + 110 µg/mL sodium pyruvate, 40 µg/mL 
proline, 50 µg/mL ascorbate 2-phosphate, 0.1 µM dexamethasone, 1% ITS +premix (BD 
Biosciences, Bedford,MA), and 10 ng/mL TGF-β3 treatment (R&D systems, 
Minneapolis, MN).   At days 1, 7, and 21 cells were isolated for RNA isolation, and at 
days 14 and 21 beads were fixed for histological preparation. 
 
5.2.5 Histological Preparation 
 At desired time points, alginate beads were recovered and fixed for 3 hr at room 
temperature in 4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO) with 0.1 M sodium 
cacodylate and 10 mM calcium chloride.  Samples were then washed for 24 hr at room 
temperature in 0.1 M sodium cacodylate and 10 mM calcium chloride.  Following 
washing, samples were placed in histological cassettes and dehydrated through a series of 
ethanol washes followed by two Citrisolv (Fisher Scientific) washes.  The samples were 
embedded in paraffin (Paraplat X-tra, Fisher Scientific) and cut into 4 µm sections and 
mounted on a glass slide (Superfrost, Fisher Scientific). 
 
5.2.6 Histochemical Staining 
 Samples were dried at 64°C for two hours, deparaffinized using Citrisolv, and 
rehydrated.  The samples were then rinsed in distilled water and stained using Masson’s 
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Trichrome, Alcian blue, and Sirius red staining solutions. (Poly Scientific, Bay Shore, 
NY).  All samples were viewed under an Axiovert 40CFL light optical microscope 
(Zeiss, Thornwood, NY) and images were captured using SPOTSOFTWARE (Diagnostic 
Instruments, Inc., Sterling Heights, MI) imaging software. 
 
5.2.7 Immunohistochemistry 
 Samples were dried at 64°C for one hour, deparaffinized using Citrisolv and 
rehydrated.  Samples were antigen retrieved using a Tris base and EDTA buffer (pH 8) 
containing TWEEN 20 steamed for 15 minutes in a Sunbeam
®
 vegetable steamer.   
Samples were incubated with PEROXIDAZED1 (Biocare, Concord, CA), an endogenous 
peroxidase blocker, and BackgroundSNIPER1 (Biocare), a blocking reagent.  Samples 
were then stained with an antibody to detect PRG4.  The primary antibody used was anti-
lubricin/PRG4 (rabbit polyclonal antibody, ab28484; Abcam, Cambridge, MA), diluted 
to a working concentration of 4 µg/mL.  The HISTOSTAIN-SP kit (Zymed, San 
Francisco, CA) was used to visualize PRG4 presence by using the horseradish peroxidase 
(HRP)-streptavidin-biotin system.  The complex formation was then detected by a 3,3’-
diaminobenzidine tetrahydrochloride (DAB) chromogen.  Samples were counterstained 
with hematoxylin, dehydrated, cleared in Citrisolv, and covered.  Negative control slides 
were stained using the same protocol, omitting the primary antibody. 
 
5.2.8 Cell Proliferation Quantification 
 Cell proliferation was first measured by Trypan blue staining and cell count using 
a hemacytometer to establish general trends in the mixed zone chondrocyte population, 
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and then by more sensitive DNA quantification to identify differences between zonal 
chondrocyte populations.  
 
5.2.9 DNA Isolation and Quantification 
 Total DNA was isolated using a DNeasy Blood and Tissue Kit (QIAGEN, 
Valencia, CA) and a Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen) was used to 
quantify DNA content.  Samples were excited at 480 nm and evaluated at an emission of 
540 nm using a florescence microplate reader (SpectraMax M5, Molecular Devices, 
Sunnyvale, CA). A standard curve was prepared using known quantities of DNA 
provided by the kit manufacturer, and used to determine DNA/alginate bead.  
 
5.2.10 RNA Isolation 
 Following isolation of chondrocytes from alginate beads, RNA was isolated using 
the RNeasy Mini Kit (QIAGEN).  Total RNA was eluted into 30 µL of RNase free water 
and detected using a NanoDrop ND-1000 Spectophotometer (NanoDrop Technologies, 
Wilmington, DE).   RNA concentrations at 1, 7, 14, and 21 days were all diluted to 
approximately 10 ng/L. 
 
5.2.11 Quantitative Reverse Transcriptase-Polymerase Chain Reaction (qRT-PCR) 
 All isolated RNA was reverse transcribed using a cDNA Archive Kit (Applied 
Biosystems, Foster City, CA), which can convert up to 10g of RNA to cDNA.  cDNA 
was mixed with Universal Master Mix (Applied Biosystems) and oligonucleotide primers 
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and Taqman probes (Applied Biosystems) for the genes of interest as well as a control 
gene.  Table 5.1 shows the sequences for all forward primers, reverse primers, and probes 
used.  Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) was the endogenous control 
gene. The reaction volume was 20 l, and the final concentration of cDNA per reaction 
well was approximately 0.5 ng/L (10 ng per well).  The reaction was conducted on a 
7900HT Fast Real-Time PCR System Prism 7000 sequence detector (Applied 
Biosystems).  The thermal profile followed was 2 min at 50°C, 10 min at 95°C, 40 cycles 
of 15s at 95°C, and 1 min at 60°C.  Gene expressions were analyzed using the 
comparative Ct method.  The day one control alginate samples were used as calibrators in 
all analysis.  Fold changes in gene expression were calculated and are reported as the 
mean RQ values with associated standard deviations (n=3), in accordance with methods 
previously described by our laboratory. [55, 212] 
 
5.2.12 Statistical Analysis 
 Each experiment was performed in triplicate (n=3).  All data was analyzed using 
one-way analysis of variance (ANOVA) and Tukey’s multiple-comparison test to 
determine statistical differences.  A confidence interval of 95% (α = 0.05) was used for 








Table 5.1.  Forward primer, reverse primer, and probe sequences used for GAPDH, Type II 
Collagen, Type I Collagen, Aggrecan, Sox9, and Proteoglycan 4 (PRG4) used for qRT-PCR. 
 
Primer and Probe sequences used for rRT-PCR 
Protein  Sequence 
GAPDH Forward Primer TGCCGCCTGGAGAAACC 
 
Reverse Primer CGCCTGCTTCACCACCTT 
Probe CCAAGTATGATGAGATCAA 
COL2A1 Forward Primer CGGGCTGAGGGCAACA 
 
Reverse Primer CGTGCAGCCATCCTTCAGA 
Probe CAGGTTCACATATACCG 
COL1A1  Forward Primer AGAACCCAGCTCGCACATG 
 
Reverse Primer CAGTAGTAACCACTGCTCCATTCTG 
Probe AGACTTGAGACTCAGCC 
AGC Forward Primer GGGAGGAGACGACTGCAATC 
 
Reverse Primer CCCATTCCGTCTTGTTTTCTG 
Probe CAGGCTTCACCGTTGAG 
SOX9 Forward Primer AACGCCGAGCTCAGCAAG 
 
Reverse Primer ACGAACGGCCGCTTCTC 
Probe TTCAGCAGTCTCCAGAGCTTGCCCA 
PRG4 Forward Primer GAGCAGACCTGAATCCGTGTATT 
 










5.3.1 Matrix Molecule Effect on Zonal Chondrocyte Populations 
 Cell proliferation is observed throughout the study, however no major differences 
are seen between zonal populations or experimental or control alginates.  Figure 5.1A 
shows results from Trypan blue staining in a population of mixed zone chondrocytes, and 
Figures 5.1B and 5.1C show DNA quantification via picogreen assay in superficial and 
middle/deep zone cells respectively.  Figure 5.1 shows proliferation throughout culture 
time for all groups, however no significant differences in proliferation rates between 
experimental and control groups are observed.  
 As shown in Figure 5.2, significant differences are seen between chondrocyte 
populations in expression of proteoglycan 4 mRNA.  Figure 5.2A shows superficial and 
middle/deep zone chondrocyte expression of PRG4 mRNA over a 7 days culture period 
in control alginate.  PRG4 expression remains elevated on days 1 and 7 by superficial 
zone cells, however middle/deep zone cells express significantly lower levels of PRG4 
mRNA on day 1, (15 fold less than superficial zone cells) and no measureable expression 
by day 7.  Superficial zone cell expression of PRG4 mRNA is significantly enhanced by 
addition of matrix molecules.  Figure 5.2B shows PRG4 mRNA expression of superficial 
cells encapsulated in control alginate, and CS and HA-alginate.  A general trend of 
increasing PRG4 mRNA expression with increasing matrix molecule concentration is 
observed.   However, on day 14 expression peaks at 0.1 mg/mL in the CS group and 2 
mg/mL in the HA group, neither of which are the maximum concentrations.  By day 14, 
all but one experimental group are significantly greater than the control alginate group: 
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0.1 mg/mL CS is 3.5 fold greater, 0.1 mg/mL HA 6.5 fold, 2 mg/mL HA 15 fold, and 5 
mg/mL HA 11 fold greater. 
 Expression of chondrocyte phenotype markers by superficial cells were also 
measured.  Figure 5.3 depicts A) aggrecan B) type II collagen and C) type I collagen 
matrix molecule mRNA expression by superficial zone cells in control, HA, and CS-
alginates throughout the culture period.  Aggrecan and type II collagen are both major 
cartilage extracellular matrix components.  Aggrecan expression remains elevated 
throughout the culture period, and on days 7 and 14 select experimental groups show 
greater expression than controls.  On day 7, all groups other than the 2 mg/mL HA groups 
are upregulated over control alginate.   On day 14, trends show increased aggrecan 
mRNA expression with increasing CS concentration.  Although measureable at days 7 
and 14, type II collagen mRNA expression decreases significantly throughout culture 
time, a consistent trend observed with culture of primary chondrocytes even during short 
culture periods.  Type I collagen is a negative marker of chondrocyte phenotype, and its 
expression typically increases with in vitro culture time.  Data shows increases in mRNA 
expression in all groups on days 7 and 14 compared to day 1.   
 Expression of chondrocyte phenotype markers by middle/deep zone cells in 
control, CS, and HA-alginate is seen in Figure 5.4.  At each time point various 
experimental groups upregulate mRNA expression, however no clear trend is discernible.  
Aggrecan expression is seen in Figure 5.4A.  On day 7, a general trend of increasing 
expression with matrix molecule concentration is observed, and 0.1 mg/mL HA and 2 
mg/mL HA groups are 2 and 1.9 fold higher than the control, respectively.  By day 14, 
only 0.1 mg/mL CS is significantly higher than the control (1.4 fold).  In type II collagen 
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mRNA expression (Figure 5.4B) a similar phenomenon is observed.  On day 1 the 2 
mg/mL HA group is significantly higher than control (1.5 fold), on day 7 the 2 mg/mL 
HA group is again significantly greater than the control (3.5 fold), and by day 14 0.1 
mg/mL HA is significantly higher than the control (1.3 fold).  Figure 5.4C shows type I 
collagen mRNA expression of middle/deep zone cells.  Here, trends appear to shift 
throughout the culture period.  On days 1 and 7 there is significant upregulation in the 
higher concentration of HA groups, however by day 14 the 5 mg/mL HA group has 
significantly reduced expression compared to control (8.2 fold).   
 
5.3.2 Matrix Molecule Effect on Chondrogenic Differentiation of Mesenchymal Stem 
Cells 
 Figure 5.5 shows mRNA expression of chondrogenic differentiation markers for 
MSCs encapsulated in control alginate, 1 mg/mL CS alginate, and 5 mg/mL HA alginate.  
The markers indicate chondrogenic differentiation, with early and elevated expression of 
transcription factor Sox9 (Figure 5.5A) and significantly elevated type II collagen 
expression by day 7 (Figure 5.5B).  Type II collagen mRNA expression is upreguated 
significantly from day 1 to day 7 in all groups, indicating the chondrogenic lineage.  By 
day 21, type II collagen expression is lower than day 7, but still significantly elevated 
over day 1.  Matrix molecules have a simulative effect on Sox9 mRNA expression.  On 
day 7 both experimental groups are significantly greater than control (CS group 4 fold, 
HA group 4.6 fold).  On day 21, HA group is significantly great than control (3 fold 




Type I collagen (Figure 5.5C) is a negative marker of the chondrocyte phenotype, 
and PRG4 (Figure 5.5D) is a marker for superficial zone chondrocytes.  Increases in type 
I collagen throughout in vitro culture are often observed in primary chondrocytes, and 
reduction indicates a more stable chondrocyte phenotype.  Here we see a clear trend in 
reduction of type I collagen mRNA in experimental groups.  On day 1, the HA groups is 
2 fold less than the control and the CS groups is 3.5 fold less than the control.  On day 7 
and 21 both experimental groups are statically similar and approximately 2.5 fold and 18 
fold less than the control respectively.  Trends in PRG4 mRNA expression (Figure 5.5D) 
show decreased expression with CS and HA presence.  On day 7 the control group has 
significantly elevated expression (5 fold greater than HA and CS groups), and on days 1 
and 21 the HA groups have significantly lower expressions, at 1.4 fold and 1.3 fold 
respectively.  At every time point HA-alginate downregulates PRG4 mRNA expression. 
 Figures 5.6 and 5.7 show staining for cartilage matrix products by differentiating 
MSCs encapsulated in control and experimental alginates.  Figure 5.6 shows staining by 
Alcian blue for sulfated proteoglycans and Figure 5.7 shows staining for collagen using 
both Masson’s trichrome (Figure 5.7A) and Sirius red (Figure 5.7B).  All stains show cell 
secretion of cartilage matrix products by days 14 and 21, further confirming 
differentiation down the chondrogenic lineage.   
 Finally, Figure 5.8 shows immunostaining for proteoglycan 4 on both days 14 
(Figure 5.8A) and 21 (Figure 5.8B) of differentiating MSCs encapsulated in control and... 
experimental alginates.  Results show negative control slides with only cell staining by 
the hematoxylin counter-stain, confirming all observed staining in other groups was 
antibody bound.  On day 14 more intense staining in observed in both the HA-alginate 
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and CS-alginate groups compared to the control group, particularly around the 
encapsulated cell clusters.  At day 21 similar results are observed, however the CS-



























































































































Figure 5.1. Proliferation by cell count per alginate scaffold via Trypan blue staining and 
hemacytometer count (A), and DNA concentration measured by picogreen assay (B,C).  A) The 
cell population is of mixed zone chondrocytes.  Proliferation is observed in all groups between 
days one and seven, and cell viability is high.  There is no significant difference in proliferation 
rates between experimental and control groups. B) The cell population is superficial zone 
chondrocytes, and C) the cell population is middle/deep zone chondrocytes.  A trend of increasing 














































































Figure 5.2. Expression of PRG4 mRNA by A) superficial zone and middle zone 
cells, and B) superficial zone cells only in experimental alginate groups. A) 
Superficial zone cells express significantly higher levels of PRG4 mRNA at days 
1, and no measurable production by middle/deep zone cells is seen on day 7. 
Superficial day 1 is the calibrator. B) By day 14, a trend of increasing PRG4 
expression with incorporated matrix molecules is observed. Control alginate day 
1 is the calibrator. A symbol indicates a group is significantly different than other 
the group within the time point.  Groups marked with the same symbol are 
statistically similar to each other, and different from others in the time point.  













































































































Figure 5.3. Expression of chondrocyte phenotype marker mRNA of superficial zone 
cells encapsulated in control alginate, CS-alginate, and HA-alginate.  A) Aggrecan 
remains elevated, with slight increases in CS and HA-alginate groups on day 7, and 
CS-alginate groups on day 14. B) Type II collagen is downregulated significantly in 
all groups by day 7. C) Type I collagen increases with culture time.  Control alginate 
day 1 is the calibrator.  Star indicates a group is significantly different than all other 






















































































































Figure 5.4. Expression of chondrocyte phenotype marker mRNA of middle/deep zone cells 
encapsulated in control alginate, CS-alginate, and HA-alginate. A) Aggrecan fold change, and 
B) type II collagen fold change.  Varying concentrations of matrix molecules appear to 
upregulate expression profiles on days 7 and 14. C) Type I collagen increases with culture 
time.  By day 14 experimental groups appear to have a stabilizing effect on chondrocyte 
phenotype, as observed by reduction in type I collagen expression.  Control alginate day 1 is 
the calibrator.  A symbol indicates a group is significantly different than all other groups in the 
time point, groups marked with the same symbol are statistically similar and different from 






























































































































Figure 5.5. Expression of chondrogenic differentiation and phenotype markers by MSCs 
encapsulated in control alginate, 1 mg/mL CS-alginate, and 5 mg/mL HA-alginate.  A) 
Experimental groups upregulate Sox9 expression on days 7 and 21, and type II collagen 
expression (B) on day 21.  C) At all time points, experimental groups reduce type I 
collagen expression. D) At all time points HA-alginate significantly downregulates PRG4 
expression.  Control alginate day 1 is the calibrator.  Star indicates a group is significantly 
different than all other groups in the time point.  Means and standard deviations are 







Control                                            HA Alginate CS Alginate
Day 14
Day 21
Figure 5.6. Histochemical staining of differentiating MSCs encapsulated in 
control, CS and HA alginate.  Alcian blue stain for sulfated proteoglycans is 
shown.  Cells appear as pink, cell nuclei darker pink, the alginate is stained a 
dark blue, and the sulfated proteoglycans secreted by the cells are stained 
lighter blue.  Secreted molecules are observed around cells or cell cultures 










Control                                             HA Alginate                                        CS Alginate
Day 14
Day 21
Control                                             HA Alginate                                        CS Alginate
Day 14
Day 21
Figure 5.7. Histochemical staining of differentiating MSCs encapsulated in 
control, CS, and HA alginate.  Both stains detect collagen.  Figure 5.7A is 
Masson’s trichrome stain (cells are stained dark violet and collagens are stained 
blue) and Figure 5.7B is Sirius red stain (cells are dark brown and collagen is red).  
















Control                                       HA Alginate                                    CS Alginate                     Negative Control
Day 14
Day 14
Control                                       HA Alginate                                    CS Alginate                     Negative Control
Day 21
Day 21
Figure 5.8. Immunostaining for proteoglycan 4 (PRG4) secreted by 
differentiating MSCs in control, CS, and HA alginate.  Negative control group 
shows staining omitting primary antibody.  Figure 5.8A shows day 14 images 
and Figure 5.8B shows day 21 images.  PRG4-specific staining is observed, and 





 Proteoglycan 4 (PRG4), also called lubricin, [213] superficial zone protein, [171] 
megakaryocyte stimulating factor (MSF) precursor, [171] and camptodactyly-
arthropathy-coxa vara-pericarditis (CAPC) protein [214] are homologous lubrication 
proteins which are encoded by the PRG4 gene.  Here we refer to these lubricating 
proteins as PRG4, recognizing that slight differences do exist.  In the present study we 
confirm that alginate-encapsulated superficial zone chondrocytes produce PRG4 mRNA 
throughout the culture period, and present the novel finding that production can be 
upregulated by HA and CS.  Middle/deep zone chondrocytes express limited PRG4 
mRNA in culture, and none by day 7.  Further, bone marrow derived MSCs express 
PRG4 mRNA during chondrogenic differentiation, and this expression is reduced by HA 
and CS.  These findings have useful applications for regenerating functional superficial 
zone cartilage tissue and full thickness cartilage with zonal organization and cellular 
phenotype.     
 The protein encoded by the PRG4 gene plays a critical role in biochemical 
lubrication. [196]   While boundary lubrication and the exact function of PRG4 are 
complex and not fully understood, it is known that PRG4 interacts with hyaluronic acid 
(HA) [215] both in synovial fluid [216] and on the surface of articular cartilage, [217] 
and that the complex significantly contributes to joint lubrication. [218, 219]   The 
presented work examines the important relationship between HA and PRG4 mRNA and 
protein expression in the context of an engineered construct.   
 We demonstrate that both HA and CS can augment mRNA expression of PRG4 
by superficial zone chondrocytes.  By day 14, all experimental groups show greater 
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mRNA expression than the control alginate group.  Peaks in mRNA expression are seen 
at 0.1 mg/mL CS and 2 mg/mL HA, indicating there is an optimum concentration for this 
upregulation which is below the maximum concentrations of 1 mg/mL CS and 5 mg/mL 
HA.  Increased cell adhesion via HA and CS may contribute to changes in cell mRNA 
expression.  Chondrocytes bind to HA via the CD44 cell surface receptor, and previous 
results from our laboratory confirm upregulation of CD44 mRNA and protein production 
by chondrocytes encapsulated in alginate containing HA. [55] 
 We also hypothesize that the PRG4 product will complex with encapsulated HA, 
and that some PRG4 will diffuse from the hydrogels into the culture media, a finding 
previously reported the literature. [203]  A limitation of the presented study is that the 
amount of PRG4 lost to the media was not quantified.  Enhancing the ability of the 
superficial zone to both produce and localize lubricating proteins may aid in reducing 
friction and help repair tissue function following injury or disease.  Previous studies have 
indentified the ability of an engineered construct to localize PRG4 directly correlates with 
lubrication. [203]  Therefore, identifying constructs which can retain the produced PRG4 
will be critical for successful lubrication strategies.    
Despite its critical importance in lubrication and cartilage’s frictional properties, 
there is limited research investigating PRG4 production, regulation, function, and role in 
tissue engineering constructs.  TGF-’s have been shown to stimulate PRG4 production 
in chondrocytes, [170, 171, 220, 221] as well as infrapateller fat pad progenitor cells. 
[222]  MSCs in alginate culture secrete PRG4, [203] however the factors which can 
stimulate or regulate this production are unknown.  The ability of TGF-s to stimulate 
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PRG4 production may be linked to their role in intrinsic cartilage repair mechanisms, as 
they are found to be elevated in both injured and arthritic cartilage. 
 We show here that bone marrow MSCs express PRG4 in the presence of media 
containing TGF-3.  This stimulation can be further modified by incorporation of either 
HA or CS to our alginate scaffolds.  We observed a significant decrease in PRG4 mRNA 
expression in HA-alginate groups at all time points, and a significant decrease in the CS-
alginate group on day 7.  As PRG4 is known to readily diffuse from hydrogels into 
solution, we speculate that entrapment of the protein by either HA or CS triggered the 
encapsulated cell population to reduce PRG4 production.  HA and PRG4 interaction is 
highly likely, as this occurs in native tissue.  Immunostaining results support this 
hypothesis, as more intense antibody-specific staining is observed in both HA and CS-
alginate groups.   
 In addition to affecting superficial zone phenotype, HA and CS also influenced 
MSC chondrogenesis.  We saw a significant reduction in type I collagen mRNA 
expression in both HA and CS groups throughout the study.  These findings are 
consistent with others which indicate that during TGF-β induced MSC chondrogenesis 
additional signals such as growth factors, [223] or encapsulated matrix molecules [75], 
are necessary to reduce type I collagen expression.  HA and CS groups also have elevated 
Sox9 mRNA expression throughout the study, again showing a beneficial effect on 
chondrogenesis.  The large-scale use of HA and CS is considerably more economic than 




 Interestingly, the inverse effect is observed in terms of PRG4 mRNA expression 
between MSCs and superficial zone chondrocyte populations.  As mentioned, inclusion 
of the molecules generally increases mRNA expression in superficial populations and 
decreases expression in MSC populations.  If the cause of reduced gene expression in the 
MSCs is due to entrapped protein presence, it is unclear why superficial cells respond 
differently.  However, as distinct in their expression of PRG4 in normal cartilage tissue 
these cells may respond to matrix signals differently than their middle/deep counterparts 
or a progenitor population.  Significant variation between chondrocyte and MSC PRG4 
production in alginate cultures has previously been reported. [203]       
 Additional differences between cell populations include those observed between 
the superficial and middle/deep zone cultures.  Most notably, PRG4 mRNA expression is 
significantly lower at day one in middle/deep zone cells compared to superficial zone 
cells, and by day 7 undetectable (Figure 5.2).  This trend is consistent with reports in the 
literature of PRG4 production by zonal populations over culture time. [136]  Aggrecan 
mRNA follows roughly the same expression trend in superficial and middle zone 
cultures, however, differences are observed in type I and type II collagen mRNA levels 
between populations.  As seen in Figure 5.3, at day 7 there is a sharp decrease in 
superficial zone chondrocyte expression of type II collage mRNA, which correlates with 
a share increase in type I collagen expression.  Comparing to Figure 5.4, middle and deep 
zone chondrocytes express higher levels of type II collagen mRNA throughout culture, 
and the sharp rise in type I collagen mRNA expression is not seen until day 14.  As type I 
collagen is a negative marker for chondrocyte phenotype and type II collagen is a positive 
marker, these results indicate middle/deep zone cells have more robust phenotype 
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retention in hydrogel culture than superficial zone cells.  These results are also consistent 
with reports of elevated mRNA and production of cartilage matrix markers in middle and 
deep zone cells versus superficial zone cells in three dimensional culture. [164, 198]            
 Diffusion, or degradation followed by diffusion, of the entrapped CS and HA 
particles out of the alginate hydrogels during culture is a possibility, as they are not 
covalently bonded to the alginate backbone.  Changes in HA and CS concentration over 
time could account for changes in mRNA expression and PRG4 localization observed 
throughout time points.  Staining for PRG4 appears most intense in the middle of the 
study for the HA group, at day 14 (Figure 5.8), but by day 21 has decreased and appears 
similar to the control.  A reduction in the concentration of HA available for PRG4 
interaction could play a role in this observed change.  Conversely, staining for PRG4 
appears the most intense in the CS group on day 21, suggesting differences between the 
entrapped HA and CS.  Diffusion of acidic proteins out of alginate hydrogels has been 
reported as inversely proportional to their molecular weight.  Acidic proteins are thought 
to minimally interact with the alginate matrix, and molecules which do interact with 
alginate would have longer diffusion times. [224] Due to its large size HA is unlikely to 
readily diffuse, however enzymatic degradation or breakdown of the alginate matrix over 
time would increase diffusivity.  A similar study with a poly(ethylene glycol) diacryate 
polymer backbone utilized a similar method to successfully fabricate PEGDA-HA semi-
interpenetrating networks. [164]  Based on size, diffusion potential of CS is much higher.  
The high net negative charge of the molecule and interaction with cells in native tissue 
also make interactions with cells, cell secreted products, or ions in the hydrogel likely as 
well. [225]   
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5.5 Conclusion  
 In conclusion, superficial zone chondrocyte expression of PRG4 mRNA is 
significantly enhanced through addition of both HA and CS to alginate scaffolds.  
Conversely, PRG4 expression is downregulated by CS and HA in differentiating MSCs, 
possibly due to build up of entrapped protein as PRG4 complexes with HA or becomes 
entangled by CS.  HA and CS induce favorable effects on chondrogenesis though 
upregulation of transcription factor Sox9, and downregulation of type I collagen.  Taken 
together, these results indicate that HA and CS incorporation to alginate scaffolds can aid 
in production of critical lubricating protein mRNA, stabilize differentiating MSCs, and 






6 Zonal Cartilage and Mesenchymal Stem Cell Coculture and 
Conditioned Media Delivery  
 
6.1 Introduction  
Important difference exists between the zones of articular cartilage.  It is 
becoming clear that the superficial zone is distinct from the middle and deep zones of the 
tissue both in matrix composition and cellular function.  Here cells are smaller and more 
densely packed than in other zones, and are aligned parallel to the articulating surface.   
Their activity is directly involved in lubrication at the cartilage surface.  Superficial zone 
chondrocytes are the only zonal population to secrete elevated levels of proteoglycan-4, 
[133, 135] a protein which can complex with hyaluronic acid, [215] and is a critical 
component of joint lubrication. [219] 
Due to the important functional differences between cartilage zones, recent 
attention has focused on regeneration of stratified, zonally organized repair tissue. [204, 
226, 227]  However, cell source remains a major challenge for zonal cartilage 
engineering efforts.  Bone marrow derived mesenchymal stem cells (MSCs) are a popular 
potential treatment population for articular cartilage defects.  Typically, MSCs are 
cultured in a micromass or hydrogel and delivered chondrogenic media supplemented 
with transforming-growth factor βs (TGF-βs) and dexamethasone to induce 
chondrogenesis.  Methods for inducing zone-specific chondryctes are yet to be 
established, but growth factor delivery [222] and cues from the scaffold environment 
[227] may aid in guiding progenitor populations to zone-specific cells.   
Here we investigate a novel method of inducing zone-specific chondrocytes from 
MSCs; soluble signals derived from zonal cartilage tissue explants.  While coculture of 
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these two populations has been reported, results have been mixed, and there are no 
reports of zonal coculture models.  A clear trend has not been established on the exact 
influence or the mechanisms of influence between these two cell populations.  Some 
studies report that chondrocyte secreted factors alone can influence the differentiation of 
MSCs.  For example, it was reported that soluble secreted factors from mature cartilage 
explants were able to upregulate Sox9 gene expression and type II collagen synthesis in 
MSCs.  However, type II collagen gene expression was not upregulated in the MSC 
population and the authors indicate the possibility that the increase in collagen synthesis 
could have been from the cartilage explants themselves.  Cartilage explants were shown 
to secret TGF-β for up to 14 days, and upregulation of VEGF-164α, MMP-13, TIMP-1, 
and TIMP-2 was detected in the culture media, but it is not known which cell population 
they originated from. [228]  Additional studies report that soluable factors derived from 
chondrocytes were able to upregulate chondrogenic markers and matrix production by 
MSCs, [229, 230] and reduce hypertrophic markers in MCSs. [228, 231]  Growth factors 
such as IGF-1, BMPs, and TGF-βs were detected in chondrocyte conditioned media and 
indentified as necessary for the upregulation of type II collagen gene and protein 
expression. [229]  Secreted factors from osteoarthritic chondrocytes were also able to 
induce chondrogenesis in MSCs and downregulate markers of hypertrophy. [232]  
However, there are also studies which report direct contact culture of MSCs and 
chondrocytes resulted in MSC differentiation, but secreted factors from chondrocytes did 
not. [233, 234]         
Conflicting results are also reported on the effects of MSCs and chondrocytes 
cultured together in micromass or in hydrogels.  Some studies report a direct benefit of 
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coculture on MSC chondrogeneis. [233-236]  However, from these studies it is not 
always clear which population is upregulated in gene and protein expression of 
chondrogenic markers.  Several studies which have cultured MSCs and chondrocytes of 
different species together noted that while there was upregulation of matrix products and 
gene markers in the recovered cell population, that these were the result of chondrocyte 
– not MSC activity. [237, 238]  Similarly, micromass coculture of human MSCs and 
chondrocytes showed increases in matrix accumulation was likely from chondrocytes, 
and that the MSCs which did undergo chondrogenesis also underwent hypertrophy. 
[239]  While the two cell populations definitely influence each other, from current 
reports it is unclear if MSCs are primarily responsible for upregulating the chondrocyte 
phenotype in the chondrocyte population, or if chondrocytes are primarily responsible 
for inducing chondrogenesis in the MSC population – or both.  Also unclear, is the 
extent to which MSCs undergo hypertrophy in coculture models, and if chondrocyte 
secreted factors alone can guide MSC behavior. 
In the presented work we aim to establish the potential of zonal cartilage-derived 
soluble factors to drive zonal differentiation of MSCs.  We investigate both a coculture 
model and a conditioned media model to assess the impact of communication between 
cell populations.  Due to the distinct phenotype and function of superficial zone 
chondrocytes, we hypothesize signals derived from this group will have a unique effect 
on the differentiation of MSCs.  The goal of the presented study is to identify culture 





6.2 Materials and Methods 
6.2.1 Superficial and Middle/ Deep Zone Explant Section Isolation 
 Zonal chondrocyte explants were isolated according to a previously published 
laboratory protocol. [198]  Briefly, cartilage plugs (4 mm diameter, 3-6 mm height) were 
harvested from the femoral condyles of 20 week old calves using a Sklar Tru-Punch 
disposable biopsy punch (Sklar Instruments, West Chester, PA).  The top 10% (0.3 - 0.6 
mm) was taken as the superficial zone, and remaining tissue up was defined as the middle 
and deep tissue zones.  Any subchondral bone was removed, samples were minced, 
rinsed twice in Dulbecco’s Modified Eagle Medium/Nutrient Mixtures F-12 Ham 
(DMEM/F12) media (Gibco/Invitrogen, Carlsbad, CA), and placed in a six well plate for 
coculture. 
 
6.2.2 Bone Marrow Stromal Cell Isolation 
 Primary bovine bone marrow tissue was harvested from the tibia 3 week old 
calves.  The tissue was suspended in growth media (Minimal Essential Medium , 
(Gibco/Invitrogen) supplemented with 0.1% penicillin/streptomycin antibiotics and 0.2 
mM of ascorbic acid), filtered through a 70 m mesh, and centrifuged to isolate the cell 
population.  This population was then enriched for mesenchymal stem cells (MSCs) via 
plastic adhesion by plating in monolayer and culture in growth media with 10% fetal 
bovine serum.  After two passages cells were trypsinized (Gibco/Invitrogen) and counted 





6.2.3 Cell Encapsulation and Coculture 
 Alginate solution was mixed with isolated MSCs and injected through an 18-
gauge syringe into continuously stirred 0.1 M calcium chloride (CaCl2) (Sigma-Aldrich).  
The resulting cellular density was approximately 100,000 per bead, and each spherical 
bead had a diameter of approximately 5 mm (approximately 2 x 106 cells\mL).  Control 
beads were cultured in serum-free chondrogenic media made of;  high glucose αMEM 
(Gibco/Invitrogen) + 110 µg/mL sodium pyruvate, 40 µg/mL proline, 50 µg/mL 
ascorbate 2-phosphate, 0.1 µM dexamethasone, 1% ITS +premix (BD Biosciences, 
Bedford,MA), and 10ng/mL TGF-β3 treatment (R&D systems, Minneapolis, MN).  
Coculture groups were set up with either superficial or middle/deep explants chips in the 
bottom of a six well plate, a transwell membrane  placed in the well, and alginate beads 
containing MSCs on top of the membrane.   See Figure 6.1 for illustration of coculture 
experimental set up.  Each group cocultured with superficial or middle/deep explants 
chips was delivered chondrogenic media with or without 10ng/mL TGF-β3.  At days 1, 7, 
and 21 MSCs were isolated from the alginate beads by delivery of 0.1 M EDTA for 20 
min at 37°C.  The solution was then centrifuged to form a cell pellet, which was 
resuspended in phosphate-buffered saline (PBS) and used for RNA extraction.  At days 7 
and 21 beads were fixed for staining. 
 
6.2.4 Conditioned Media Incubation and Delivery 
To control for communicate between cell populations a conditioned media study 
was setup with the same experimental groups.  In this setup, zonal explants chips and 
alginate encapsulated MSCs were cultured in separate wells.  Growth factor free 
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chondrogenic media was delivered to zonal explant chips and allowed to incubate for 48 
hours, after which the media was collected, relevant groups were supplemented with 
TGF-β3, and it was delivered to alginate encapsulated MSCs.  See Figure 6.2 for 
illustration of conditioned media experimental set up.   At days 1, 7, and 21 cells were 
isolated for RNA extraction, and at days 7 and 21 beads were fixed for staining. 
 
6.2.5 Histological Preparation 
 At desired time points, alginate beads were recovered and fixed for 3 hours at 
room temperature in 4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO) with 0.1 M 
sodium cacodylate and 10 mM calcium chloride.  Samples were then washed for 24 hr at 
room temperature in 0.1 M sodium cacodylate and 10 mM calcium chloride.  Following 
washing, samples were placed in histological cassettes and dehydrated through a series of 
ethanol washes followed by two Citrisolv (Fisher Scientific) washes.  The samples were 
embedded in paraffin (Paraplat X-tra, Fisher Scientific) and cut into 4 µm sections and 
mounted on a glass slide (Superfrost, Fisher Scientific). 
 
6.2.6 Histochemical Staining 
 Samples were dried at 64°C for two hours, deparaffinized using Citrisolv, and 
rehydrated.  The samples were then rinsed in distilled water and stained using Alcian blue 
and Sirius red staining solutions (Poly Scientific, Bay Shore, NY).  All samples were 
viewed under an Axiovert 40CFL light optical microscope (Zeiss, Thornwood, NY) and 
images were captured using SPOTSOFTWARE (Diagnostic Instruments, Inc., Sterling 




 Samples were dried at 64°C for one hour, deparaffinized using Citrisolv and 
rehydrated.  Samples were antigen retrieved using a Tris base and EDTA buffer (pH 8) 
containing TWEEN 20 steamed for 15 minutes in a vegetable steamer.   Samples were 
incubated with PEROXIDAZED1 (Biocare, Concord, CA), an endogenous peroxidase 
blocker, and BackgroundSNIPER1 (Biocare), a blocking reagent.  Samples were then 
stained with primary antibody to detect PRG4 and type II collagen.  The primary 
antibodies used were anti-lubricin/PRG4 (rabbit polyclonal antibody, ab28484; Abcam, 
Cambridge, MA) diluted to a working concentration of 4 µg/mL, and anti-collagen II 
(ab300, Abcam) diluted to a working concentration of 5 µg/mL .  The HISTOSTAIN-
SP kit (Zymed, San Francisco, CA) was used to visualize PRG4 presence by using the 
horseradish peroxidase (HRP)-streptavidin-biotin system.  The complex formation was 
then detected by a 3,3’-diaminobenzidine tetrahydrochloride (DAB) chromogen.  
Samples were counterstained with hematoxylin, dehydrated, cleared in Citrisolv, and 
covered.  Negative control slides were stained using the same protocol, omitting the 
primary antibody. 
 
6.2.8 RNA Isolation 
 Following isolation of MSCs from alginate beads, RNA was isolated using the 
RNeasy Mini Kit (QIAGEN).  Total RNA was eluted into 30 µL of RNase free water and 
detected using a NanoDrop ND-1000 Spectophotometer (NanoDrop Technologies, 
Wilmington, DE).   RNA concentrations at 1, 7, and 21 days were diluted to 
approximately 10 ng/L. 
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6.2.9 Quantitative Reverse Transcriptase-Polymerase Chain Reaction (qRT-PCR) 
 Isolated RNA was reverse transcribed using a cDNA Archive Kit (Applied 
Biosystems, Foster City, CA), which can convert up to 10g of RNA to cDNA.  cDNA 
was mixed with Universal Master Mix (Applied Biosystems) and oligonucleotide primers 
and Taqman probes (Applied Biosystems) for the genes of interest as well as a control 
gene.  Table 6.1 shows the sequences for all forward primers, reverse primers, and probes 
used.  Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) was the endogenous control 
gene. The reaction volume was 20 l, and the final concentration of cDNA per reaction 
well was approximately 0.5 ng/L (10 ng per well).  The reaction was conducted on a 
7900HT Fast Real-Time PCR System Prism 7000 sequence detector (Applied 
Biosystems).  The thermal profile followed was 2 min at 50°C, 10 min at 95°C, 40 cycles 
of 15s at 95°C, and 1 min at 60°C.  Gene expressions were analyzed using the 
comparative Ct method.  The day one control alginate samples were used as calibrators in 
all analysis.  Fold changes in gene expression were calculated and are reported as the 
mean RQ values with associated standard deviations (n=3), in accordance with methods 
previously described by our laboratory. [55, 212] 
 
6.2.10 Statistical Analysis 
 Each experiment was performed in triplicate (n=3).  All data was analyzed using 
one-way analysis of variance (ANOVA) and Tukey’s multiple-comparison test to 
determine statistical differences.  A confidence interval of 95% (α = 0.05) was used for 
all analysis and means and standard deviations are shown on each figure.   
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Table 6.1. Forward primer, reverse primer, and probe sequences used for GAPDH, Type II 
Collagen, Type I Collagen, Aggrecan, Sox9, and Superficial Zone Protein (SZP) used for qRT-
PCR. 
 
Primer and Probe Sequences used for qRT-PCR 
Protein  Sequence 
GAPDH Forward Primer TGCCGCCTGGAGAAACC 
 
Reverse Primer CGCCTGCTTCACCACCTT 
Probe CCAAGTATGATGAGATCAA 
COL2A1 Forward Primer CGGGCTGAGGGCAACA 
 
Reverse Primer CGTGCAGCCATCCTTCAGA 
Probe CAGGTTCACATATACCG 
COL1A1  Forward Primer AGAACCCAGCTCGCACATG 
 
Reverse Primer CAGTAGTAACCACTGCTCCATTCTG 
Probe AGACTTGAGACTCAGCC 
AGC Forward Primer GGGAGGAGACGACTGCAATC 
 
Reverse Primer CCCATTCCGTCTTGTTTTCTG 
Probe CAGGCTTCACCGTTGAG 
SOX9 Forward Primer AACGCCGAGCTCAGCAAG 
 
Reverse Primer ACGAACGGCCGCTTCTC 
Probe TTCAGCAGTCTCCAGAGCTTGCCCA 
PRG4 Forward Primer GAGCAGACCTGAATCCGTGTATT 
 




















Chondrogenic media +/- TGF-β3
Chondrogenic media +/- TGF-β3
Superficial Zone Cartilage Chips
Middle/Deep Zone Cartilage Chips
Figure 6.1. Schematic of coculture experimental set up.  A) Monoculture MSC 
control, B) superficial zone coculture, and C) middle/deep zone coculture.  
Throughout the groups are referred to as control, S+, S-, M+, or M-.  S/M denotes 
superficial or middle/deep zone coulture and +/- denotes with or without TGF-β3 








































Figure 6.2. Schematic of the conditioned media experimental set up.  A) 
Monoculture MSC control, B) superficial zone conditioned media, and c) 
middle/deep zone conditioned media.  Throughout the groups are referred to 
as control, S+, S-, M+, or M-.  S/M denotes superficial or middle/deep zone 






6.3.1 Zonal Coculture Differentiation of MSCs: Gene Expression 
 Figure  6.3 shows mRNA expression for chondrogenic markers during coculture 
chondrogenesis.  Sox9, a transcription factor which regulates chondrogenesis, is 
expressed throughout the culture period by all groups, as seen in Figure 6.3A.  At day 1 
expression is similar among all groups, and at day 7 all groups are upregulated over day 
1, with the middle/deep zone + TGFβ  (M+) coculture group upregulated 1.4 fold over 
the control group.  By day 21 a shift in pattern in observed.  The control group remains 
elevated, however all experimental groups other than superficial zone – TGF-β3 (S-) are 
significantly downregulated compared to the control.  The S- has the highest Sox9 
mRNA expression, upregulated at 3.4 fold over the control.  
Corresponding to this Sox9 upregulation in the S- group at day 21 is significant 
upregulation in chondrocyte phenotype markers.   Type II collagen and aggrecan are 
major matrix components of articular cartilage and thus mark the chondrogenic lineage.  
Proteoglycan 4, unique to the superficial zone, marks the phenotype of these cells.  In the 
S- group on day 21 type II collagen is upregulated 11.4 fold over the control (Figure 
6.3B), aggrecan 5.6 fold over the control (Figure 6.3C), and proteoglycan 4 1.75 fold 
over the control (Figure 6.3E) - thus indicating that interactions between MSCs and 
superficial zone explants have a favorable effect on chondrogenic differentiation.   
Superficial zone coculture groups at day 7 are also upreguated over control 
groups, again indicating that interactions between superficial zone explants and MSCs is 
beneficial.  In the S+ group, Sox9 expression is upregulated 1.13 fold (not significant), 
type II collagen 50 fold (significant), and aggrecan 1.4 fold (significant) compared to 
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control groups on day 7.  In the S-, type II collagen is significantly upregulated 1.6 fold 
over the control.     
Type I collagen and proteoglycan 4 are markers for chondrocyte, and superficial 
zone chondrocyte phenotype respectively.  At earlier time points (days 1 and 7) groups 
with TGF-β3 delivery show upregulated proteoglycan 4 expression, indicating the growth 
factor is playing a role in its expression.  However, by day 21 the only group with 
elevated expression over the control is the S- group, indicating that exogenous TGF-β3 
delivery is no longer as effective, or some influence of the coculture system has come 
into play.  Type I collagen, a negative phenotype marker, is significantly elevated in all 
experimental groups on days 7 and 21, other than the S- group on day 21 for which it is 
significantly downregulated (1.14 fold compared to the control group), again indicating a 
favorable effect of the S- coculture group on chondrogenesis.           
 
6.3.2 Zonal Coculture Differentiation of MSCs: Protein Production 
 Figures 6.4 and 6.5 show staining for extracellular matrix components at days 7 
and 21 by alginate encapsulated MSCs in control and experimental groups.  Results 
confirm gene expression data and indicate that coculture can cause upregulation of 
chondrogenic protein expression even in the absence of exogenous TGF-β3 delivery.   
Figure 6.4A shows staining by Alcian blue for sulfated proteoglycans.  Here alginate is 
stained dark blue, secreted proteoglycans light blue, and cells pink.  Increases in secreted 
proteoglycan staining are seen on day 21 in all groups.  Figure 6.4B shows staining by 
Sirius red for collagens, again showing increases in staining from days 7 to day 21.  
Major differences between groups are not clear from histological staining, but both 
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Alcian blue and Sirius red appear to have more staining clusters in the control, M+, and 
M- groups compared to both the S+ and S- groups on day 21.   
 Figure 6.5A shows immunostaining for type II collagen and Figure 6.5B 
immunostaining for proteoglycan 4.  Again, the only differences observed for type II 
collagen are in M+ and M- groups with some elevation in staining intensity.   No 
apparent difference is observed between time points for proteoglycan 4 expression, 
perhaps due to the diffusion of protein and lack of accumulation within the hydrogel.         
  
6.3.3 Conditioned Media Differentiation of MSCs 
 Gene and protein expression data demonstrate significantly less robust 
chondrogenesis in all experimental conditioned media groups as compared to a 
monoculture, TGF-β3 delivered control.  This indicates the chondrogenic differentiation 
in experimental groups in the coculture model is dependent on some form of 
communication between the mature chondrocyte and MSC populations.   
 
6.3.4 Conditioned Media Differentiation of MSCs: Gene Expression 
 Figure 6.6 shows chondrogenic mRNA markers over the course of the 
conditioned media study.  All experimental groups are downregulated compared to a 
control delivered chondrogenic media supplemented with TGF-β3.  There is decreased in 
Sox9 mRNA expression in all experimental groups at all time points compared to the 
control, and at day 21 the control is significantly greater than all experimental groups.  
There is also a trend of decreased Sox9 expression between groups which did not 
received TGF-β3 delivery.  However, even in experimental groups supplemented with 
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TGF-β3 delivery Sox9 expression levels are still not restored to control values.   
Following the same trend, the expression of type II collagen is significantly reduced in all 
experiment groups as compared to the control at days 7 and 21, indicating a lack of the 
chondrocyte phenotype.  At both later time points there are no significant differences 
between type II collagen experimental groups and the control is on average 236 fold and 
47 fold greater than the experimental groups on days 7 and 21 respectively.  Aggrecan 
expression follows the same trend, however, with a less dramatic decline in experimental 
groups.   
 Differences between coculture and conditioned media experiments are also 
observed in phenotype markers proteoglycan 4 and type I collagen expression, as seen in 
Figure 6.6D and 6.6E.  On day one experimental groups with TGF-β3 delivery express 
similar or greater, levels of proteoglycan 4 mRNA.  However, by days 7 and 21 
proteoglycan 4 expression is reduced or not detected.  In general type I collagen 
expression is low across experimental groups, with the exception of the superficial 
conditioned + TGF-β3 group at day 21. 
 
6.3.5 Conditioned Media Differentiation of MSCs: Protein Production  
 Protein data supports the gene expression data and shows very little accumulation 
of cartilaginous matrix products – indicating lack of robust and sustained differentiation.  
Figure 6.7 shows histology staining for Alcain blue (6.7A) and Sirius red (6.7B), and 
very few differences are observed between days 7 and 21.  The only group other than the 
control to show clusters of matrix accumulation is the middle/deep zone conditioned + 
TGF-β3 group.  Figure 6.8 shows immunostaining for type II collagen (6.8A) and 
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proteoglycan 4 (6.8B), again very little matrix accumulation is seen and no observable 






























































































































































































Figure 6.3. Chondrogenic differentiation markers by mRNA expression of MSCs 
cocultured with zonal cartilage explant chips.  An “S” indicates coculture with superficial 
zone sections, an “M” with middle/deep zone sections, and a “+” indicates TGF-β3 
delivery.  Control groups are standard chondrogenic differentiation media with TGF-β3.  
A unique mark indicates a group is significantly different than all other groups within the 
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Figure 6.4. Histochemical staining of alginate encapsulated MSCs cocultred with zonal 
cartilage explant chips.  An “S” indicates coculture with superficial zone sections, an “M” 
with middle/deep zone sections, and a “+” indicates TGF-β3 delivery.  Control groups are 
standard chondrogenic differentiation media with TGF-β3.  A) Alcian blue stain for 
sulfated proteoglycans.  Cells appear as pink, the alginate is stained a dark blue, and the 
sulfated proteoglycans secreted by the cells are stained lighter blue. B) Sirius red stain, 
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Figure 6.5. Immunostaining of alginate encapsulated MSCs cocultured with zonal 
cartilage explant chips.  An “S” indicates coculture with superficial zone sections, an “M” 
with middle/deep zone sections, and a “+” indicates TGF-β3 delivery.  Control groups are 
standard chondrogenic differentiation media with TGF-β3.  A) Staining for type II collagen 
specific antibody, B) staining for proteoglycan 4 specific antibody.  Negative control group 





































































































































































Figure 6.6. Chondrogenic differentiation markers by mRNA expression of MSCs cultured 
in zonal cartilage explant conditioned media.  An “S” indicates delivery of superficial zone 
conditioned media, an “M” with middle/deep zone conditioned media, and a “+” indicates 
TGF-β3 delivery.  Control groups are standard chondrogenic differentiation media with 
TGF-β3.  A unique mark indicates a group is significantly different than all other groups 
within the time point, groups with the same mark are statistically similar.  Means and 
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Figure 6.7. Histochemical staining of alginate encapsulated MSCs cultured in zonal 
cartilage explant conditioned media.  An “S” indicates delivery of superficial zone 
conditioned media, an “M” with middle/deep zone conditioned media, and a “+” indicates 
TGF-β3 delivery.  Control groups are standard chondrogenic differentiation media with 
TGF-β3.  A) Alcian blue stain for sulfated proteoglycans.  Cells appear as pink, the 
alginate is stained a dark blue, and the sulfated proteoglycans secreted by the cells are 
stained lighter blue. B) Sirius red stain, cells are dark brown and collagen is red.  All scale 
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Figure 6.8. Immunostaining of alginate encapsulated MSCs cultured in zonal cartilage 
explant conditioned media.  An “S” indicates delivery of superficial zone conditioned 
media, an “M” with middle/deep zone conditioned media, and a “+” indicates TGF-β3 
delivery.  Control groups are standard chondrogenic differentiation media with TGF-β3.  
A) Staining for type II collagen specific antibody, B) staining for proteoglycan 4 specific 
antibody.  Negative control group shows staining omitting primary antibody.  All scale 




 Cuculture results show upregulation of chondrogenic markers thoughout the 
study.  At the day 7 time point the superficial zone coculture group with TGF-β3 
supplementation (S+) has higher mRNA expression than the control for all chondrogenic 
markers; Sox9 (1.1 fold greater), type II collagen (40 fold greater), aggrecan (1.4 fold 
greater), and proteoglycan 4 (2 fold greater).  By day 21 the superficial zone coculture 
group without TGF-β3 supplementation (S-) has significantly greater expression of 
chonrogenic markers than all other groups, with Sox9 expression 3.3 fold greater than 
control, type II collagen 4 fold, aggrecan 1.4 fold, and proteoglycan 4 1.7 fold greater 
than control mRNA expression.  These results show a clear trend of more robust 
chodrogenesis in groups cocultured with superficial zone cartilage explants.  Although 
middle/deep zone coculture groups express similar levels of markers on days 1 and 7, by 
day 21 this expression has decreased considerably in all groups.     
 Cells of the superficial zone are metabolically distinct from those of the middle 
and deep zones, [152, 158, 198] so variation in their influence over a progenitor 
population is not surprising.  The most established and understood difference between the 
superficial zone and deeper tissue zones is the production and presence of the lubricating 
protein proteoglycan 4, which is critical for boundary mode lubrication at the articulating 
surface. [133-136]   Recent evidence also supports another major difference between the 
top layers of articular cartilage tissue and the lower layers; the presence of a progenitor 
cell population. [145, 185, 225, 240, 241]  Traditionally cartilage was considered a 
homogenous tissue, with little to no cell turn over, no progenitor population, and no 
appositional growth.  This view was challenged with identification of a Notch-1 positive 
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colony forming population, with high expansion potential and phenotype plasticity within 
the superficial zone. [145]  Additional studies have identified a side population within the 
superficial zone that is Hoechst 3342 excreting, marking the stem cell phenotype. [185, 
240]   
 While the presence of a progenitor population within articular cartilage has now 
been independently reported by several groups, the relative percentage of progenitor cells 
and the precise distribution has not been determined.  It seems clear that the superficial 
zone is enriched for such a population, but to what extent in unclear.  A 2009 study 
reported over 45% of cells throughout the tissue depth stained positive for the stem cell 
markers Notch-1, Stro-1, and VCAM (CD106), with increased staining for all in the 
superficial zone.   However, when the authors used the Hoechst3342 dye and FACS 
analysis a side population of only 0.14% of the total population was found, [240] which 
is consistent with a previous side population report of 0.1% of the total cell population, 
and found only in the superficial zone. [185]  A recent study in 2011 reported 16% of 
cartilage cells were positive for mesenchymal stem markers CD105 and CD166.  The 
same study reported that 40% of superficial zone cells were positive for CD166, 39% of 
middle zone cells were positive for CD166, and 10% of deep zone cells were positive. 
[241]  At present it is unclear what the relative percentage of stem/progenitor cells is and 
exactly where that population is zonally distributed.  It has been hypothesized that both 
that the progenitor population is much higher than originally thought, and that mature 
chondrocytes may be positive for some stem cells markers and thus distort the detected 
progenitor numbers.  In either case, results support that the superficial zone contains the 
highest relative percentage of a progenitor population as compared to other zones.  A 
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stem cell niche within the superficial zone, with distinct chondoitin sulfate sulfation 
motifs which play a role in controlling signaling molecule availability, has also been 
reported which further supports this evidence. [225]      
 From the results of our coculture study it is also clear that the superficial zone is 
able to provide distinct signals to differentiating MSCs which result in expression of 
chondrogenic markers, and even the superficial zone chondrocyte marker, proteoglycan 
4.  The gene expression pattern of the superficial zone coculture induced chondrogenesis 
is more robust than the pattern observed for the standard chondrogenic control media.    
As evidence now supports a population of stem/progenitor cells within the superficial 
zone, stem cell differentiation may be a normal biological process within this zone, and 
thus signals derived from it provide favorable signals for chondrogenesis.  What is not 
clear from our data is the source, or identity, of the soluable factors which induce 
chondrogenesis in the superficial zone coculture groups.  As the explanted tissue would 
contain both a superficial zone chondrocyte population and the reported progenitor 
population it is not clear which population influenced alginate encapsulated MSC 
differentiation.  In terms of responsible soluble factors, TGF-β1,2,3 are reported at 
elevated levels in superficial zone tissue, [242] and previous studies in our laboratory 
show superficial zone cells in alginate culture express significantly higher levels of IGF-1 
mRNA as compared to cultured middle and deep zone cells. [243]  Bone morphogenetic 
proteins (BMPs), along with other signaling molecules, are also likely to play a key role.    
 Our results also show that the chondrogenesis induced by the coculture groups is 
dependent on communication between the explanted tissue cell populations and the 
MSCs, as evidenced by the conditioned media study.  Here we show that the 
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chondrogenesis seen the coculture study is not induced unless the groups are cultured in 
proximity to each other.  This provides the hypothesis that there is critical communication 
between cell populations within the superficial zone that allows for progenitor cell 
maintenance and differentiation.  
Also of note is the upregulation of proteoglycan 4 mRNA expression at early 
time points by groups which received TGF-β3 delivery in both coculture and conditioned 
media studies.  This is consistent with other reports that TGF-β delivery, along with BMP 
delivery, can upregulate proteoglycan 4 (superficial zone protein) expression in bovine 
progenitor cell populations derived from the superficial zone of articular cartilage, [185, 




 In the presented study we demonstrate that cartilage explants from the superficial 
and middle/deep zones of articular cartilage are able to induce MSC chondrogenesis 
through soluble signaling factors to varying degrees.  The most robust differentiation is 
observed in the superficial zone coculture group, even without exogenous TGF-β3 
delivery.  Superficial zone explants were also able to provide signals which upregulated 
the superficial zone phenotype marker PRG4 in the encapsulated MSC population.  
Furthermore, we show that the coculture induced chondrogenesis is dependent on 
communication between the cell populations.  Conditioned media from the same zonal 
explants was unable to induce chondrogenesis, even when supplemented with exogenous 
TGF-β3.  We provide further evidence of important differences between the zones of 
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articular cartilage and show that signals derived from the superficial zone have a role in 




7 Chondrogenic Differentiation of Mesenchymal Stem Cells 
Encapsulated in Photocrosslinked Alginate and Hyaluronic Acid 
 
7.1 Introduction  
Articular cartilage is a highly organized tissue maintained by the resident 
chondrocytes.  Its function is to provide a low-friction, wear-resistant, and protective 
surface that allows the joint to withstand compressive forces and maintain smooth 
movement. [5, 245]  Chondrocytes are embedded in a matrix of collagen, proteoglycans, 
and glycosaminoglycans. [2, 5]  This network allows for cell adhesion, mechanical 
support, and the transduction of chemical and mechanical signals. [245] 
Cartilage tissue, however, has minimal reparative capabilities due to the decrease 
in chondrocyte metabolism as a result of disease, injury, and age.  This hinders the ability 
of the tissue to repair damage and maintain homeostasis, and can lead loss of tissue 
structure and the development of disease, such as osteoarthritis.  Tissue engineering 
efforts aim to replace lost or damaged cartilage tissue. [2, 5, 33, 245]  An important 
component of tissue engineering is the use of an appropriate biomaterial scaffold.  This 
scaffold provides the framework for tissue to be regenerated and eventually implanted 
into a defect. [246]  
Current cell based treatments use autologous chondrocytes, which present 
problems such as donor site morbidity, and inadequent numbers of recovered 
chondrocytes for transplantation.  Adult mesenchymal stem cells (MSCs) are a potential 
alternative to autologous chondrocytes.  MSCs are easily obtained in many tissues such 
as bone marrow, adipose tissue, and the synovial membrane.  Additionally, they have a 
high proliferation capacity, so a small sample can be cultured into a large population.  
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Chondrogenesis can be induced by the exposing MSCs to transforming growth factor-β 
(TGF-β).  This growth factor is found to upregulate expression of transcription factor 
Sox9 followed by matrix molecules such as type II collagen and aggrecan. [103] 
Tissue engineering scaffolds should provide an environment for the maintenance 
of cell morphology as well as the growth of tissue.  Scaffolds should be biodegradable to 
allow for the biological tissue to eventually replace the artificial scaffold. [247]  
Hydrogels are common scaffolds used for tissue engineering applications.  Like natural 
cartilage tissue, hydrogels have extremely high water content, which allows for nutrient 
and waste transport.  Alginate is a natural polysaccharide derived from brown algae 
containing repeating units of mannuronic and guluronic acid.  In the presence of divalent 
cations, these alginate functional groups form crosslinks that solidify a liquid alginate-
cell solution into a three-dimensional gel structure. Alginate hydrogels have been shown 
to support chondrocyte survival, maintain spherical morphology, and allow for cartilage 
matrix synthesis in vitro. [5, 56] 
Alternative methods for crosslinking alginate hydrogels are being researched for 
more desirable clinical applications.  In this study, the addition of methacrylate groups to 
the alginate polymer chains allows it to undergo free radical polymerization initiated by a 
photoinitiator during UV light exposure.  This forms a covalent crosslink between 
methacrylate groups instead of the ionic crosslink formed by the calcium in non-modified 
alginate. [247]  The main advantage to photocrosslinkable hydrogels is that the 
crosslinking process can be performed in situ.  The liquid alginate-cell solution can be 
injected into the cartilage defect and crosslinked using UV light to fill the irregular shape 
of the injury. [248, 249]  This eliminates the need to fabricate the chondrocyte-embedded 
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hydrogel in vitro and then implant it into the joint using a more invasive procedure.   
Additionally, the ability to match the shape of the defect allows for improved integration 
between the native tissue and the engineered scaffold.  Furthermore, hydrogels formed by 
methacrylated alginate provide the capability to control the mechanical properties, 
swelling ratios, and degradation rates by altering the concentrations of substrate and 
photoinitiator, and the amount of UV exposure. [250, 251]  
There are limitations to the photocrosslinking method.  The procedure exposes 
cells to harmful UV light, chemical photoinitiators, and organic solvents.  Therefore, 
minimal exposure to these elements is ideal for a viable cell system.  A shorter UV 
exposure time and the use of low cytotoxicity photoinitiators can decrease harmful 
cellular effects.  Irgacure 2959 is the primary photoinitiator used for photocrosslinking 
alginate, but it is found that the photoinitiator VA-086 has lower toxicity, and will 
therefore be used in this experimental procedure. [247]  Previous studies on 
methacrylated alginate systems have reported on the mechanical properties of the 
photocrosslinked hydrogels, and the viability of encapsulated cell populations.  There are 
no reports of effects on gene expression profiles, or stem cell differentiation in 
photocrosslinked alginate.  In the presented work we aim to evaluate the potential of 
photocrosslinked alginate systems to support stem cell chondrogenesis as measured by 
gene and protein expression of chondrogenic markers.      
Alginate provides a favorable environment for chondrocyte growth, however 
there are limited site for adhesion and thus may not provide adequate signals for the 
proper synthesis and organization of matrix proteins.  In this experiment, methacrylated 
alginate constructs were created that incorporated hyaluronic acid, a highly prevalent 
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cartilage ECM component.  Hyaluronic acid is a long, unbranched polysaccharide chain, 
which binds a large number of GAG chains, as well as chondrocytes via the CD44 cell 
surface receptor.  Hyaluronic acid has been shown to contribute to the assembly of the 
cartilage matrix, binding growth factors, and controlling cell proliferation.  Hyaluronic 
acid has been shown to cause an increase in cell proliferation and GAG expression by 
chondrocytes in hydrogel culture. [206] Composites of gelatin-HA-CS [208] and 
collagen-HA-CS [209] have also been demonstrated as favorable environments for 
chondrocyte growth.  
In this work, we present methods for encapsulating mesenchymal stem cells into 
photocrosslinked methacrylated alginate with the addition of hyaluronic acid to the 
construct.  We evaluate for the first time the viability of MSCs in photocrosslinked 
alginate, and also MSC chondrogenesis in photocrosslinked alginate with and without 
hyaluronic acid additive.  We hypothesis photocrosslinked alginate will provide a 
favorable and nontoxic environment for chondrogenesis and that HA will influence gene 
and protein markers of the chondrocyte lineage.     
 
7.2 Materials and Methods  
7.2.1 Methacrylated Alginate Synthesis 
Methacrylated alginate was synthesized based on the methods of previous studies. 
[246, 247] Alginic acid (Sigma-Aldrich, St. Louis, MO) was dissolved in deionized water 
to make a 2.5% w/v alginate solution.  The same volume of methacrylic anhydride 
(Sigma-Aldrich) was added to the alginate solution.  For the duration of the reaction, the 
solution was maintained at room temperature and a pH of 7 by adding 5N NaOH 
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dropwise every 3-4 hours.  The reaction was run over a total of 72 hours.  The mixture 
was then poured into ethanol (5x original volume of alginate solution) to precipitate out 
the methacrylated alginate product.  Under the biohood, the ethanol and modified alginate 
solution was vacuum filtered using a Buchner funnel through 5 μm filter paper.  The 
entire filter apparatus was previously sterilized in the autoclave prior to use.  The 
precipitate was recovered wet from the filter and re-dissolved in sterile PBS.  The product 
was precipitated out a second time, spread over a glass dish, and left to dry in the biohood 
for 24 hours.   
 
7.2.2 Bovine Mesenchymal Stem Cell Isolation 
Primary bovine bone marrow tissue was harvested from the tibia 3 week old 
calves.  The tissue was suspended in growth media (α-minimal essential medium 
(Gibco/Invitrogen, Carlsbad, CA) supplemented with 10% penicillin/streptomycin 
antibiotics (Gibco/Invitrogen) and 0.2 mM of ascorbic acid (Sigma-Aldrich)), filtered 
through a 70 m mesh, and centrifuged to isolate the cell population.  This population 
was then enriched for mesenchymal stem cells via plastic adhesion by plating in 
monolayer and culture in growth media with 10% fetal bovine serum.  After two passages 
cells were trypsinized (Gibco/Invitrogen) and counted using Trypan blue staining and a 
hemacytometer.  
 
7.2.3 Hyaluronic Acid Alginate  
Hyaluronic acid (Sigma-Aldrich) was dissolved in PBS to make a 5% w/v 
solution.  The solution was sterile filtered using a 0.22 μm syringe filter.  Under the 
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biohood, previously sterilized methacrylated alginate powder was added to the HA 
solutions to make a 2% w/v alginate solution.  The final solution was filtered through a 
0.8 μm syringe filter.   
 
7.2.4 Cell Encapsulation and Culture 
The photoinitiator, VA-086 (Wako Chemicals), was dissolved in 70% ethanol and 
then added to each of the alginate solutions to make a 1.4% w/v solution.  The MSCs 
were pelleted and mixed with each of the alginate solutions (with and without HA) to 
obtain a cell density of 3x10
6
 cells/mL.  A syringe was used to transfer 2 mL of each cell-
seeded alginate into a 6 well plate.  The plate was then exposed to 5 minutes of UV light 
(365 nm longwave, 2 μW/cm
2
).   Cylindrical sections of the crosslinked alginate were cut 
using a 4 mm Sklar Tru-Punch disposable biopsy punch  (Sklar Instruments, West 
Chester, PA).  The constructs were then washed with PBS and suspended in αMEM with 
10% FBS growth media for viability studies and chondrogenic media for differentiation 
studies.  
For the cell viability tests, non-modified alginate was made using methods 
previously established by our laboratory. [54, 56, 210]  Briefly, alginic acid was mixed 
with 0.15 M sodium chloride (Sigma-Aldrich) and 0.025 M HEPES sodium salt (J.T. 
Baker, Phillipsburg, NJ) in deionized water (pH 7.4) and then sterile filtered using a 0.22 
μm syringe filter.  The alginate solution was mixed into an isolated cell pellet for a 
resulting alginate-cell density of 3x10
6
 cells/mL.  This solution was injected through an 
18-gauge syringe into a 0.1 M calcium chloride (Sigma-Aldrich) bath to form beads.  The 
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beads were stirred in the calcium chloride for 15 minutes and then transferred to αMEM 
with 10% FBS.   
 
7.2.5 Cell Viability and Metabolism 
Before conducting mRNA and histological analyses, cell viability was assessed 
using both LIVE/DEAD® Viability/Cytotoxicity kit (Invitrogen) and MTT (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay on days 1 and 10.  The 
Live/Dead kit was used following the manufacturer’s guidelines.  Tests were performed 
on the methacrylated alginate constructs, the unmodified alginate beads, and a dead 
control.  Samples were incubated with the PBS for 1 hour to diffuse out the media and 
proteins from the constructs.  The PBS was aspirated off of the constructs and 1 mL of 
the Live/Dead solution was added to each well.  The constructs were incubated at room 
temperature in the dark for 45 minutes and then observed under the microscope using 
fluorescent light.   
To assess cell metabolism, MTT analysis was performed on the constructs.  Live 
cells reduce MTT to pigmented formazan which can be solubilized and the absorbance 
can be read on microplate reader.  The hydrogels were transferred to wells so that there 
were three biological replicate wells for each experimental group.  The MTT solution 
(Sigma-Aldrich) equal to 10% of the volume of media was added to each well.  The 
constructs were incubated for 3-4 hours.  The MTT solvent (Sigma-Aldrich) was then 
added directly to the culture in an amount equal to the original culture volume.  The 
constructs were then incubated overnight to allow all of the crystals to dissolve and 
diffuse out of the constructs.  For each sample, 100 μL of the solution was plated into 3 
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wells (96 well plate) so that each group also had three technical replicates.  The 
spectrophotometer was used to measure absorbance at a wavelength of 570 nm, and a 
background absorbance of wavelength 690 nm was subtracted from this value.  The total 
absorbance was then divided by the construct volume to account for the difference in 
construct shape between the experimental and control groups.   
 
7.2.6 Chondrogenic Differentiation  
MSCs encapsulated in photocrosslinked alginate were cultured in serum-free 
chondrogenic media made of;  high glucose αMEM (Gibco/Invitrogen) + 110 µg/mL 
sodium pyruvate, 40 µg/mL proline, 50 µg/mL ascorbate 2-phosphate, 0.1 µM 
dexamethasone, 1% ITS +premix (BD Biosciences, Bedford,MA), and 10ng/mL TGF-β3 
treatment (R&D systems, Minneapolis, MN).  At day 1, 7, 14, and 21 hydrogels were 
exposed to a solution of 20 mg/mL alginate lyase (Sigma-Aldrich) for 30 minutes and the 
cell population was recovered by centrifugation.    
 
7.2.7 RNA Isolation 
RNA was isolated from isolated cells constructs using the RNeasy Mini Kit 
(QIAGEN, Valencia, CA).  Total RNA was eluted into 40 μL of RNase free water and 
detected using a NanoDrop ND-1000 Spectophotometer (NanoDrop Technologies, 






7.2.8 Quantitative Reverse Transcriptase-Polymerase Chain Reaction (qRT-PCR) 
Isolated RNA was reverse transcribed using a cDNA Archive Kit (Applied 
Biosystems, Foster City, CA), which can convert up to 10g of RNA to cDNA.  cDNA 
was mixed with Universal Master Mix (Applied Biosystems) and oligonucleotide primers 
and Taqman probes (Applied Biosystems) for the genes of interest as well as a control 
gene.  Table 7.1 shows the sequences for all forward primers, reverse primers, and probes 
used.  Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) was the endogenous control 
gene. The reaction volume was 20 l, and the final concentration of cDNA per reaction 
well was approximately 0.5 ng/L (10 ng per well).  The reaction was conducted on a 
7900HT Fast Real-Time PCR System Prism 7000 sequence detector (Applied 
Biosystems).  The thermal profile followed was 2 min at 50°C, 10 min at 95°C, 40 cycles 
of 15s at 95°C, and 1 min at 60°C.  Gene expressions were analyzed using the 
comparative Ct method.  The day one control alginate samples were used as calibrators in 
all analysis.  Fold changes in gene expression were calculated and are reported as the 
mean RQ values with associated standard deviations (n=3), in accordance with methods 
previously described by our laboratory. [55, 212] 
 
7.2.9 Statistical Analysis 
Each experiment was performed in triplicate (n=3).  All data was analyzed using 
one-way analysis of variance (ANOVA) and Tukey’s multiple-comparison test to 
determine statistical differences.  A confidence interval of 95% (α = 0.05) was used for 




7.2.10 Histological Preparation 
On days 1, 7, 14, 21, methacrylated alginate constructs were fixed for 4 hours at 
room temperature in 4% paraformaldehyde (Sigma-Aldrich) with 0.1 M sodium 
cacodylate (Sigma-Aldrich) and 10 mM calcium chloride (Sigma-Aldrich).  Samples 
were placed in histological cassettes and then washed for 24 hr at room temperature in 
0.1 M sodium cacodylate and 10 mM calcium chloride.  Samples were dehydrated 
through a series of ethanol washes (40%, 50%, 60%, 70%, 95%, and 100% x 3) for 15 
min each followed by two 15 min washes in Citrisolv (Fisher Scientific) and two 30 min 
washes in paraffin (Paraplat X-tra, Fisher Scientific).  The samples were then embedded 
in paraffin blocks, cut into 4 µm sections, and mounted on a glass slide (Superfrost, 
Fisher Scientific). 
 
7.2.11 Histology Staining 
Samples were dried at 64°C for two hours, deparaffinized using Citrisolv, and 
rehydrated.  The samples were then rinsed in distilled water and stained using Alcian 
blue, Safranin-O and Sirius red staining solutions (Poly Scientific, Bay Shore, NY).  All 
samples were viewed under an Axiovert 40CFL light optical microscope (Zeiss, 
Thornwood, NY) and images were captured using SPOTSOFTWARE (Diagnostic 







Table 7.1. Forward primer, reverse primer, and probe sequences used for GAPDH, Type II 
Collagen, Type I Collagen, Aggrecan, Sox9, and Superficial Zone Protein (SZP) used for qRT-
PCR. 
 
Primer and Probe sequences used for qRT-PCR 
Protein  Sequence 
GAPDH Forward Primer TGCCGCCTGGAGAAACC 
 
Reverse Primer CGCCTGCTTCACCACCTT 
Probe CCAAGTATGATGAGATCAA 
COL2A1 Forward Primer CGGGCTGAGGGCAACA 
 
Reverse Primer CGTGCAGCCATCCTTCAGA 
Probe CAGGTTCACATATACCG 
COL1A1  Forward Primer AGAACCCAGCTCGCACATG 
 
Reverse Primer CAGTAGTAACCACTGCTCCATTCTG 
Probe AGACTTGAGACTCAGCC 
AGC Forward Primer GGGAGGAGACGACTGCAATC 
 
Reverse Primer CCCATTCCGTCTTGTTTTCTG 
Probe CAGGCTTCACCGTTGAG 
SOX9 Forward Primer AACGCCGAGCTCAGCAAG 
 
Reverse Primer ACGAACGGCCGCTTCTC 
Probe TTCAGCAGTCTCCAGAGCTTGCCCA 
PRG4 Forward Primer GAGCAGACCTGAATCCGTGTATT 
 







7.3.1 MSC Viability in Photocrosslinked Constructs 
The Live/Dead Viability/Cytotoxicity Kit determines cell viability by detecting 
intracellular esterase activity (living) with green-fluorescent calcein-AM, and 
compromised plasma membrane integrity (dead) with red ethidium homodimer-1.  With 
both a live (cells in calcium crosslinked alginate) and dead control (cells in calcium 
crosslinked alginate exposed to toxic levels of methanol) for each time point, we can 
confirm the methacrylated alginate constructs maintain living cells.  Based on previous 
research, a methacrylated construct exposed to 5 minutes of UV light with 1.4% w/v VA-
086 concentration can be expected to have 80% cell viability immediately after 
crosslinking. [247]  As shown in Figure 7.1C, the cell viability of the methacrylated 
alginate on day 1 is similar to that of the positive control group with no signs of red 
fluorescence.  The live control appears to have a brighter fluorescent stain due to the 
difference in thickness of the constructs (control is spherical where methacrylated is 
cylindrical).  On day 10, the methacrylated alginate cell viability is not as high as in the 
control alginate group. Figure 7.1F shows that dead cells are present in the scaffold, 
indicated by the red halo, but the majority of the cells in the construct are still alive, 
indicated by the green.  
MTT is able to assess cell viability by measuring relative cell respiratory levels.  
The optical density reading is proportional to the metabolic respiration, and can therefore 
be used as a comparative measurement tool.  As the control construct is a different shape 
than the methacrylated alginate construct, the optical density reading was divided by 
volume to normalize the cell number.  In Figure 7.2, we see that the amount of metabolic 
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respiration for each group is similar on day 1, and the methacrylated alginate group has 
slightly decreased respiration on day 10 as compared to the control group, however there 
is no statistical difference between groups.  Absorbance increased in both groups from 
day 1 to day 10, indicating cell proliferation.  
 
7.3.2  MSC Chondrogenesis in Photocrosslinked Constructs 
Sox9 is a transcription factor which induces chondrogenesis and upregulates type 
II collagen expression.  As seen in Figure 7.3A Sox9 mRNA expression is detected 
throughout the study, however it decreases with time.   Robust chondrogenic induction is 
indicated by sustained and elevated Sox9 gene expression throughout the study period. 
[252, 253] Figure 7.3A indicates poor chondrogenesis, which is further supported by the 
mRNA expression profiles of type II collagen and aggrecan, as seen in Figures 7.3B and 
7.3C.  Type II collagen is upregulated on days 7 and 14, however not to extent that is 
normally observed during robust chondrogenesis. Aggrecan expression also decreases 
with time throughout the culture period.  
 Chondrocyte phenotype markers are shown in Figure 7.4.  Proteoglycan 4 is a 
lubricating protein found at the joint surface and is a marker for the superficial zone 
chondrocyte phenotype.  Type I collagen is a negative marker for the chondrocyte 
phenotype.  Figure 7.4A shows mRNA expression of proteoglycan 4, which again 
decreases with culture time for both control and experimental groups.  Type I collagen 
mRNA expression, Figure 7.4B, also decrease with culture time, a trend which usually 
indicates phenotypically stable chondrocytes. [253, 254]    
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Histological staining shows limited secretion of cartilage matrix products, as seen 
in Figures 7.5-7.7.  Figure 7.5 shows Alcian blue staining where cells are stained light 
pink, and alginate matrix dark blue.  Typically light blue stain indicates negatively 
charged cell-secreted proteoglycans, however here light blue appears to indicate a 
difference in alginate density as there is no matrix accumulation seen around cells or 
groups of cells.  The addition of hyaluronic acid in particular appears to cause a change in 
the scaffolds absorption of Alcian blue stain – with large areas of the scaffold appearing 
lighter blue, indicating fewer negatively charged species.  In Figure 7.6 and Figures 7.7 
very little matrix accumulation is observed.  Figure 7.6 shows Safranin-O staining again 
for negatively charged proteoglycans.  Here the alginate is stained a faint pink, secreted 
proeglycans a darker pink, and cells dark brown.  Figure 7.7 shows Sirius red staining for 
collagens, where cells are stained dark brown and collagen red.  Minimal collagen is 
observed, with some faint staining directly surrounding encapsulated cells.       
 
7.3.3 Hyaluronic Acid Influence 
Little difference is observed between control photocrosslinked alginate groups 
and experimental photocrosslinked groups with hyaluronic acid.  The only trend observed 
is an upregulation in gene markers on day 7 in the HA groups.  Other than Sox9 all gene 
markers are significantly upregulated over the control in the HA group on day 7; type II 
collagen is 5.2 fold higher, aggrecan is 3.26 fold higher, proteoglycan 4 is 2.13 fold 
higher, and type I collagen is 11.77 fold higher.  One day 1, proteoglycan 4 expression is 
also 2.58 fold higher in the HA group than the control.  The only differences in 
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histological staining appear to be due to the presence of HA in the scaffold, as observed 





























Figure 7.1. Live/dead fluorescent staining.  Green fluorescence indicates live cells by 
calcein AM cleavage by cytoplasmic esterases.  Red fluorescence indicates dead cells as 
ethidium homodimer-1 binds with nucleic acids of membrane-compromised cells.   (A) 
Day 1 alginate control, (B) Day 1 alginate dead control, (C) Day 1 methacrylated alginate, 
(D) Day 10 alginate control, (E) Day 10 methacrylated alginate dead control, (F) Day 10 
methacrylated alginate.  After 10 days dead cells are observed in the photocrosslinked 
alginate, as indicated by the red glow, however most cells are alive, as indicated by the 
green staining.  Note that control constructs are thicker and thus have more cells, as they 






































































Figure 7.2.  Cell metabolism by MTT analysis.  Absorbance per 
volume is shows on the y-axis which corresponds to cell metabolic 
rates.  Cells isolated from photocrosslinked methacrylated alginate and 
calcium crosslinked non-modified alginate control.  Methacrylated and 
control alginate constructs vary in shape so the absorbance is 
normalized by the construct volume.  Metabolic rates are comparable 
between control and experimental groups and no statistical differences 




















































































Figure 7.3. Chondrogenic differentiation markers by mRNA expression of MSCs encapsulated 
in photocrosslinked alginate (Control alginate) and photocrosslinked alginate with hyaluronic 
acid (HA alginate).  Control alginate day one is used as the calibrator.  Differentiation markers 
are expressed but fall off over culture time, and by day 21 are significantly reduced.  A unique 
mark indicates a group is significantly different than all other groups within the time point.  



























































Figure 7.4. Chondrocyte phenotype markers of MSCs 
encapsulated in photocrosslinked alginate (Control alginate) and 
photocrosslinked alginate with hyaluronic acid (HA alginate).  
Control alginate day one is used as the calibrator.  Both markers 
generally are reduced with culture time.  A unique mark 
indicates a group is significantly different than all other groups 
within the time point.  Means and standard deviations are 
















Figure 7.5. Alcian blue staining of MSCs encapsulated in control photocrosslinked 
alginate (Control alginate) and photocrosslinked alginate with hyaluronic acid (HA 
alginate).  Cells appear are stained pink, negative charges stain blue, either alginate or 




























Figure 7.6. Safranin O staining of MSCs encapsulated in control photocrosslinked 
alginate (Control alginate) and photocrosslinked alginate with hyaluronic acid (HA 
alginate). Cells are stained dark brown, alginate is stained light pink, and sulfated 




















Figure 7.7. Sirius red staining of MSCs encapsulated in control photocrosslinked 
alginate (Control alginate) and photocrosslinked alginate with hyaluronic acid (HA 






7.4 Discussion  
 In the presented work we have functionalized the alginate polymer with a 
methacrylate group to allow for crosslinking by UV light exposure.  We report high 
encapsulated cell viability after 10 days, and no statistical difference between cell 
metabolism as measured by MTT assay between cells encapsulated in calcium 
crosslinked alginate and modified photocrosslinked alginate.  However, MSC 
chondrogenesis in photocrosslinked alginate, both with and without HA additive, is 
limited and chondrogenic gene markers decrease with time throughout the culture period.  
For robust chondrogenesis Sox9 mRNA expression should remain elevated throughout 
the 21 day culture period, but as seen in Figure 7.3A expression decreases with each time 
point.  Following this trend are decreases in aggrecan and proteoglycan 4 mRNA 
expression with time, and limited type II collagen mRNA upregulation.  The maximum 
type II collagen expression is seen on day 14, where the control group is 26.6 fold greater 
than day one.  This is an order of magnitude below the type II collagen upregulation 
normally observed in our laboratory during MSC chondrogenesis in calcium crosslinked 
alginate.  Reports from the literature cite ranges from 1,000 to 150,000 for type II 
collagen upregulation over day 1 observed throughout differentiation culture – again far 
above what is observed here. [228, 255]  Histological staining confirms limited 
production of cartilage extracellular matrix markers, with little if any observed staining 
for both proteoglycans and collagen.  Taken together, results indicate that while cells 
remain viable in the photocrosslinked alginate, the scaffold does not provide a favorable 
environment for MSC chondrogenesis, even with the addition of hyaluronic acid.   
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 A methacrylated form of alginate which could be crosslinked using a UV light 
source was first reported in 2001.  Physical properties of the resulting hydrogel were 
characterized and reported to be dependent on the degree of methacrylate modification, 
and thus the number of covalent crosslinks. [256]  Since then a handful of studies have 
evaluated cellular viability in methacrylated alginate hydrogels.  A study in 2009 reported 
high viability by live/dead fluorescent staining of bovine chondrocytes encapsulated in 
methacralyated alginate crosslinked using photointiator Irgacure D2959 and cultured for 
7 days. [250]  A study using the same system reported high chondrocyte viability for up 
to 6 weeks and production of glycosaminoglycans (GAGs).  Incorporation of the 
adhesion peptide sequence Arg-Gly-Asp to the methacrylated alginate stimulated both 
chondrocyte proliferation and GAG production. [251]  Interestingly, a 2008 study using 
bovine nucleus pulposus (NP) cells reported that viability was dependent on the degree of 
alginate methacylation; the higher the degree of methacrylation, the lower the viability.  
Viability also decreased with time throughout the study in all methacrylated groups and 
cell encapsulated in groups with the highest degree of methacrylation did not secrete 
characteristic proteoglycans. [246]       
 Harmful effects of methacylated monomers on cell populations have also been 
reported in research for dental materials. [257]  Dental materials are commonly polymers 
which are formed in situ from methacylate acid-based monomers. [258] However, the 
polymerization process is always incomplete and a considerable fraction of methacrylate 
monomers or co-monomers may be released through mechanical stress or enzymatic 
degradation via hydrolyzable ester bonds. [259]  Methacylate monomers have been 
reported to induce both cytotoxic and genetoxic effects. [260]  Specifically, they have 
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been shown to interact with DNA in human lymphocytes, causing single and double-
strand breaks and alterations in DNA bases that were associated induction of apoptosis 
and changes in the cell cycle. [261-263]  In the presented work we hypothesis that 
incomplete crosslinking, and/or esterase activity, may have increased the concentration of 
methacylate monomers over culture time, and resulted in adverse effects on the 
encapsulated cell population.  We hypothesize that methacrylate monomers may have 
interacted with MSCs and caused cellular changes which resulted in limited 
chondrogenic differentiation.  Future studies are necessary to identify the mechanisms of 
action involved in these changes, and potential threshold values below which 
methacrylate monomers may be tolerated by an encapsulated cell population.    
 
7.5 Conclusion 
In agreement with previous studies we report high cell viability and no statistical 
difference in metabolic activity between MSCs cultured in calcium crosslinked alginate 
and photocrosslinked alginate at day 10.  Despite viability, chondrogenesis of the 
encapsulated MSC population was limited. While chondrogenic markers such as Sox9, 
type II collagen, proteoglycan 4, and aggrecan mRNA were detected during culture, most 
markers slowly fell off throughout the culture period.  Type II collagen was upregulated 
to some extent on day 7 and 14, however values were an order of magnitude below what 
is observed in our studies of MSC chondrogenesis in calcium crosslinked alginate.  
Futhermore, by day 21 no type II collagen mRNA was detectable.  Histological staining 
for secreted collagen and proteoglycan confirm poor chondrogenic induction.  Harmful 
effects of the initiator system or photocrosslinking are unlikely to be responsible for the 
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observed cell behavior, as those changes should be seen immediately after the 
photocrosslinking reaction.  Due to incomplete crosslinking and enzymatic activity, it is 
likely that the methacrylate monomer concentration may increase with culture time.  We 
hypothesize that increasing concentrations of the monomer throughout the culture period 
resulted in the limited potential of encapsulated MSCs to undergo chondrogenic 




8 Summary  
 
Functional articular cartilage is dependent on zonal tissue organization and the 
integrated activity of distinct chondrocyte subpopulations.  Chondrocytes of the 
superficial zone maintain the extracellular matrix to resist tension and provide lubrication 
at the joint surface.  The middle and deep zones provide the tissue’s high compressive 
strength.  Proteoglycan 4, a critical lubricating protein, is secreted largely by superficial 
zone cells and is one of the most classified zonal differences.  Despite critical zonal 
differences, there are currently no clinical therapies which aim to regenerate stratified 
articular cartilage.  The overall goal of the presented work was to classify major 
differences in gene and protein expression between isolated zonal chondrondrocyte 
subpopulations, and evaluate the potential of mesenchymal stem cells to differentiate into 
chondrocytes of zonal phenotypes.   
 The first objective was to classify the zonal distribution in gene expression of 
major extracellular matrix components, the growth factor IGF-1 and its extracellular 
binding protein, IGF-BP3, both with and without exogenous IGF-1 delivery.  
Chondrocyte populations of the superficial, middle, and deep zone were isolated and 
cultured separately in alginate hydrogels for 8 days.  Differences in gene expression of 
subpopulations were observed throughout the study.  Middle and deep zone cells were 
similar in terms of matrix production, and expressed significantly higher amounts of 
aggrecan and type II collagen mRNA compared to superficial zone cells.  IGF-1 mRNA 
expression was elevated in the superficial zone, and IGF-BP3 expression was elevated in 
middle and deep zone cells throughout the study.  Exogenous delivery of IGF-1 did not 
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have the simulative effects anticipated, perhaps due to the presence of FBS, but did 
positively affect phenotype retention in deep zone cells.  Furthermore, delivery of IGF-1 
generally decreased expression of endogenous IGF-1.  By day 8, IGF-1 delivery 
increased binding protein expression throughout all zones.  From these findings, middle 
and deep zone cells were determined to be phenotypically similar, and distinct from the 
superficial zone population.  Future studies therefore utilized two isolated populations; 
superficial zone chondrocytes and middle/deep zone chondrocytes.    
The second objective was to identify the potential of hyaluronic acid (HA) and 
chondroitin sulfate (CS) to influence zonal phenotype retention of chondrocyte 
subpopulations as well as zonal-differentiation of mesenchymal stem cells (MSCs).  
Superficial zone cells, middle/deep zone cells, and MSCs were isolated and cultured in 
control alginate, HA-alginate, and CS-alginate.  Cell populations were evaluated for 
chondrocyte phenotype markers, including the lubricating protein proteoglycan 4 
(PRG4). Superficial zone chondrocytes expressed significantly higher levels of PRG4 
mRNA (by day 7 middle/deep zone cell expression was not detectable), and this 
expression was significantly enhanced through addition of both HA and CS to alginate 
scaffolds.  Conversely, PRG4 mRNA expression was downregulated by CS and HA in 
differentiating MSCs, possibly due to build up of entrapped protein. HA and CS had 
favorable effects on chondrogenesis though upregulation of transcription factor Sox9, and 
downregulation of type I collagen.  These results indicate that HA and CS incorporation 
to alginate scaffolds can aid in production of critical lubricating protein mRNA, stabilize 
differentiating MSCs, and sequester lubricating proteins within the scaffold.  Results also 
highlight PRG4 as a marker for the superficial zone chondrocyte phenotype.     
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The third objective was to establish the potential of zonal cartilage-derived 
soluble factors to drive zonal differentiation of MSCs.  We investigated both a coculture 
explant model and a conditioned media explant model to assess the impact of 
communication between cell populations.  Superficial zone explants and middle/deep 
zone explants with and without TGF-β3 were used for both studies.  Results 
demonstrated that cartilage explants from the superficial and middle/deep zones of 
articular cartilage are able to induce MSC chondrogenesis through soluble signaling 
factors to varying degrees.  The most robust differentiation was observed in the 
superficial zone coculture group, even without exogenous TGF-β3 delivery.  Superficial 
zone explants were also able to provide signals which upregulated PRG4 expression in 
the encapsulated MSC population.  Furthermore, results showed that coculture induced 
chondrogenesis is dependent on communication between the cell populations.  These 
results provide further evidence of important differences between the zones of articular 
cartilage and show that signals derived from the superficial zone have a role in guiding 
progenitor cell fate.     
 The fourth objective was to evaluate the viability of MSCs in photocrosslinked 
alginate, and MSC chondrogenesis by TGF-β3 in photocrosslinked alginate with and 
without hyaluronic acid additive.  It was hypothesized that photocrosslinked alginate 
would provide a favorable and nontoxic environment for chondrogenesis and that 
hyaluronic acid would influence gene and protein markers of the chondrocyte lineage.  
Alginate was functionalized with a methacrylate group and photocrosslinked using an 
initiator and UV light source.  Hyaluronic acid was added to experimental groups prior to 
photocrosslinking.  In agreement with previous studies we report high cell viability and 
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no statistical difference in metabolic activity between MSCs cultured in calcium 
crosslinked alginate and photocrosslinked alginate at day 10.  Despite viability, 
chondrogenesis of the encapsulated MSC population was limited. While chondrogenic 
markers such as Sox9, type II collagen, proteoglycan 4, and aggrecan mRNA were 
detected during culture, most markers slowly fell off throughout the culture period.  By 
day 21 no type II collagen mRNA was detectable.  We hypothesize that increasing 
concentrations of the monomer throughout the culture period resulted in the limited 
potential of encapsulated MSCs to undergo chondrogenic differentiation.    
 In conclusion, in an effort to move zonal cartilage engineering closer to clinical 
practice we have classified differences in gene expression of matrix and signaling 
molecules by tissue depth, confirmed PRG4 as a marker for superficial zone cells, 
evaluated scaffold environments to aid in PRG4 expression and localization, and 
demonstrated MSC express PRG4 during TGF-β3 induced chondrogenesis.  We show 
hyaluronic acid and chondroitin sulfate can both enhance PRG4 mRNA expression in 
superficial zone cells during alginate culture, and aid in chondrocyte phenotype retention 
of differentiating MSCs.  We hypothesize hyaluronic acid interacts with cell-secreted 
PRG4 and therefore may be a useful tool in localization of lubricating proteins.  We also 
demonstrate that soluble signals derived from superficial zone explants can drive 
chondrogenesis of alginate encapsulated MSCs and upregulate PRG4 expression when 
the two populations are cultured in proximity.  Taken together these studies highlight the 
importance of modeling the superficial zone as distinct both in function and cellular 





9 Future Directions 
 
 The completed work has provided insight to chondrocyte subpopulation 
phenotype and the ability of MSCs to express zone-specific markers.  These studies have 
also generated new questions and inspiration for future works.   
    We observed that signals derived from superficial zone explants can drive MSC 
chondrogenesis.  We also saw that IGF-1 is secreted at elevated levels by superficial zone 
cells in culture.  The literature reports that the superficial zone contains a progenitor cell 
population.  Many fundamental questions remain unanswered about this population and 
its potential role in tissue repair.  Such as, is progenitor cell chondrogenesis a normal 
function within the superficial zone?  What is the relative ratio of the progenitor 
population to the total cell population?  Do superficial zone chondrocytes secrete 
signaling molecules to drive this differentiation, and if so what are they?  Do the 
progenitor cells secrete molecules which influence chondrocyte activity?  How can we 
stimulate the progenitor population to aid in native tissue repair capacity?  Flow 
cytometry methods could be utilized to isolate and recover a progenitor population from 
superficial zone tissue which could then be studied in vitro.   
 Hyaluronic acid complexes with PRG4 in the body to aid in lubrication, and is 
also a major part of the cartilage extracellular matrix.  We report it can affect gene 
expression of PRG4 in superficial zone cells and influence MSC chondrogenesis.  
However, in our model hyaluronic acid was not covalently bonded to the alginate 
polymer.  Utilizing a scaffold made out of HA, or covalently binding it to the alginate 
network could control for any potential temporal effects of the molecule due to diffusion.  
Furthermore, greater control over the concentration of HA within the scaffold would 
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allow for its cellular effects to be studied with greater control.  Alternate 
photocrosslinking chemistry or a reduction in alginate methacrylatation could also be 
studied to identify a more suitable environment for MSC chondrogenesis in 
photocrosslinked hydrogels.  This will allow for injectable delivery and aid in clinical 
relevance.        
 Finally, there are limited studies investigating dynamic culture conditions for 
chondrogenic differentiation of MSCs.  Our laboratory has recently developed a Tubular 
Perfusion System (TPS) bioreactor, in which a cell population encapsulated in alginate 
beads can easily be cultured in dynamic conditions.  Evaluating the potential of this 
system to enhance chondrogenesis would be of value.  Furthermore, identifying dynamic 
culture parameters which could upregulate zonal phenotype markers, such as PRG4, 
would directly contribute to the goals of the presented work.    
 Current treatment options are limited for damaged or diseased cartilage.  
Osteoarthritis alone affects a large percent of the population, particularly those over 60, 
and can cause chronic pain, severely impacting quality of life.  Cell-based regenerative 
treatment options are limited, and largely result in inadequate fibrocartilage repair tissue.  
Adult stem cell populations hold promise for improving therapies, however their potential 
to date has not been realized.  Any future work which can bring stem cell therapies closer 
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